Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRP,Agouti-related protein,42754,0.25144912375882,0.00487242138067922,0.241899177852688,0.260999069664951,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN1,CCN family member 1,42569,0.324894635842704,0.00703710699020884,0.311101906141894,0.338687365543513,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLR,Low-density lipoprotein receptor,42644,0.366700045775514,0.00421480026844209,0.358439037249368,0.374961054301661,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPL,Lipoprotein lipase,42636,-0.18093717660316,0.0045424125796662,-0.189840305259306,-0.172034047947014,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFGE8,Lactadherin,42611,0.211750978246128,0.00410794883110898,0.203699398537155,0.219802557955102,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPY,Pro-neuropeptide Y,42721,0.328695100378975,0.00600671474286353,0.316921939482962,0.340468261274987,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0842965422528613,0.00214177430393507,0.0800986646171485,0.088494419888574,1.11253692979776e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHR,Growth hormone receptor,40283,0.106240652166476,0.00274072970662162,0.100868821941497,0.111612482391454,2.21713439682762e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADIPOQ,Adiponectin,40539,-0.252665248757041,0.00671891330216776,-0.26583431882929,-0.239496178684792,9.08160925043579e-292
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCG,Pro-glucagon,42346,0.457761212883274,0.0124015263025884,0.433454221330201,0.482068204436347,6.93253957554074e-284
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES1,Liver carboxylesterase 1,42661,0.291723033161284,0.00795718560522817,0.276126949375037,0.307319116947531,1.44305751940671e-280
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.117450265997165,0.00326551904131428,0.111049848676189,0.123850683318141,1.55423501568112e-270
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF9,Protein turtle homolog A,40511,0.291965308765582,0.00809152943941662,0.276105911064325,0.307824706466838,5.78952254594547e-270
NMR metabolomics,X23501.Triglycerides in Large VLDL,FURIN,Furin,42679,0.115028327382637,0.00321089592775337,0.10873497136424,0.121321683401034,1.44307929744622e-268
NMR metabolomics,X23501.Triglycerides in Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.261299451384567,0.00736288378345418,0.246868199168997,0.275730703600137,1.24867664139877e-261
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBC,Inhibin beta C chain,42611,0.140369305903251,0.00405039327542054,0.132430535083426,0.148308076723075,4.0005908524353e-252
NMR metabolomics,X23501.Triglycerides in Large VLDL,F7,Coagulation factor VII,42671,0.102614471694131,0.003071296896666,0.0965947297766661,0.108634213611597,3.26767003590679e-235
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.107678202321026,0.00324954440541079,0.101309095286421,0.114047309355631,1.41024172079206e-231
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.17665228524794,0.00533869192419196,0.166188449076524,0.187116121419356,7.27647060253427e-231
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP1,Neuropilin-1,42705,-0.0910996769859556,0.00275411772504787,-0.0964977477270495,-0.0857016062448618,8.74967945726074e-231
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.134067778216856,0.00408931404189407,0.126052722694744,0.142082833738968,2.62669994419583e-225
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.3846625910962,0.0119399026748473,-0.408064800338901,-0.361260381853499,1.70118634376249e-219
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.134058889971328,0.00419778090295982,0.125831239401527,0.142286540541129,8.26269700735847e-216
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG2,Desmoglein-2,42611,-0.0858875840007878,0.00270820732335761,-0.0911956703545687,-0.0805794976470069,6.53254771391788e-213
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.14650324393016,0.0046785770929805,0.137333232827918,0.155673255032402,7.41884243352191e-208
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN3,Contactin-3,42611,0.0966686932800237,0.00310693178219937,0.090579106986913,0.102758279573134,2.79801887334635e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.251367368429763,0.00808248884861506,0.235525690286478,0.267209046573049,5.72761099597837e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.24529669109113,0.0078928153583745,0.229826772988716,0.260766609193544,8.04601667790385e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.266896177123712,0.0085974393714408,0.250045195955688,0.283747158291736,2.20738550007435e-204
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH,Parathyroid hormone,40182,0.252365479102028,0.00811039104147514,0.236469112660737,0.268261845543319,8.55108747234878e-204
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9,Complement component C9,40532,-0.162460354008466,0.00525037903617584,-0.17275109691937,-0.152169611097561,6.8497152847018e-202
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTR,Transthyretin,40424,0.0769771096754527,0.00250047266980183,0.0720761832426411,0.0818780361082643,7.25311459851869e-200
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.094708927792645,0.00312401445343448,0.0885858594639135,0.100831996121377,4.27914400931297e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.186368265036603,0.00619087321522733,-0.198502376538448,-0.174234153534757,8.70802644323344e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCHE,Cholinesterase,40346,0.0824857914482569,0.0027658142817452,0.0770647954560364,0.0879067874404775,4.18264135454088e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.444760089862349,0.0149664889730623,0.415425771475147,0.474094408249552,6.08525686117558e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLTP,Phospholipid transfer protein,42752,-0.106084877494759,0.00358072216760228,-0.11310309294326,-0.0990666620462589,5.75831777425823e-187
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROC,Vitamin K-dependent protein C,42663,0.0740878485297556,0.00250918774398839,0.0691698405515384,0.0790058565079729,1.01376552100826e-185
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.306845923845552,0.0104208217851154,0.286421113146726,0.327270734544378,1.03533844443577e-184
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.329221119279366,0.0113578750447228,0.30695968419171,0.351482554367023,3.08946707214868e-179
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL23,C-C motif chemokine 23,42676,0.12137886955296,0.00419691745366355,0.11315291134378,0.129604827762141,1.7296223904778e-178
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL27,C-C motif chemokine 27,42636,0.17009271609589,0.00589368061592731,0.158541102088672,0.181644330103107,9.38074818105867e-178
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPM,Carboxypeptidase M,42655,0.0962886456515829,0.00337562590098372,0.0896724188856548,0.102904872417511,8.11837760321328e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS15,Enteropeptidase,42587,0.259418078941512,0.00913129351523284,0.241520743651656,0.277315414231368,1.88651356220427e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.230445745542796,0.0081330411976395,0.214504984795423,0.246386506290169,1.72301917415833e-171
NMR metabolomics,X23501.Triglycerides in Large VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0880044825624915,0.00310150433418414,-0.0940834310574924,-0.0819255340674906,4.87420654477747e-171
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA4,Kallistatin,40342,0.0680307593447388,0.00240025166606045,0.0633262660792603,0.0727352526102173,1.04866644846721e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,APCS,Serum amyloid P-component,40419,0.0963006461104749,0.00340252840402579,0.0896316904385844,0.102969601782365,2.79785021295092e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.096166770230757,0.00345392563826362,0.0893970759797603,0.102936464481754,6.01310071207336e-166
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFM,Afamin,40539,0.0554078828019716,0.0019872285471792,0.0515129148495003,0.0593028507544428,1.55420592875643e-165
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR37,Prosaposin receptor GPR37,42357,0.189702529723369,0.00684517904979782,0.176285978785765,0.203119080660972,2.39939360966796e-164
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.105985803043653,0.00386109831139574,-0.113553555733989,-0.0984180503533177,1.93662740776434e-161
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.207590101828381,0.00767740165798191,0.192542394578737,0.222637809078026,7.13702691047889e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.159247862189551,0.00592465023561953,-0.170860176651365,-0.147635547727737,5.16168579057618e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHBG,Sex hormone-binding globulin,40532,-0.135816497054037,0.00504434625310871,-0.14570341571013,-0.125929578397943,7.87228382057103e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0833699967794697,0.00311640521333475,0.0772618425613336,0.0894781509976058,1.24372763779666e-153
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUSB,Beta-glucuronidase,42711,0.162707222079132,0.0060951343323497,0.150760758787727,0.174653685370538,4.86873237904533e-153
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.157763907337866,0.00593229239924182,0.146136614235353,0.16939120044038,7.91501097634181e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKB,Creatine kinase B-type,40527,-0.159006799581432,0.00604055822291225,-0.17084629369834,-0.147167305464524,2.82274108748404e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.09769118753491,0.00377594060154415,-0.105092031113936,-0.0902903439558834,4.35357042375165e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.145068924274941,0.00559922361913332,0.13409444598144,0.156043402568443,7.88048331534839e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.18013514457402,0.00700519421218482,0.166404963918138,0.193865325229902,2.22843388060575e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA3,Glutathione S-transferase A3,42346,0.197435801654072,0.00767740238513243,0.182388092979212,0.212483510328931,2.44362197108527e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0881284013249522,0.00343634239700839,-0.0948636324230887,-0.0813931702268158,1.06463128208056e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0508708472274754,0.00199041056776002,0.0469696425146658,0.0547720519402851,1.25587620952595e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIP2,Cysteine-rich protein 2,42495,0.0937744148272127,0.00369014369122413,0.0865417331924134,0.101007096462012,3.76485569340157e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.1856558163508,0.00733491232188071,0.171279388199914,0.200032244501686,4.33770004889931e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.068148712357403,0.00269509887757702,0.062866318557352,0.0734311061574539,7.47257091703616e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0833482350920882,0.00332555098408139,0.0768301551632887,0.0898663150208878,1.5725630044404e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFP,Properdin,40539,0.0559871345306131,0.00223796826655058,0.051600716728174,0.0603735523330523,1.69697187445541e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAT,Tissue-type plasminogen activator,42760,0.126898142261258,0.0050871446336294,0.116927338779344,0.136868945743172,2.52422935129808e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.047645331867679,0.00191153786986263,0.0438987176427482,0.0513919460926097,4.4128538552801e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFH,Complement factor H,39956,0.0572990323847591,0.00229410891522769,0.0528025789109128,0.0617954858586054,6.81720770859486e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF21,Fibroblast growth factor 21,42689,0.293392315524112,0.0118097614131393,0.270245183154359,0.316539447893865,2.95166429778956e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.0665342619210538,0.00267728517817794,0.061286782971825,0.0717817408702826,9.76076092749118e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0636417022605298,0.00256938463571453,0.0586057083745294,0.0686776961465303,1.81583005675873e-132
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR3,Anterior gradient protein 3,42326,0.148323674170214,0.00603455234931989,0.136495951565547,0.160151396774881,1.83320958256122e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.128330490478147,0.005224858014811,0.118089768769117,0.138571212187176,2.29831425762289e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCA,Alpha-synuclein,40283,0.28397845848809,0.0115382796416743,0.261363430390408,0.306593486585772,2.83808648392699e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0704727191033994,0.00287062931874548,-0.0760991525681406,-0.0648462856386583,3.09623353408213e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.102236601553468,0.00416887424773324,-0.110407595079025,-0.0940656080279105,5.85595558602478e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO3,Beta-enolase,40223,0.144717895762574,0.00591825403226993,0.133118117859325,0.156317673665823,1.20459961880046e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUMB,Protein numb homolog,40199,0.201160119054207,0.00824089211207619,0.185007970514538,0.217312267593877,3.30821780144501e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.140737837805155,0.00577920124672695,0.12941060336157,0.15206507224874,1.03984643851464e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.179614907703429,0.00743417141848963,0.16504393172319,0.194185883683669,2.99438855438198e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFI,Complement factor I,40539,0.047345354267442,0.00196613221947563,0.0434917351172697,0.0511989734176142,5.31978242330901e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0740027782008486,0.00308245587581053,0.0679611646842599,0.0800443917174372,1.01966281992075e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.0746962894786596,0.00312457393710423,0.0685721245619353,0.0808204543953839,1.00230919496567e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.296052696116685,0.0124257126208129,0.271698299379892,0.320407092853479,6.39949034546326e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.263064409270791,0.0110787234661546,0.241350111277128,0.284778707264454,4.50014328260799e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS1,Protein MTSS 1,40449,0.26678424891372,0.0112191315003874,0.244794751172961,0.28877374665448,5.40064042465101e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.164999796293695,0.0069566022833484,0.151364855818332,0.178634736769058,2.1463525840371e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPIND1,Heparin cofactor 2,40516,0.0669639905885471,0.00282500480498879,0.061426981170769,0.0725010000063251,2.86370125520551e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLA,Alpha-galactosidase A,40267,0.0885326260822642,0.00374238414224168,0.0811975531634705,0.0958676990010579,9.6510957412458e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY1,Aminoacylase-1,42636,0.143929425032308,0.00610379608936627,0.13196598469715,0.155892865367465,1.68734089263974e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPB1,Beta-ureidopropionase,40511,0.212968490018856,0.00903905949549408,0.195251933407687,0.230685046630024,7.25193327070398e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH1,Somatotropin,42613,-0.406931193062285,0.017340994962009,-0.440919543187822,-0.372942842936747,2.24221920684703e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,F9,Coagulation factor IX,42663,0.0427520651103909,0.00182385183472294,0.0391773155143339,0.0463268147064479,3.94312996925016e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL16,C-C motif chemokine 16,42794,0.123660244068944,0.00527654776274126,0.113318210453971,0.134002277683916,4.16600577388213e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.134789713794839,0.00574838557863336,0.123522878060718,0.14605654952896,1.07155839866387e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.130635201692433,0.00559856000647667,0.119662024079738,0.141608379305127,4.93432594917128e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA1,Glutathione S-transferase A1,42611,0.191145263818765,0.00832272237416337,0.174832727965405,0.207457799672126,1.60048495599539e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.194999619406857,0.00848572947469659,0.178367589636452,0.211631649177262,3.53019820934579e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR5,Cadherin-related family member 5,42636,0.0895698161096147,0.00391829612044435,0.0818899557135438,0.0972496765056856,1.69738924204977e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLKB1,Plasma kallikrein,40293,0.0566017628879181,0.00248256617482158,0.0517359331852678,0.0614675925905684,1.72936062340863e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.317114301553941,0.0139192013543692,0.289832666899377,0.344395936208504,2.32407067543241e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0911206307234248,0.0040250985512031,0.0832314375630667,0.0990098238837828,2.21945463423873e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.15526966783527,0.00686330630756079,0.141817587472451,0.168721748198089,3.35129979833764e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTYMK,Thymidylate kinase,40511,0.154805146677825,0.00683938600669807,0.141399950104697,0.168210343250953,5.66019733413977e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.142424161910041,0.00632677566301559,-0.154824642209552,-0.13002368161053,3.53217181683046e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.219191876560962,0.00975029186837709,0.200081304498943,0.238302448622981,6.84464092325882e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0715317679410093,0.00318715369524119,0.0652849466983366,0.0777785891836821,1.45049641110876e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRP,Gastrin-releasing peptide,40223,0.127005739927382,0.00565458934838159,0.115922744804554,0.138088735050209,2.78164061775095e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,F10,Coagulation factor X,40532,0.0640015550637133,0.00286069269970625,0.058394597372289,0.0696085127551375,1.58754614603109e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0556250057042872,0.00250034033890716,0.0507243386400292,0.0605256727685452,1.03433823145555e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.090261983162247,0.00406138354239578,0.0823016714191513,0.0982222949053427,1.69991100207048e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,P4HB,Protein disulfide-isomerase,42563,0.0860708647546248,0.00387312376592798,0.0784795421734059,0.0936621873358436,1.81342010391397e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0617251897018689,0.0027867451889691,0.0562631691314894,0.0671872102722483,8.59496785728264e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.253524556651384,0.0114465962185984,0.231089228062931,0.275959885239837,8.81895969117991e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,FYB1,FYN-binding protein 1,42590,0.205100396777288,0.00928902566095669,0.186893906481813,0.223306887072763,3.81926861282134e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.203370803543964,0.00922066354865448,0.185298302988601,0.221443304099327,6.18193694914222e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJAP1,Tight junction-associated protein 1,42679,0.183445855961994,0.00832234480757524,0.167134060139146,0.199757651784841,8.22941016654997e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOMO1,Nodal modulator 1,42611,0.0515982253482194,0.00234269474340155,0.0470065436511523,0.0561899070452864,1.21814021498522e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRN,"Attractin, Isoform 2",40539,0.0372441923861103,0.00169104693215537,0.0339297403990858,0.0405586443731349,2.66006813589587e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLUL1,Clusterin-like protein 1,42621,-0.0998329324080047,0.00454798413686955,-0.108746981316269,-0.0909188834997404,5.87537816560635e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.266063298156808,0.0121656670348263,0.242218590768549,0.289908005545068,8.06140787351169e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0883481862196068,0.00404779330326797,-0.096281861094012,-0.0804145113452016,8.2160894633905e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH9,Myosin-9,40527,0.252478139954676,0.0115509270831817,0.22983832287164,0.275117957037712,8.96094482578128e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.148936077907599,0.00683999767861728,0.135529682457509,0.162342473357689,6.17297781178843e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,EEF1D,Elongation factor 1-delta,40511,0.199790956296269,0.00921514236997372,0.181729277251121,0.217852635341418,3.67902402499919e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.211582335790034,0.00980289537143469,0.192368660862022,0.230796010718046,1.36427202180172e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,HJV,Hemojuvelin,40482,0.0962114283253577,0.00445622873784302,0.0874772199991854,0.10494563665153,2.4447058019686e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.236328792000675,0.0109545264078878,0.214857920241215,0.257799663760135,3.49539805884553e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0948608592387661,0.00441409345630043,0.0862092360644172,0.103512482413115,9.53511744968914e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES3,Carboxylesterase 3,42587,0.153160582663867,0.00713590150205117,0.139174215719847,0.167146949607887,1.67465121672888e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2AP,CD2-associated protein,42636,0.13815091010251,0.00644096608269472,0.125526616580429,0.150775203624592,2.23710648579143e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.19295910643335,0.00901221577530394,0.175295163513754,0.210623049352946,5.14859772779232e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYAP1,Synapse-associated protein 1,40283,0.123440131996446,0.00577436178629212,0.112122382895313,0.134757881097578,2.16961884520267e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.118441285745424,0.0055558547601089,0.10755181041561,0.129330761075237,3.66452701388172e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORT1,Sortilin,42613,0.0797387511910869,0.00374307671437497,0.0724023208309119,0.0870751815512618,4.61548849052438e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.14362981616835,0.00676114684838533,0.130377968345515,0.156881663991186,1.58859642570812e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.227416858567735,0.0107083902166851,0.206428413743032,0.248405303392438,1.7996929731472e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4R,Reticulon-4 receptor,42721,0.0741176621015501,0.00349282855309206,0.0672717181374897,0.0809636060656105,2.48349489482324e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0480474323127041,0.00226919036289246,0.0435998192014349,0.0524950454239733,6.4838768560404e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0558503150771963,0.00264235277006838,0.0506713036478623,0.0610293265065303,2.71675854190076e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYNU,Kynureninase,42754,0.0950660066943398,0.00450646501507533,0.0862333352647922,0.103898678123887,3.16949538718651e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0500098728453987,0.00238053228926499,0.0453440295584393,0.0546757161323581,2.04103589674973e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11R,Junctional adhesion molecule A,42611,0.118126167172897,0.0056255747667891,0.10710004062999,0.129152293715803,2.40494022975877e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLN,Promotilin,42594,0.189014263318491,0.00900987836049969,0.171354901731912,0.206673624905071,3.59358445628374e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0409617147354257,0.00195854062455556,0.0371229751112968,0.0448004543595546,1.26950820257817e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXLNA,Alpha-taxilin,42495,0.18582993323784,0.00888895642019159,0.168407578654264,0.203252287821415,1.62049294201102e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXT,Oxytocin-neurophysin 1,42711,0.293385160042322,0.0140369326078105,0.265872772131014,0.320897547953631,1.68907950880686e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0672884250232185,0.00322039260218608,0.0609764555229338,0.0736003945235032,1.93657296338934e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.133257122465861,0.0064135189593222,0.12068662530559,0.145827619626133,4.50027569040151e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.165789512509987,0.00798405019481286,0.150140774128154,0.18143825089182,5.11671620221513e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.179663740072565,0.00865336525825148,0.162703144166392,0.196624335978738,5.39042307425208e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXIN1,Axin-1,42594,0.198703560092514,0.00959138459601666,0.179904446284321,0.217502673900706,7.17141071671065e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A4,Protein S100-A4,42679,0.11946252425906,0.00577219680855061,0.108149018514301,0.130776030003819,1.06467803254094e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,BECN1,Beclin-1,40223,0.125411967739553,0.00605191510611704,0.113550214131563,0.137273721347542,1.29676692240764e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.233875484893789,0.0112978450995649,0.211731708498642,0.256019261288936,1.9487374908271e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.111823548861005,0.0054186619905036,0.101202971359618,0.122444126362392,3.67373070338959e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0493467227603454,0.0023936509613732,0.0446551668760539,0.0540382786446369,5.35884424439677e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP5,Retinol-binding protein 5,42587,0.116662933389068,0.00565872264664986,0.105571837001635,0.127754029776502,5.39118454525545e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL16,Pro-interleukin-16,42754,0.0855466324142873,0.00419163812281689,0.0773310216935662,0.0937622431350084,3.25306417687255e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.113742261068687,0.00556531920981776,0.102834235417444,0.12465028671993,3.45501124835199e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN1,Dynactin subunit 1,42721,0.133647742109487,0.00655413282523002,0.120801641772036,0.146493842446938,4.63892962557957e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.172485721440932,0.00850057725165492,0.155824590027689,0.189146852854176,6.67632914872575e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAB2,Stabilin-2,40527,0.0574864429942735,0.00284074008072442,0.0519185924360537,0.0630542935524934,1.76497556154166e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN2,Ficolin-2,42597,0.0842616889867675,0.00417109253311657,0.076086347621859,0.092437030351676,2.03119112844156e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.185855376572916,0.00922526478428181,0.167773857595723,0.203936895550108,5.98231294966922e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.169443529267925,0.00841235342295735,0.152955316558928,0.185931741976921,1.20022842807273e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0814393175167539,0.004044099390458,0.0735128827114562,0.0893657523220515,1.22817228870423e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.164999008697629,0.00822154825366957,0.148884774120436,0.181113243274821,2.63894829003763e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.113661381610996,0.00566276849359167,0.102562355363556,0.124760407858436,2.70916528628113e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.163484090659259,0.008149259516953,0.147511542006031,0.179456639312487,5.47925634082562e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPY,Pancreatic prohormone,42600,0.210820354375153,0.0105281977660024,0.190185086753788,0.231455621996518,6.48466769365662e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS2,Protein MTSS 2,40451,0.19964847931957,0.00997067018822116,0.180105965750656,0.219190992888483,1.14218913568314e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.0982674976215249,0.00492169508203973,0.0886209752607271,0.107914019982323,2.0811536351718e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.129433553137939,0.00649137593334817,0.116710456308577,0.142156649967302,3.58286978378766e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.133467545560596,0.00669558935539779,0.120344190424017,0.146590900697176,3.99852526851187e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.209048740631588,0.0105102724973025,0.188448606536875,0.229648874726301,8.84316696125099e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0576906233284475,0.00290040562796446,0.0520058282976372,0.0633754183592579,9.22031690295786e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZN,Kazrin,40449,0.209333803675841,0.0105412005565916,0.188673050584921,0.22999455676676,2.76181305997474e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.144959456399861,0.00730904816991436,0.130633721986829,0.159285190812894,2.81083571108501e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTD,Biotinidase,40539,0.0412813439965918,0.00208624500515347,0.0371923037864909,0.0453703842066926,1.05692145693735e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0271143765592656,0.00137102686522011,0.0244271639034342,0.029801589215097,1.38410660178925e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0845012234626667,0.00428431337176195,0.0761039692540133,0.0928984776713202,2.19786402584307e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0564856904272891,0.00286286255853928,0.0508744798125521,0.0620969010420261,3.1673374383034e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.0950626354795741,0.00482011097550497,0.0856152179675843,0.104510052991564,3.74951840520706e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.23097183719966,0.0117428986514017,-0.253987918556407,-0.207955755842913,6.18284845095652e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORD,Sorbitol dehydrogenase,42658,0.133250818391362,0.00678917333887426,0.119944038647168,0.146557598135555,1.37868187761483e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.192875796989021,0.00984816191905136,0.17357339962768,0.212178194350362,5.11390480016727e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.107933296754768,0.00552993707601617,0.0970946200857765,0.11877197342376,1.11826717730642e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.060037618243195,0.00307667762022461,0.0540073301075548,0.0660679063788352,1.98918416841735e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPY30,Protein dpy-30 homolog,42651,0.119014932720501,0.00612370145628687,0.107012477866179,0.131017387574823,5.32680779980436e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.042618702129251,0.00219065030457399,0.038325027532286,0.046912376726216,6.34612494598376e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0664140499322213,0.00342008130816,-0.0731174092962149,-0.0597106905682277,7.19921842216892e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0661512058147582,0.00340932896054993,0.0594689210520803,0.072833490577436,9.90946049390197e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPC,C-type natriuretic peptide,42594,0.0989170798748507,0.00510516464330698,0.0889109571739691,0.108923202575732,1.65252623850464e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0602959179553513,0.00311697224345361,0.0541866523581822,0.0664051835525204,2.97179323456298e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYY,Peptide YY,40116,0.201435910428576,0.0104014857662037,0.181048998326816,0.221822822530335,3.5334718449882e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.133342096632006,0.00688958829821956,0.119838503567496,0.146845689696517,4.41975009504801e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREG1,Protein CREG1,42445,0.0755038060291784,0.00392098906191626,0.0678186674678225,0.0831889445905342,1.6171862970911e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.15264088209458,0.00793064885930605,0.13709681033034,0.16818495385882,1.977846877277e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.165327198026173,0.00862105825411982,0.148429923848098,0.182224472204247,7.23626783623696e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.122021602043514,0.00637459237394527,0.109527400990581,0.134515803096447,1.31439033641419e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARF6,ADP-ribosylation factor 6,40449,0.207996609505918,0.010851528626923,0.186727613397149,0.229265605614687,1.32207378487061e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHBP1,EH domain-binding protein 1,40511,0.144021132435587,0.00751548819438598,0.129290775574591,0.158751489296584,1.40844549301988e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEG1,Protein HEG homolog 1,40283,0.0523190462574418,0.00273306781114841,0.0469622333475909,0.0576758591672927,2.17775579309899e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM1,Isthmin-1,42594,0.0748360358101846,0.00391645310332539,0.0671597877276668,0.0825122838927023,2.52055442451782e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.140175074355239,0.00732961069005214,0.125809037402737,0.154541111307742,3.11854580708981e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.143923803748723,0.00753454205662235,0.129156101317743,0.158691506179703,4.67102346157049e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCR,Breakpoint cluster region protein,42594,0.176509352592781,0.00925360326483944,0.158372290193695,0.194646414991866,4.70172478277162e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNA4,Plexin-A4,42594,0.158222658804939,0.00832759227032455,0.141900577955103,0.174544739654775,1.89008974665445e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHK,Ketohexokinase,40223,0.120607330442724,0.00635904626712986,0.108143599759149,0.133071061126298,5.81463074103171e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.06356589324234,0.00335659753966926,0.0569869620645882,0.0701448244200917,5.82123636521441e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD63,CD63 antigen,42475,0.098309603459486,0.00519491088787391,0.0881275781192531,0.108491628799719,7.82458025834993e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAXX,Protein PAXX,40283,0.0872225873720884,0.00460344877545705,0.0781998277721926,0.0962453469719842,8.12993649006741e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.141286941240514,0.00746337007156737,0.126658735900242,0.155915146580787,1.1495343772104e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.169999113850019,0.00899250676521152,0.152373800590204,0.187624427109833,1.69678499544439e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR2,Cadherin-related family member 2,42587,0.135382658321457,0.00717770400329189,0.121314358475005,0.149450958167909,2.4384741762611e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R9B,Neurabin-2,42754,0.179281909201981,0.00950742238506253,0.160647361327258,0.197916457076703,2.57587758634294e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0485693027333476,0.00258158211266516,-0.0536292036741713,-0.0435094017925239,5.74694963707908e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.127996851862345,0.00679503805586541,0.114678577272849,0.141315126451841,5.83778043801318e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBIN,Erbin,42587,0.194391111851317,0.010345302937484,0.174114318093849,0.214667905608786,9.04589387284481e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.215996369047104,0.0115101207424621,0.193436532391879,0.23855620570233,2.16967649122155e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0940670087759042,0.00504009137993846,0.0841884296712248,0.103945587880584,9.54102954949433e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,BACH1,Transcription regulator protein BACH1,42594,0.138520543834131,0.00742353291849937,0.123970419313872,0.15307066835439,9.86391166239199e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0507882907281404,0.00271907255234163,0.0454589085255508,0.05611767293073,1.07940047390728e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,FN1,Fibronectin,40539,0.0503956429554755,0.00270505376188396,0.045093737582183,0.0556975483287681,2.50413337544308e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0547614953899016,0.00294467191350445,0.0489899384394328,0.0605330523403703,3.03539703053245e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCLY,Selenocysteine lyase,42674,0.0883061784902494,0.00475607663007802,0.0789842682952965,0.0976280886852023,5.2542367896697e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.202143869069164,0.0108777556501824,0.180823467994806,0.223464270143521,5.93378629409292e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0556634544499997,0.00299650339968624,0.0497903077866147,0.0615366011133847,6.70382231952708e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.108509578246778,0.00584994470607609,0.0970436866228685,0.119975469870687,7.52375405817217e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.130821272670944,0.00705470964204402,0.116994041772537,0.14464850356935,8.40829859679181e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.104117074348965,0.00562139623762321,0.0930991377232231,0.115135010974706,1.28359737861678e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.158652385716188,0.00855844456827295,0.141877834362373,0.175426937070003,1.36521780414407e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC1,Stanniocalcin-1,42711,0.0851016904441767,0.00460240892229492,0.0760809689564786,0.0941224119318747,2.08337009056319e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.203401277645806,0.0110421426814779,0.181758677990109,0.225043877301503,1.13150516519007e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0760163106899497,0.00413350465189841,0.0679146415722288,0.0841179798076705,1.26643681473619e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.192354919698581,0.0104652152623423,0.171843097784391,0.212866741612772,1.53509790485864e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.161642798741846,0.00880293909133288,0.144389038122834,0.178896559360859,2.1299032507811e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS8,Prostasin,42568,0.0784153326162883,0.00427553548900448,0.0700352830578395,0.0867953821747371,3.18884247565929e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.128254148500307,0.00701753708477712,0.114499775814144,0.14200852118647,1.46466724487815e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.119568088962734,0.00656107664246123,0.10670837874351,0.132427799181958,2.65698135740704e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0875897464748259,0.00480922673934733,-0.0970158308839466,-0.0781636620657051,3.05938349261216e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.227963878670134,0.0125601962627476,0.203345893995148,0.252581863345119,9.46270277235395e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.17581642291483,0.00968718286457653,0.15682954450026,0.1948033013294,9.46857513532313e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.13717414326658,0.00755077433325398,0.122374625573402,0.151973660959757,1.07812338833773e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.125718678708964,0.00692919848052204,0.112137449687141,0.139299907730788,1.10922312346403e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD6,T-cell differentiation antigen CD6,42746,0.0967165747440572,0.00537499467631433,0.0861815851784811,0.107251564309633,1.47942596933967e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP20,Centrosomal protein 20,42346,0.136864783457219,0.00761086688587067,0.121947484360913,0.151782082553526,1.90117375271707e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.249872431627171,0.0139110467796525,0.222606779939052,0.27713808331529,2.64102800441181e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.132885372584426,0.00739949851274972,0.118382355499437,0.147388389669415,2.77264786784367e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLA2,Src-like-adapter 2,40482,0.18904412562659,0.0105332487027949,0.168398958169112,0.209689293084068,4.86603436116668e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH2,Neutral ceramidase,42495,0.0976040851418099,0.00546154628088038,0.0868994544312844,0.108308715852335,1.32160714647724e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.110421023233804,0.00618411328158,0.0983001612019074,0.122541885265701,1.78083247763114e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,FETUB,Fetuin-B,42663,0.0582688810244339,0.00327639022869265,0.0518471561761963,0.0646906058726715,5.86943951125413e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL32,Interleukin-32,42594,-0.0803516902194636,0.00451905057477994,-0.0892090293460323,-0.0714943510928949,6.33203178547266e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.192616662902316,0.0108256372996825,0.171398413794938,0.213834912009693,7.18164537449807e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,MVK,Mevalonate kinase,42370,0.144596985284929,0.00814474257318497,0.128633289841486,0.160560680728371,1.04933406415586e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.195706148999769,0.01103936672738,0.174068990214104,0.217343307785434,2.22690326273822e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO1,Forkhead box protein O1,42594,0.152587614146951,0.00863399528860145,0.135664983381292,0.16951024491261,4.11897254299746e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK1,Dickkopf-related protein 1,42711,0.105409473374568,0.00597642052712879,0.0936956891413957,0.117123257607741,7.47681010299301e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0888909059824541,0.0050435466625283,0.0790055545238986,0.0987762574410096,1.36637776381553e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0367763729753526,0.0020895735556501,0.0326808088062784,0.0408719371444268,1.45666746416665e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB2,Carboxypeptidase B2,40516,0.0397045307205405,0.00225739268694804,0.0352800410541223,0.0441290203869586,2.42998367785757e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0524816921727923,0.00298421570100635,0.0466326293988199,0.0583307549467648,2.55634468209581e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSD,Cathepsin D,41747,0.0755232368287247,0.00429933991305561,0.0670965305991357,0.0839499430583137,2.92214682820084e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0658692083203715,0.00376225527376972,0.0584951879837829,0.0732432286569602,7.0140222082551e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.197586821263673,0.0113088979015926,0.175421381376552,0.219752261150795,1.31715523784715e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,EZR,Ezrin,42711,0.0425013243839501,0.0024333650341773,0.0377319289169626,0.0472707198509376,1.43190425729163e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEP,Leptin,42636,0.118071210889636,0.00676263395747218,0.104816448332991,0.131325973446282,1.62168468660027e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.173849392610638,0.00997237460393883,0.154303538386918,0.193395246834358,2.50479592946088e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAB2,Disabled homolog 2,42721,0.193485346796902,0.0111023385907315,0.171724763159069,0.215245930434736,2.77053551242079e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.181253793294757,0.0103969771691508,0.160875718043221,0.201631868546292,3.6514727757488e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL22,C-C motif chemokine 22,42509,0.093984928404464,0.00540847495965877,0.0833843174835328,0.104585539325395,6.69107399073576e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.137729771619399,0.00792578234741691,0.122195238218462,0.153264305020336,9.33714125244522e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3F,Semaphorin-3F,42636,0.0480073089901554,0.00276676814113766,0.0425844434335256,0.0534301745467852,1.02469712446424e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.140048714563214,0.00808135872887941,0.12420925145461,0.155888177671817,2.12364255431386e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOST,Sclerostin,42613,0.0687263177374481,0.00397203089995064,0.0609411371735448,0.0765114983013513,2.35768020686738e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.150212944752295,0.0086858144348228,0.133188748460042,0.167237141044548,2.73042449189126e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEXIM1,Protein HEXIM1,42594,0.141849912187354,0.0082111213707145,0.125756114300754,0.157943710073955,3.75063304715797e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.130436139816733,0.00754403965993653,0.115649822083257,0.145222457550208,3.94767247952483e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.183626025359426,0.0106404811007324,0.162770682401991,0.204481368316862,5.04158845350623e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMIP,C-Maf-inducing protein,40451,0.144768233381519,0.00841314996417592,0.128278459451735,0.161258007311304,1.60509488045376e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK2,Docking protein 2,42636,0.210339849448088,0.0122373496321905,0.186354644168994,0.234325054727181,1.6254198257137e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGF,Hepatocyte growth factor,42754,0.0609572430931959,0.00355017177517182,0.0539989064138592,0.0679155797725327,2.17655061960928e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPK2,SRSF protein kinase 2,42594,0.14568295519353,0.00848888096655598,0.12904474849908,0.162321161887979,2.56367871322108e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0905643765973565,0.00527985227812555,0.0802158661322304,0.100912887062483,4.01291209676014e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.116177754443779,0.0067868600643937,0.102875508717568,0.129480000169991,5.5213553289641e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBP,Protein AMBP,42706,0.0365722816908766,0.00213689604572604,0.0323839654412536,0.0407605979404997,5.57575025813144e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0695740129664832,0.00406160365341956,0.0616132698057809,0.0775347561271855,5.91567590759076e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1A,Meprin A subunit alpha,40449,0.125775890152839,0.00737763821502914,0.111315719251382,0.140236061054296,2.30714446410258e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.177427383668195,0.0104360976622007,0.156972632250281,0.197882135086108,5.04215573829592e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.144517579256543,0.00850256955733852,0.12785254292416,0.161182615588927,5.39505643449459e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.123368737397509,0.0072597644674325,0.109139599041341,0.137597875753676,5.74097541928865e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.155343410496812,0.00914183167633728,0.137425420411191,0.173261400582433,5.79771559270112e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.132287120440522,0.00780149864526808,0.116996183095796,0.147578057785247,7.95632737806353e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.16683981975912,0.00983604708991087,0.147561167462894,0.186118472055345,1.00779711039974e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,AAMDC,Mth938 domain-containing protein,40223,0.0915812484884708,0.00540467041682207,0.0809880944714996,0.102174402505442,1.33604029838079e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0608394864645109,0.00359469780972999,-0.0678850941715817,-0.0537938787574401,1.35064091534393e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.164655872356502,0.00973110567037078,0.145582905242575,0.183728839470428,1.4350281476681e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.064110873649643,0.00378920557250204,0.056684030727539,0.071537716571747,1.49760930014596e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.117994983690211,0.006972679118954,0.104328532617061,0.131661434763361,1.93487037976964e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0439434329662553,0.00260604785830616,0.0388355791639752,0.0490512867685354,3.75720705675879e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0744289118993435,0.00440857238104627,0.0657881100324928,0.0830697137661942,3.79634804409363e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINK1,Misshapen-like kinase 1,40483,0.159076294649647,0.00942593489125149,0.140601462262794,0.1775511270365,3.97345520146753e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.106232524714638,0.00629651221808845,0.0938913607671849,0.118573688662092,4.30206006794224e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2B3,SH2B adapter protein 3,42346,0.167001841999721,0.00991652308528199,0.147565456752568,0.186438227246874,5.59600328048406e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.19061170093924,0.0113268878535755,0.168411000746232,0.212812401132248,6.78299647475041e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDUA,Alpha-L-iduronidase,42721,0.0795155595496347,0.00472781274415917,0.0702490465710828,0.0887820725281867,7.73637072451632e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN1,Perilipin-1,42311,0.0599116820599968,0.00356448846365093,0.052925284671241,0.0668980794487526,9.66652358170629e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP43,Centrosomal protein 43,42255,0.11819745640498,0.00703584599924686,0.104407198246456,0.131987714563504,1.12138135294745e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPD52L2,Tumor protein D54,40283,0.182818682003783,0.0108804209093215,0.161493057021513,0.204144306986053,1.38600037348082e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN2,Prorelaxin H2,40257,0.0852776650503645,0.00507984587006325,0.0753211671450405,0.0952341629556885,1.78332676497477e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.122910774600555,0.00732275304768759,0.108558178627087,0.137263370574023,1.79963850811501e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0680384044583685,0.00405755733038627,0.0600855920908114,0.0759912168259256,1.80093735097701e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.158055581296719,0.0094289148001189,0.139574908288486,0.176536254304952,2.02221506802748e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOT,Angiomotin,40283,0.0661188743230062,0.00394173710824355,0.0583930695908488,0.0738446790551635,2.21346077966236e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,THOP1,Thimet oligopeptidase,42571,0.0526238884710548,0.00314761476091604,0.0464545635396594,0.0587932134024502,4.08815220928268e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.037084643341223,0.00223444415158158,0.0327051328041231,0.0414641538783229,3.04641231725572e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0784107111983239,0.00472726692067808,0.0691452680337948,0.0876761543628529,4.70658372816783e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNST,Consortin,42636,0.182939538776254,0.0110494759989315,0.161282565818348,0.20459651173416,5.77277726958528e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.097772416721829,0.00590111449912369,0.0862062323035465,0.109338601140111,6.18276755987436e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELP,P-selectin,42689,0.0944266074427918,0.005705714315386,0.0832434073846352,0.105609807500948,6.42649663597337e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.142352035040265,0.00860554546326289,0.12548516593227,0.15921890414826,7.34658262400232e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPHN1,Oligophrenin-1,40483,0.180008014477669,0.0108717982599409,0.158699289888185,0.201316739067153,7.37900698190562e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNMBP,Dynamin-binding protein,42495,0.10093508656077,0.00611911434413627,0.0889416224462626,0.112928550675277,1.58752787761459e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.15858811644493,0.00961523489404243,0.139742256052606,0.177433976837253,1.65346699106248e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.15936475802695,0.00966366409184617,0.140423976406931,0.178305539646968,1.69165891977812e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.176270429578531,0.0107065032974785,0.155285683115473,0.197255176041589,2.61174618600263e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0859098357659036,0.00522488102502359,0.0756690689568573,0.0961506025749498,3.79288743727491e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR,GMP reductase 1,42754,0.0827707946850424,0.00503540241671157,0.0729014059482877,0.092640183421797,3.91239318549733e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0539273419121708,0.00328386603408939,0.0474909644853556,0.060363719338986,7.04923751528265e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0552254978958748,0.00336783249940631,-0.0618264495947112,-0.0486245461970385,7.41829126793205e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRAP,BRCA1-associated protein,40342,0.181831251705161,0.0110828623463162,0.160108841506381,0.20355366190394,8.60191599755438e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.116045651280386,0.00708224091662356,0.102164459083804,0.129926843476968,9.25257814042293e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAMBP,STAM-binding protein,42476,0.105629414106982,0.0064465362197997,0.0929942031161749,0.11826462509779,9.36013385528561e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLK1,Protein delta homolog 1,42794,0.0920675007428105,0.00562030668551046,0.08105169963921,0.103083301846411,9.71358941203945e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0556095498340276,0.00340010182021589,0.0489453502664044,0.0622737494016507,2.04936150376848e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0916126906610201,0.00560379423378806,0.0806292539627955,0.102596127359245,2.14704046564011e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCXR,L-xylulose reductase,42679,0.0874668373304096,0.00536120517548677,0.0769588751864555,0.0979747994743637,2.86114934822589e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP2,Methionine aminopeptidase 2,42689,0.0946969372032837,0.00581002320052822,0.0833092917302484,0.106084582676319,3.6883001793359e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD5,Programmed cell death protein 5,42711,0.0955023772921233,0.00587095471180855,0.0839953060569786,0.107009448527268,6.144072366402e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,USO1,General vesicular transport factor p115,42587,0.149000519790211,0.00915943404382286,0.131048029064318,0.166953010516103,6.16598265651821e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.124785857313055,0.00767476033889387,0.109743327048823,0.139828387577287,6.91931829454953e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.187606213732355,0.0115333295506833,0.165000887813016,0.210211539651694,7.95397356585903e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.106604927760563,0.00656649325259608,0.0937346009854742,0.119475254535651,1.04058189925323e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.18753425854702,0.0115535723094242,0.164889256820548,0.210179260273491,1.09001631417279e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRN,Agrin,42676,0.0602472420174639,0.00371425820285281,0.0529672959398724,0.0675271880950554,1.29448708034348e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEFTY2,Left-right determination factor 2,42689,0.0827603733199286,0.00510394079539479,0.0727566493609548,0.0927640972789024,1.41242571969917e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSO,Cathepsin O,42754,0.0508372669155489,0.00313838818942411,0.0446860260642776,0.0569885077668201,1.82591486504621e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.108615246518795,0.00670194217312925,-0.121751053178128,-0.0954794398594614,2.05148347191789e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.121606817669162,0.00750353756225508,0.106899884047142,0.136313751291182,2.05501969694898e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.124347999375183,0.00767298358486977,0.109308951548838,0.139387047201528,2.08421445161031e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.109009221740662,0.00673441891211942,0.095809760672908,0.122208682808416,2.19058894993054e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.0329137089559262,0.00203335738998112,0.0289283284715632,0.0368990894402893,2.23024132818762e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.106962796061697,0.0066138347044566,0.0939996800409621,0.119925912082432,2.7719045746644e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0627764183775135,0.00388340534119544,0.0551649439087705,0.0703878928462566,3.1027268314536e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0906409605135686,0.00560932429566623,0.0796466848940628,0.101635236133074,3.42865101798484e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.109570308806047,0.00678666847229666,0.0962684386003451,0.122872179011748,4.30395193614808e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT1,Deaminated glutathione amidase,40223,0.078014506949741,0.00483359832106273,0.068540654240458,0.0874883596590239,6.13835075060939e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.125692629631253,0.00779998219473194,0.110404664529579,0.140980594732928,7.07352757919791e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.0912398650533114,0.00566447166266553,0.080137500594487,0.102342229512136,7.83555261708986e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0445345234239073,0.00276535120022946,0.0391144350714576,0.0499546117763571,8.28005753884034e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX15,Sorting nexin-15,40283,0.0889233660293912,0.00551785151502695,0.0781083770599384,0.099738354998844,8.96648807895706e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.103159981571202,0.00640913225407592,0.0905980823532128,0.11572188078919,9.71590178054561e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.170625003613272,0.010616942290251,0.14981579672438,0.191434210502164,1.39495536667566e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUCB2,Nucleobindin-2,42683,0.0605731399568289,0.00376997681369122,0.0531839854019941,0.0679622945116636,1.47972343684191e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.125035926912064,0.00778044461574974,0.109786255465195,0.140285598358934,1.78646463213411e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA2,Apolipoprotein A-II,40532,-0.0805828201688634,0.00501565624051497,-0.0904135064002727,-0.070752133937454,1.89107843231834e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINH1,Serpin H1,40302,0.210920585842271,0.0131277525913137,0.185190190763296,0.236650980921246,1.93245274436261e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0328351686834579,0.00204741475089519,0.0288222357717033,0.0368481015952125,2.39339030951185e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.0984990740974874,0.00614329721764503,0.0864582115509032,0.110539936644072,2.59832859435646e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.127054318101997,0.00791836295543505,0.111534326709344,0.14257430949465,2.62862871205394e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELN,Elastin,40511,0.0599803582250439,0.00373861794261349,0.0526526670575215,0.0673080493925663,2.71576929389623e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCTN3,Tectonic-3,40511,0.0490059816298498,0.00305593173349011,0.0430163554322091,0.0549956078274904,3.03746352306694e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0571147437785763,0.00357623445225867,0.0501053242521493,0.0641241633050033,6.99872518055912e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.136055797885453,0.00851147346592105,0.119373309892247,0.152738285878658,7.10157120257728e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.103399490756427,0.00647706695773259,0.0907044395192713,0.116094541993583,9.50513136289136e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.170683313670001,0.0107130091042561,0.149685815825659,0.191680811514343,1.59474469789864e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.117481723821832,0.00738419944000024,0.103008692919432,0.131954754724233,1.81667411919966e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMN,Protein amnionless,42370,0.0765579996865468,0.00481391935526874,0.0671227177502201,0.0859932816228736,2.00636896347241e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGFR,Opioid growth factor receptor,42587,0.0527697014730092,0.00331866241725426,0.0462651231351909,0.0592742798108276,2.04884701923518e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.109714737637614,0.00690755481300592,0.0961759302041225,0.123253545071106,2.67820665854176e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.128624136382526,0.00809888254746766,0.11275032658949,0.144497946175563,3.43785783839346e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP10,Stromelysin-2,42608,-0.0952560494527266,0.0060100829702635,-0.107035812074443,-0.0834762868310101,4.57873855736932e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM13A,Protein FAM13A,40449,0.108646352566665,0.00685269226833248,0.0952150757207335,0.122077629412597,5.2706912614381e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.130215299214198,0.00823242190377734,0.114079752282794,0.146350846145602,7.55756296804457e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.125855666170679,0.00797992863549469,0.11021500604511,0.141496326296249,1.90606012073685e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0809429654383313,0.005138935652813,0.0708706515588178,0.0910152793178447,2.1245859957233e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELE,E-selectin,42794,0.0814709744422443,0.00518490561044049,0.071308559445781,0.0916333894387077,3.75548936940782e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.083031729731193,0.00529164050740221,0.0726601143366847,0.0934033451257014,5.33978209363129e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.14440051316046,0.00919574314481419,0.126376856596624,0.162424169724296,5.52246150952353e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.100275766190532,0.00639377397641227,0.0877439691967643,0.1128075631843,6.17940166081209e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.131324620333298,0.00837447889639671,0.11491064169636,0.147738598970235,7.83951988174682e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.113107022843978,0.00721861274051914,0.0989585418725607,0.127255503815396,9.53619606866444e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST13,Hsc70-interacting protein,40283,0.0898709124052397,0.00573942933573045,0.078621630907208,0.101120193903271,1.11726666920411e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,MITD1,MIT domain-containing protein 1,42495,0.152850120338573,0.00977246143685597,0.133696095922335,0.172004144754811,1.17504540799587e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.100719094525586,0.00643560993171154,0.0881052990594318,0.113332889991741,1.23462097296084e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0600576868897627,0.00385314844448482,0.0525055159385725,0.067609857840953,3.36615203054815e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0983389885908027,0.00630949527499318,0.085972377851816,0.110705599329789,3.47516319349056e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0517221896446089,0.00332388250135629,-0.0582369993472672,-0.0452073799419505,3.97320463174185e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.170441821013684,0.0109591004705575,0.148961984091392,0.191921657935977,5.54506197499137e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.12239057906304,0.00788739718710633,0.106931280576312,0.137849877549769,9.50755854163156e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.0998412555790734,0.00644270495021816,0.0872135538766459,0.112468957281501,1.29828411284739e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,F13B,Coagulation factor XIII B chain,40479,0.0409328915030996,0.00264333885856243,0.0357519473403173,0.046113835665882,1.54734172428538e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLB1,Beta-galactosidase,42495,0.0654657065210355,0.00423127056772501,0.0571724162082945,0.0737589968337765,1.57101080181562e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXN,Paxillin,42311,0.0808610912140558,0.00522810190711879,0.070614011476103,0.0911081709520086,1.72762166220364e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT2,Omega-amidase NIT2,40462,0.115117771524262,0.00744062220651347,0.100534151999495,0.129701391049028,1.91179675462915e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0844814571021503,0.00546726952083975,-0.0951973053629962,-0.0737656088413044,2.13368118110422e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.158326369506128,0.0102479229696238,0.138240440485666,0.178412298526591,2.18937022893894e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0828559909950968,0.00537785921779065,0.0723153869282271,0.0933965950619665,5.19278601876962e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.0930696671780789,0.00604707351196704,0.0812174030946235,0.104921931261534,5.35445970875486e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,MME,Neprilysin,42587,0.127572582658298,0.00829404341281709,0.111316257569176,0.143828907747419,6.19758362116675e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.123666361339161,0.0080426706531491,0.107902726858989,0.139429995819333,6.67732490945915e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0430541480279352,0.00280127114576098,0.0375636565822437,0.0485446394736268,7.38672930644462e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.103225727994074,0.0067168190891066,0.0900607625794253,0.116390693408723,9.13427618154704e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.139189151083238,0.00906100495901904,0.121429581363561,0.156948720802916,1.04599287143458e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDHD2,Phospholipase DDHD2,40482,0.102608002891324,0.006681145354277,0.0895129579969412,0.115703047785707,1.06887442718825e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0425222611774855,0.00276918513549598,0.0370946583119134,0.0479498640430576,1.10131808063884e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRKL,Crk-like protein,42636,0.163704870415538,0.0106706236855124,0.142790447991934,0.184619292839142,1.12522580617882e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCC,Tubulin-specific chaperone C,42495,0.12556284508777,0.00818780238574291,0.109514752411714,0.141610937763826,1.25094177096293e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0837662601100038,0.00547762440033295,0.0730301162853512,0.0945024039346564,2.37170454830825e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP5,Fatty acid-binding protein 5,42678,0.105401364183974,0.00690980583947025,0.0918581447386119,0.118944583629335,4.22074764006379e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,BID,BH3-interacting domain death agonist,42594,0.104590574935084,0.00686151319520794,0.0911420090724768,0.118039140797692,4.99709206985858e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.137919037171671,0.00905302871761896,0.120175100885138,0.155662973458204,6.8563299439114e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.130233802216109,0.00855690283177359,0.113462272665833,0.147005331766386,7.10169275233802e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0697465484542305,0.00457938657795705,-0.0787221461470263,-0.0607709507614347,7.25832895615066e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.0625691963679522,0.00410871583335082,0.0545161133345846,0.0706222794013198,7.65343760376116e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.127724152898733,0.00838893213463626,0.111281845914846,0.14416645988262,7.82621490581935e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0744226729930378,0.00488860354557794,0.064841010043705,0.0840043359423705,8.06713037147362e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPL,N-acetylneuraminate lyase,40511,0.0705346093843562,0.00464596332649556,0.0614285212644249,0.0796406975042875,1.49835082600061e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBNL,Drebrin-like protein,42676,0.14165608055107,0.00934683604846115,0.123336281896086,0.159975879206053,1.84847696840283e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTDH,Protein LYRIC,40199,0.144937661453725,0.00955895858498406,0.126202102627157,0.163673220280294,2.06853232059411e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGF,Placenta growth factor,42754,0.0412152170880466,0.00272113930711,0.035881784046111,0.0465486501299822,2.10961671643996e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.0893399454007601,0.00590249001611626,0.0777710649691722,0.100908825832348,2.49035770584905e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,EREG,Proepiregulin,42476,0.124493647221658,0.00822639910264777,0.108369904980469,0.140617389462848,2.60914276273297e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GLB2,Endophilin-B2,40483,0.102984199053395,0.00680214224092848,0.0896520002611753,0.116316397845615,2.8099835584143e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOF,Apolipoprotein F,40532,-0.0367874385149767,0.00243244963515601,-0.0415550397998825,-0.0320198372300709,3.56713909119922e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEC31A,Protein transport protein Sec31A,40223,0.118071953535095,0.00781292381062062,0.102758622866278,0.133385284203911,4.35145327399031e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEPR,Leptin receptor,42636,-0.0480814021896283,0.00318906707093055,-0.0543319736486522,-0.0418308307306044,5.98953456444408e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADD1,Alpha-adducin,40283,0.109284154317964,0.00724412129200827,0.0950856765856281,0.123482632050301,6.40912768465312e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD1,COMM domain-containing protein 1,40223,0.0927418458362187,0.00615574705315604,0.0806765816120328,0.104807110060405,8.67867028408601e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.176729376543441,0.011773045813289,0.153654206749395,0.199804546337488,1.59288840028086e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0910331126858726,0.00606405650123762,0.0791475619434469,0.102918663428298,1.88614977135555e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.102683244959188,0.00684156345573841,0.089273780585941,0.116092709332436,1.97044905868622e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBPL,FK506-binding protein-like,40449,0.0893910171521981,0.00597021685821106,0.0776893921101044,0.101092642194292,3.35907312596045e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN2,CCN family member 2,42624,0.0842714323618299,0.00563307264129794,0.0732306099848859,0.0953122547387738,3.39229571942166e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.177931183203113,0.0119002618885876,0.154606669901481,0.201255696504744,4.55967568778495e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.0929365386007038,0.00622032115323953,0.0807447091403544,0.105128368061053,5.36726615493925e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0831938204131343,0.0055731612878427,0.0722704242889626,0.094117216537306,6.70239697904062e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0355078029085934,0.00238418037853757,0.0308348093666598,0.040180796450527,9.12481937806666e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1S,Complement C1s subcomponent,40539,0.0316567625411364,0.00212428456842812,0.0274931647870173,0.0358203602952555,9.39765685310843e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.137337048518981,0.00921855026528295,0.119268689999026,0.155405407038935,1.00535901732312e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0523612410564784,0.00351827407179086,-0.0592570582371885,-0.0454654238757683,1.06339837844569e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0767849764838542,0.00516136333626351,0.0666687043447777,0.0869012486229307,1.15811895135826e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,QDPR,Dihydropteridine reductase,42581,0.0645347480400915,0.00434008021371836,0.0560281908212035,0.0730413052589794,1.29371034890177e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0844880653936004,0.0056797633843977,0.0733557291601809,0.0956204016270199,1.44233939538698e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.0980698086135302,0.00660269240840074,0.0851285314930648,0.111011085733996,1.64740121953557e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR2,GMP reductase 2,40283,0.10191176227859,0.00685665362278657,0.0884727211779281,0.115350803379251,1.70911243261964e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0436418762937515,0.00294683663793969,0.0378660764833897,0.0494176761041133,3.16435172203017e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0367302086241408,0.00248352890990934,0.0318624919607185,0.0415979252875631,4.14585880009441e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.127910703600427,0.0086415831688702,0.110973200589441,0.144848206611413,4.19921541424183e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSB,Arylsulfatase B,42587,0.0828022759123364,0.00561388079048253,0.0717990695629906,0.0938054822616821,7.48108627866357e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGA,Protein O-GlcNAcase,40449,0.105358539773531,0.00714046071845885,0.0913632367653519,0.119353842781711,8.13852420815466e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL5,C-C motif chemokine 5,42689,0.149975451789639,0.0101728538255792,0.130036658291504,0.169914245287774,8.21227213857867e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0657485698079239,0.00445932209726147,0.0570082984972914,0.0744888411185564,8.23456926921736e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D23,TBC1 domain family member 23,42587,0.134411186020513,0.00912874790101429,0.116518840134525,0.152303531906501,1.0864888125786e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,IST1,IST1 homolog,40375,0.148286558476925,0.0100644880171116,0.128560161963387,0.168012954990464,1.11998762156898e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.077863086195861,0.00528813870761082,0.0674983343289438,0.0882278380627782,1.27762378983184e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0581182040447841,0.00395299432777202,0.0503703351623509,0.0658660729272172,1.50927493354303e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES2,Cocaine esterase,42587,0.0823750326096254,0.0056091590642213,0.0713810808437517,0.0933689843754992,1.89151307836897e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOD,Apolipoprotein D,40033,-0.0653166287931543,0.00445881311013795,-0.0740559024890247,-0.0565773550972839,3.94527790036199e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL13,C-C motif chemokine 13,42734,0.103328511153789,0.00706116646878587,0.0894886248749691,0.11716839743261,4.00910237257278e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK1,Docking protein 1,40483,0.202668538135603,0.0138550148582628,0.175512709013408,0.229824367257798,5.12931469609697e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2L,Ataxin-2-like protein,40482,0.0719610040091988,0.00492564343224754,0.0623067428819936,0.0816152651364039,6.68270968841069e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH2,Cadherin-2,42636,0.0530406066639321,0.0036336767651051,0.0459186002043261,0.0601626131235381,6.82582950213755e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0735006008175963,0.00503948370506024,0.0636232127556782,0.0833779888795144,8.2613617211028e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.076593514053016,0.00526426895520654,0.0662755469008112,0.0869114812052208,1.37667340113116e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.111677527110213,0.00767361307046674,0.0966372454920983,0.126717808728328,1.49533817565886e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGLN1,Egl nine homolog 1,42594,0.0824599529283353,0.00567109227154851,0.0713446120761003,0.0935752937805704,1.54584330117757e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTPBP2,GTP-binding protein 2,40182,0.119758345951258,0.00824210809337323,0.103603814088247,0.13591287781427,2.14740590542867e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0725706078026983,0.00499559504904406,0.062779241506572,0.0823619740988247,2.2428135913909e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0889204037850476,0.0061440843033038,0.0768779985505721,0.100962809019523,4.15089218633613e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN3,Ataxin-3,40483,0.0919530487033978,0.0063555551439634,0.0794961606212295,0.104409936785566,5.06943080826412e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC13,Mucin-13,42311,0.0772802596538782,0.00534856306575284,0.0667970760450026,0.0877634432627538,5.8500637780336e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAG1,Dystroglycan,42676,0.0676902883018542,0.00468540509133188,0.0585068943228438,0.0768736822808647,5.86530618097677e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0487451861363727,0.0033744415267475,0.0421312807439476,0.0553590915287978,6.03807782348951e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.0792809366958908,0.00549443039257657,0.0685118531264407,0.0900500202653409,7.70230444312116e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0849558103152445,0.00588563446005396,0.0734199667735387,0.0964916538569503,8.33760540373875e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.113919843083732,0.00789983234360532,0.0984361716902659,0.129403514477199,8.73721615975592e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0691386329892654,0.0047953937804029,0.0597396611796758,0.0785376047988551,1.04278346918585e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD36,Platelet glycoprotein 4,40199,0.0658875975561039,0.00457147296528598,0.0569275105441434,0.0748476845680644,1.14302042165835e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0646401505801757,0.00449758706501563,0.0558248799327451,0.0734554212276064,1.71460352199458e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0857113366053459,0.00596611544382367,0.0740177503354515,0.0974049228752403,1.85580470858929e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.111428468804837,0.00775081137959032,0.0962368785008399,0.126620059108834,1.91660659404852e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASHC3,WASH complex subunit 3,40483,0.109662027405798,0.00763876426050253,0.0946900494552133,0.124634005356383,2.49748969640106e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53,Cellular tumor antigen p53,42346,0.0630814965103995,0.00440394963238157,0.0544497552309317,0.0717132377898674,3.45482808280887e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0572005767392689,0.00399561609804351,0.0493691691871036,0.0650319842914342,3.81396523693931e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB3,Plexin-B3,42597,0.06848477054722,0.00478470241754971,0.0591067538088226,0.0778627872856174,3.95397971360397e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0303427421098085,0.00212502941524831,-0.0345077997636952,-0.0261776844559218,6.41673210440395e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPART,Spartin,40283,0.111412490538579,0.00780476936173657,0.0961151425895758,0.126709838487583,7.98013257487516e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.128716457145757,0.00902860390902126,0.111020393484075,0.146412520807438,1.03920746393286e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.142904582222347,0.0100324846409427,0.123240912326099,0.162568252118594,1.06513502389134e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.132007186725787,0.00927013250669369,0.113837727012667,0.150176646438907,1.12901688590819e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYDGF,Myeloid-derived growth factor,40511,0.142592052470375,0.010012157959029,0.122968222870678,0.162215882070072,1.24698934200787e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0606738925414653,0.00426697166513578,0.0523106280777992,0.0690371570051314,1.49971239596527e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,TWF2,Twinfilin-2,40527,0.120415530218394,0.00846392302995463,0.103826241079683,0.137004819357105,1.53707105661604e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0388281513391521,0.00273286331494661,-0.0441845634364475,-0.0334717392418568,2.00646802523547e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.115477122184514,0.00814058324188477,0.0995215790304197,0.131432665338608,2.8240136545023e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS8,Galectin-8,42711,0.0866761042215438,0.00611625561802666,0.0746882432102116,0.0986639652328761,2.90271791163548e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0551985020228693,0.0038985947426522,0.047557256327271,0.0628397477184676,4.02951842989938e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN1,Pantetheinase,40532,0.105239860559026,0.00743548056955489,0.0906663186426984,0.119813402475354,4.28355708353466e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL17,C-C motif chemokine 17,42604,0.13254525066724,0.00937221138422352,0.114175716354162,0.150914784980318,4.38841162392894e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPACT,Protein IMPACT,40483,0.0808183786689313,0.00572361289052833,0.0696000974034958,0.0920366599343668,6.87044775596101e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.118112374305232,0.00837480497194102,0.101697756560227,0.134526992050236,8.71276212667665e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.122826586565438,0.00873218464009999,0.105711504670842,0.139941668460034,1.2708227078533e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0875721186602642,0.00622649353442449,0.0753681913327922,0.0997760459877362,1.30267908366247e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPP,Lipoma-preferred partner,40116,0.0945781038962897,0.00672013702008478,0.0814066353369236,0.107749572455656,1.34783593695573e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,RWDD1,RWD domain-containing protein 1,42711,0.0902126982900137,0.00642691698946025,0.0776159409906716,0.102809455589356,1.90620771459705e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.125600122408692,0.00894170453642795,0.108074381517293,0.143125863300091,1.91747398491261e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.102807223610386,0.00733874470973109,0.0884232839793128,0.117191163241459,3.30146259794752e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.208139402642059,0.0148621654207037,0.17900955841748,0.237269246866638,3.42705102235557e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLG4,Disks large homolog 4,40483,0.100090151896217,0.00715255895706376,0.0860711363403724,0.114109167452062,3.98189847409095e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASC3,Protein CASC3,40182,0.0599857628558005,0.00428727425261383,0.0515827053206774,0.0683888203909236,4.19023567728474e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.101836767259894,0.0072864935274448,0.0875552399461024,0.116118294573686,4.4462590975726e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0395403427686077,0.00283091141434824,0.0339917563964851,0.0450889291407303,5.0074286953168e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBXN1,UBX domain-containing protein 1,40283,0.0973316334169059,0.00697170412921505,0.0836670933236445,0.110996173510167,6.3456192291003e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.147866261332227,0.0106125159886364,0.127065729994499,0.168666792669954,8.04629580049024e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0860261869456686,0.00617699873718606,0.0739192694207839,0.0981331044705533,8.78172505162035e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.134987238294539,0.00969161931756717,0.115991664432108,0.153982812156971,9.83496126375762e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.124046157040871,0.00891410903670235,-0.141517810752807,-0.106574503328934,1.0209815438903e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0699511296345545,0.00502322495694478,0.0601056087189427,0.0797966505501662,1.04245746570295e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.092215072787838,0.00662460334269718,0.0792308502361515,0.105199295339525,1.1135724571574e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.124493568687765,0.00896865597800059,0.106915002970884,0.142072134404646,1.65324199105533e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRL,Appetite-regulating hormone,42636,0.120741187192934,0.00869956593571552,0.103690037958932,0.137792336426937,1.69444102913499e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.0514091000726919,0.00370463587020085,0.0441480137670982,0.0586701863782856,1.74666598972372e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0820160364634792,0.00594708462009802,0.0703597506080871,0.0936723223188713,5.74880905937188e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICA1,Islet cell autoantigen 1,42370,0.110921221554227,0.00804612694853585,0.0951508127350965,0.126691630373357,6.17276938112585e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0681711179368923,0.0049418163204651,0.0584851579487807,0.0778570779250039,6.24269809775633e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC5,Glypican-5,42495,0.0795004673079761,0.00577251642798938,0.0681863351091169,0.0908145995068353,7.36798521373839e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.118915695849561,0.00863463347666744,0.101991814235293,0.135839577463829,7.45387931494752e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXJ3,Forkhead box protein J3,40199,0.061519192909094,0.00446434742254819,0.0527690719608996,0.0702693138572885,7.61118288791171e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUOM,Fucose mutarotase,40283,0.0889912761348515,0.00646038478471496,0.0763289219568102,0.101653630312893,8.11858415170623e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0637409978404837,0.00463095545256734,0.0546643251534517,0.0728176705275157,8.18425876103011e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMNL1,Formin-like protein 1,42311,0.0872426841786058,0.00633840749947536,0.0748194054796341,0.0996659628775775,8.30715886493426e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.0579735914595593,0.00421418386516942,0.0497137910838273,0.0662333918352914,8.96533396351554e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0718758757927474,0.00522962836424683,0.0616258041988236,0.0821259473866712,1.09143772329527e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.155571935805938,0.0113121167511632,0.133400186973658,0.177743684638218,1.09864270774659e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0623175885593037,0.00453869242813761,0.053421751400154,0.0712134257184534,1.29907662951529e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.118890493176268,0.00869220214209843,0.101853776977755,0.135927209374781,2.64101938706942e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.100307732816664,0.00734178268180397,0.0859178387603282,0.114697626873,3.24349871990616e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.117848110785193,0.00864205827775535,0.100909676560793,0.134786545009594,4.68682830776542e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0555416752349921,0.0040746634170091,0.0475553349376543,0.0635280155323299,5.05018337182141e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0236574984568822,0.00173837320335373,0.0202502869783089,0.0270647099354555,7.54030917252559e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.11762837402128,0.0086544126337913,0.100665725259049,0.134591022783511,8.60106931554526e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0506239565131778,0.00373147720928554,0.0433102611829782,0.0579376518433775,1.1879041612757e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.0954127531459456,0.00702965408492248,0.0816346311394975,0.109190875152394,1.24609507800033e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.180307841892581,0.0133170212811792,0.15420648018147,0.206409203603692,1.70305271332746e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.104102618620573,0.00770745510650052,0.0889960066118317,0.119209230629314,2.68781187065565e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0908330026363737,0.00672188303718429,0.0776581118834925,0.104007893389255,2.77487063840905e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,YJU2,Splicing factor YJU2,40451,0.0447657699864249,0.00331623927888596,0.0382659409998084,0.0512655989730414,3.31622431985627e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,THPO,Thrombopoietin,42357,0.053831860180001,0.00399346865637023,0.0460046616135153,0.0616590587464866,3.84557309126109e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.105237807989167,0.00781293689548251,0.0899244516740214,0.120551164304313,4.36089881549198e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.128365942170115,0.00953019333456272,0.109686763234372,0.147045121105858,4.376088464887e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0740397538775005,0.00549420697535513,0.0632711082058045,0.0848083995491966,4.55671080669372e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDC,Nuclear migration protein nudC,42754,0.0853447623405288,0.00633799039919859,0.0729223011580996,0.097767223522958,4.57691806060267e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0963362983402004,0.00715499948269133,0.0823124993541254,0.110360097326275,4.68297971982194e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0809314444693112,0.00602630071553605,0.0691198950668605,0.0927429938717618,7.52537163209117e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.150187817664448,0.0112045397568501,0.128226919741022,0.172148715587875,1.04112964295922e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMA,Granzyme A,42754,0.0487876278939846,0.00364082833253849,0.0416516043622091,0.05592365142576,1.09496985059037e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOA,Elongin-A,42587,0.0733747286784826,0.00548061914748979,0.0626327151494026,0.0841167422075626,1.29565190245729e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.127483158576707,0.00951644132830993,0.10883093357322,0.146135383580195,1.30095396929077e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.12014352277517,0.00898544153585495,0.102532057364894,0.137754988185446,1.84923006198756e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.11004687001248,0.0082321423362534,0.0939118710334231,0.126181868991536,1.88873048359627e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE4,Ribonuclease 4,40169,0.0399976755729974,0.00299466409327018,0.0341281339501879,0.045867217195807,2.24725780745898e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0948954540546597,0.00710594742861479,0.0809677970945747,0.108823111014745,2.30378486984036e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0450751920516937,0.00338048870424295,0.0384494341913775,0.0517009499120099,2.6442878949895e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUS,RNA-binding protein FUS,42336,0.0542318027364118,0.00407455284831566,0.0462456791537131,0.0622179263191104,3.68943703083836e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0772928792720023,0.0058117753350867,0.0659017996152324,0.0886839589287722,4.75390523671069e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIAE,Sialate O-acetylesterase,42646,0.062355308068134,0.00469291876582921,0.0531571872871087,0.0715534288491592,4.91546548486422e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TALDO1,Transaldolase,40499,0.0598698918831847,0.00450410979341366,0.0510418366880939,0.0686979470782755,5.12153180097043e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0763028650065876,0.00574475701955555,0.0650431412482587,0.0875625887649164,5.25901439135787e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH9,Protocadherin-9,40449,0.0468944083875211,0.00352951893469973,0.0399765512755096,0.0538122654995326,5.55435206646048e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINC1,Antithrombin-III,40516,0.0199900638114359,0.00150595577720372,0.0170383904881166,0.0229417371347552,6.50653249447461e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.107142693927271,0.00807789079494796,0.0913100279691726,0.122975359885369,6.73517054645397e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM17,Splicing factor 45,40482,0.103537652661496,0.00780336007089186,0.0882430669225482,0.118832238400444,7.02347075080392e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0883192487838275,0.0066610330311692,0.0752636240427358,0.101374873524919,7.09028559925813e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLM2,Protein GOLM2,42711,0.0313141547307311,0.00236405138864105,0.0266806140089946,0.0359476954524675,8.42626816937759e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.163665448958516,0.0123551188130309,0.139449416084975,0.187881481832056,8.52919848667794e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.102262051262316,0.00773233502563484,0.0871066746120717,0.11741742791256,1.12374349090086e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.106335159557884,0.00804434533033684,0.0905682427104234,0.122102076405344,1.21067038466443e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD226,CD226 antigen,40199,0.0573209219810998,0.0043342134168664,0.0488258636840416,0.0658159802781579,1.25809954289156e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.139711015314112,0.0105701694547665,0.118993483182769,0.160428547445454,1.384966710862e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0471756844115191,0.00357341183797028,0.0401717972090974,0.0541795716139409,1.51047231708485e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANG,Angiogenin,42618,0.0453854428843831,0.00343860335173791,0.0386457803149767,0.0521251054537894,1.57120028961041e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.090072055943378,0.0068304956132794,0.0766842845413504,0.103459827345406,1.82949112829944e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRADD,Death domain-containing protein CRADD,42476,0.100990892796151,0.00766125625630743,0.0859748305337886,0.116006955058514,1.96890762820491e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,TADA3,Transcriptional adapter 3,40451,0.0532759168149235,0.00404268492750392,0.0453522543570158,0.0611995792728311,2.2863779429288e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,YWHAQ,14-3-3 protein theta,40283,0.098729847740252,0.00749743082812461,0.0840348833171278,0.113424812163376,2.626450155283e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0585221036681538,0.00444640569365346,0.049807148508593,0.0672370588277146,2.84796851743701e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.124245237938702,0.0094498846417713,0.105723464040831,0.142767011836574,3.09507314105591e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,COCH,Cochlin,40511,0.0630666401378177,0.00479589116396602,0.0536666934564443,0.0724665868191911,3.29135060162109e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0618399865485353,0.00470536796206485,0.0526174653428882,0.0710625077541824,3.32134264793176e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0600904393580904,0.00457862708667796,0.0511163302682016,0.0690645484479791,4.70379761876995e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY4,Protein canopy homolog 4,42587,0.0990782520607448,0.00756208308925585,0.0842565692058034,0.113899934915686,5.56975728554913e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0796834971483458,0.0060839300908884,0.0677589941702045,0.0916080001264871,5.97321282560092e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,RFC4,Replication factor C subunit 4,40451,0.0283303708752919,0.00216198948033462,0.024092871493836,0.0325678702567477,6.03031004526257e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEXN,Nexilin,40532,0.0921954854325978,0.00704307691697294,0.0783910546753308,0.105999916189865,7.16226903864073e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCG,Gamma-synuclein,42495,0.0922891986954541,0.00706520722461432,0.07844139253521,0.106137004855698,9.33825999672169e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREH,Trehalase,40527,0.099295972431985,0.00760482004439614,0.0843905251449686,0.114201419719001,1.10212259413847e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL11,Eotaxin,42754,0.0490539444491454,0.00376039993011589,0.0416835605861183,0.0564243283121726,1.16131144892135e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGLL,Monoglyceride lipase,42654,0.114372245680566,0.00877611672439577,0.0971710569007506,0.131573434460382,1.37360153074215e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON2,Spondin-2,42562,-0.0479423510256485,0.00367939938412474,-0.055153973818533,-0.040730728232764,1.41986947217076e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0779402686801319,0.00598085582094904,0.0662177912710718,0.089662746089192,1.53623537481272e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIFBP,KIF-binding protein,42587,0.108491192189794,0.00834498857900249,0.0921350145749492,0.124847369804639,2.06843225216036e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0765557446818862,0.00589010775662481,0.0650111334789016,0.0881003558848708,2.18744731116876e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.110150047643943,0.00848716503886643,0.0935152041677652,0.126784891120122,2.75395817900211e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO3,Forkhead box protein O3,42346,0.126156465900409,0.00972315439112897,0.107099083293796,0.145213848507022,2.91746431033599e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6AP2,Renin receptor,42346,0.0536510676316269,0.00413948025455002,0.0455376863327089,0.061764448930545,3.49515874896594e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0547079736304912,0.00422417314026093,0.0464285942755798,0.0629873529854026,3.90434309774665e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.167925594223224,0.0129864038342615,0.142472242708072,0.193378945738377,5.07846893088353e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA11,Annexin A11,42570,0.0882647954097378,0.00682581862012108,0.0748861909143004,0.101643399905175,5.08214435538991e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,POSTN,Periostin,40527,-0.0511319734916655,0.00395331108793662,-0.0588804632240212,-0.0433834837593097,5.37440073741562e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.103157555826851,0.0079928879507561,0.0874914954433691,0.118823616210333,7.01193060127088e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.068141191345685,0.00528338284453648,0.0577857609703935,0.0784966217209765,8.63289833481388e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0659728654717626,0.00511542094816865,0.0559466404133521,0.0759990905301732,8.7998089895093e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.102888465893526,0.00798326419829144,0.0872412680648749,0.118535663722177,8.91342045307085e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM3,Dynamin-3,40482,0.0722611985799352,0.00561669910974388,0.0612524683248372,0.0832699288350332,1.29432025805565e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN3,Centrin-3,40449,0.0995745883369727,0.00774013966980158,0.0844039145841616,0.114745262089784,1.30855687742186e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.109270210030848,0.00850143917315928,0.0926073892514556,0.12593303081024,1.37686709585203e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED8,Protein TMED8,40449,0.134118567029269,0.0104288507019726,0.113678019653403,0.154559114405135,1.38339965298331e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.12733383838574,0.0099329789219726,0.107865199698673,0.146802477072806,2.3284460460816e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB9,Serpin B9,42495,0.0431454996985698,0.00336928237016436,0.0365417062530477,0.0497492931440919,2.5354644692971e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.162677591679542,0.0126966498037755,0.137792158064142,0.187563025294942,2.56135621159578e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0769410748948181,0.00600632630647081,0.0651686753341353,0.0887134744555009,2.65716225641102e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB1,Carboxypeptidase B,42794,0.0796097533249529,0.00622164120145031,0.0674153365701103,0.0918041700797955,2.84515333420393e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0571921533837836,0.00446985547816722,0.0484312366465758,0.0659530701209913,2.89656198251554e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0863995573443778,0.00675441909052651,0.0731608959269459,0.0996382187618098,3.34700446233239e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILPL2,RILP-like protein 2,40511,0.126512854129127,0.00989459512238721,0.107119447689248,0.145906260569006,3.5458933895568e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2,Prothrombin,40539,0.0194667521599003,0.00152311490368747,0.0164814469486729,0.0224520573711278,3.78083877515025e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESYT2,Extended synaptotagmin-2,40483,0.107312415346082,0.00841383438321172,0.0908212999549874,0.123803530737177,5.3103573229208e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRAS,Ras-related protein R-Ras,40182,0.169031164753848,0.0132604853840771,0.143040613401057,0.195021716106639,5.91730000669372e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL3,C-C motif chemokine 3,42594,0.0750668481168387,0.0058969953539928,0.0635087372230128,0.0866249590106646,6.61589531100604e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAX,Protein max,42311,0.136554757953759,0.0107311685297076,0.115521667635532,0.157587848271985,7.08807213469792e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0694072347175893,0.00545675363858244,0.0587119975859677,0.0801024718492108,7.52578229970057e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBKS,Ribokinase,42317,0.0647882295857943,0.00509444964154812,0.05480310828836,0.0747733508832286,7.80556340892527e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACYBP,Calcyclin-binding protein,40267,0.132017700530205,0.0104074371129781,0.111619123788768,0.152416277271642,1.28794895396182e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP10,Caspase-10,42311,0.0928548547329086,0.00732821186728364,0.0784915594730327,0.107218149992785,1.40448890125824e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0599559208017457,0.00473575821057547,0.0506738347090178,0.0692380068944736,1.60183462563554e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCB,Tubulin-folding cofactor B,42495,0.128923807336153,0.010192724493625,0.108946067328648,0.148901547343658,1.84617580604655e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0843823157131781,0.00666857487222833,0.0713119089636105,0.0974527224627456,1.88569323529598e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0686900879179361,0.00543554965877277,0.0580364105867415,0.0793437652491308,2.37171420922003e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0753227052281324,0.00596464890507864,0.0636319933741783,0.0870134170820866,2.37793060135993e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE2,Glia-derived nexin,40511,0.0828107883396512,0.00656720315744694,0.0699390701510552,0.0956825065282472,3.26744087899846e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHD3,EH domain-containing protein 3,40223,0.151206372084027,0.0119934073315047,0.127699293714278,0.174713450453776,3.41155756112838e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0411530687513592,0.00326686396954612,0.0347500153710488,0.0475561221316696,3.88229501177271e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.050950613857679,0.00405015299952486,0.0430123139786103,0.0588889137367477,4.32458564259274e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRY2,Protein sprouty homolog 2,42370,0.118544447375554,0.00942255875306733,0.100076232219542,0.137012662531566,4.334606932336e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0660193911249738,0.00524868888668469,0.0557319609070718,0.0763068213428757,4.44567670778809e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.0469250299947649,0.00373181778108464,0.039610667143839,0.0542393928456908,4.65072854334084e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0297954934815144,0.00237028667000851,0.0251497316082977,0.034441255354731,4.87058639475902e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.063124297072245,0.00502629148795303,0.053272765755857,0.0729758283886329,6.23562456532333e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIN2,Bridging integrator 2,42611,0.116026107493078,0.00924644772424197,0.0979030699535633,0.134149145032592,6.47019357871337e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.10808026046,0.0086126821824468,0.0911994033824042,0.124961117537596,7.05671538378642e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.118500926827746,0.00946096089147232,0.0999574434804607,0.137044410175032,8.68798474890293e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0631935083084356,0.00504621385200402,0.0533029291585077,0.0730840874583634,8.85903369922236e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS2,Trypsin-2,42689,0.0716522778109063,0.00572970678217332,0.0604220525178465,0.082882503103966,1.09970922106307e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.104287573207864,0.00835941384181194,0.0879031220779121,0.120672024337815,1.61396276861484e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD69,Early activation antigen CD69,42585,0.111529196784754,0.0089527397785186,0.0939818268188573,0.12907656675065,1.99906997522176e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP2,Caspase-2,42594,0.0858750513349775,0.00689442749360569,0.0723619734475104,0.0993881292224447,2.04431438074733e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0619419866853355,0.00497063829940685,0.0521995356184981,0.0716844377521729,2.06463169932239e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.121755030312294,0.00977717986434088,0.102591757778186,0.140918302846402,2.11486832918834e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0885880744077323,0.00712529139674375,0.0746225032701145,0.10255364554535,2.70392234698394e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA5,Integrin alpha-5,42611,0.0319131171611286,0.00256741738986104,0.026880979077001,0.0369452552452563,2.8075326757216e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0586723207226379,0.00472674997904918,0.0494078907637015,0.0679367506815743,3.46209884095341e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,THTPA,Thiamine-triphosphatase,40436,0.111533307725796,0.00899034445079046,0.093912232602247,0.129154382849346,4.11947573501409e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN2,Centrin-2,42311,0.085456140148213,0.00689176746682631,0.0719482759132334,0.0989640043831926,4.12344119458864e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0967198722540921,0.00779831286457662,0.0814351790395219,0.112004565468662,4.33035262621096e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.107792473756862,0.00869211805054899,0.0907559223777857,0.124829025135938,4.35696572722856e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.074314007664082,0.00599720192814249,0.0625594918849227,0.0860685234432413,4.50664101493291e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,F12,Coagulation factor XII,40539,0.052608244902766,0.00424952193766628,0.0442791819049401,0.060937307900592,5.65254196764134e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0533000986179955,0.00430837260482917,0.0448556883125303,0.0617445089234607,6.30171850948504e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.045734864163343,0.00370069646876423,0.0384814990845651,0.0529882292421209,6.76836419361495e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GET3,ATPase GET3,40511,0.0684004206517391,0.00553235939077205,0.0575569962458259,0.0792438450576523,6.89804008754931e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARK7,Parkinson disease protein 7,42611,0.0655271994593449,0.00530653249938936,0.0551263957605418,0.0759280031581481,7.68139058962345e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0716020622648607,0.0057995136325642,0.0602350155450348,0.0829691089846865,7.88804491106817e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0924503580742479,0.0074938142294463,0.0777624821845331,0.107138233963963,9.71175739119981e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0253528922318346,0.00205731437518308,0.0213205560564757,0.0293852284071934,1.13335860231105e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0450989099008658,0.0036657095491095,0.0379141191846112,0.0522837006171204,1.34033078166799e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.084170032934669,0.00684172245907372,0.0707602569148845,0.0975798089544535,1.3484483079658e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0819533863559823,0.00666269272707064,0.0688945086109239,0.0950122641010408,1.39697389924119e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF19,Fibroblast growth factor 19,42676,0.0977742549856822,0.00795267069970544,0.0821870204142595,0.113361489557105,1.48429488715075e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA1,Carboxypeptidase A1,42794,0.0787484479150079,0.00640754029911105,0.0661896689287502,0.0913072269012655,1.56358683289411e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK13,Kallikrein-13,42381,0.0581243376217018,0.00473375946733349,0.0488461690657281,0.0674025061776754,1.8184817151823e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSZ,Cathepsin Z,42648,0.0405745353274288,0.0033057577917093,0.0340952500556786,0.047053820599179,1.91161254058239e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTBDN,Retbindin,42587,0.0376091636621889,0.00306499147191352,0.0316017803772384,0.0436165469471394,1.99498551464322e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.101328362418906,0.00825312012003029,0.0851522469836466,0.117504477854165,2.0084722283667e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICALL2,MICAL-like protein 2,40182,0.0865642299121592,0.00705156604966057,0.0727431604548245,0.100385299369494,2.05040629806326e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGF,Pro-epidermal growth factor,42597,0.12891448130265,0.0105122027750033,0.108310563863643,0.149518398741656,2.1787714237205e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4D,Semaphorin-4D,42711,0.0375323600214389,0.00306412833378802,0.0315266684872143,0.0435380515556634,2.5869721028927e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0747059599323586,0.00609944665762889,0.062751044483406,0.0866608753813112,2.62048454698381e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PF4,Platelet factor 4,40463,0.122883651359097,0.0100388062180969,0.103207591171628,0.142559711546567,3.10088891572196e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0917010988102933,0.00749575690756074,0.0770094152714743,0.106392782349112,3.15362589070174e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0847569983932333,0.00693306754195491,0.0711681860110016,0.0983458107754649,3.47536470761568e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0710125149415711,0.00581219054297592,0.0596206214773383,0.0824044084058039,3.78960271398397e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0947421755849291,0.0077584996108768,0.0795355163476106,0.109948834822248,4.09353814358525e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FEN1,Flap endonuclease 1,42346,0.0797691991082297,0.00653441629710482,0.0669617431659042,0.0925766550505551,4.33158535860089e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0831929101195507,0.00681813677707162,0.0698293620364903,0.0965564582026111,5.06642244155953e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.138250953485119,0.0113514917851487,0.116002029586228,0.160499877384011,6.12464020314573e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.123279464066885,0.0101221325581523,0.103440084252906,0.143118843880863,6.64738758498198e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.147167131653854,0.0120864818913653,0.123477627146778,0.17085663616093,6.84935342159662e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0593280398094254,0.0048747869349305,0.0497734574169616,0.0688826222018892,7.27697259075096e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP7,Caspase-7,40483,0.103912877940984,0.00855245278368931,0.0871500704849527,0.120675685397015,9.30876852807447e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD244,Natural killer cell receptor 2B4,42754,0.034102850226767,0.00281043105086244,0.0285944053670766,0.0396112950864573,1.03808903485164e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.113711787568749,0.0093662826722497,0.0953538735311396,0.132069701606358,1.05609484341652e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.111781511636812,0.00921949370809035,0.0937113039689546,0.129851719304669,1.28320368223759e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0755757037382411,0.00623418050185953,0.0633567099545964,0.0877946975218858,1.30799613854498e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIAPIN1,Anamorsin,42679,0.0768273452805502,0.00634908790979374,0.0643831329773545,0.089271557583746,1.56534550326994e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.109841508566228,0.00908343651137074,0.0920379730039417,0.127645044128515,1.72990420115176e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.060036189132977,0.00496234387834647,0.0503099951314179,0.069762383134536,1.73585886171152e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0491292718692504,0.00406438087181194,0.041163085360499,0.0570954583780018,1.97156947855803e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0292374118374248,0.00242294868148558,0.024488432421713,0.0339863912531365,2.33939018631447e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMT,Catechol O-methyltransferase,42214,0.102528706102313,0.00851011285365584,0.0858488849091476,0.119208527295478,2.99037356488188e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0342455050198786,0.00284659958342328,0.028666169836369,0.0398248402033882,3.64933589136746e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARC,SPARC,42679,0.0862567120544298,0.00717167309619523,0.0722002327858872,0.100313191322972,3.76841039580483e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5E,5'-nucleotidase,42679,0.0698335419691327,0.00580659712635931,0.0584526116014684,0.0812144723367969,3.8061556904491e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,C19orf12,Protein C19orf12,42311,0.0785092319188381,0.0065293685576085,0.0657116695459254,0.0913067942917508,3.96804921408124e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0779583277434084,0.00648060400352633,0.0652563438964968,0.09066031159032,3.96959731337059e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0745439180366166,0.00620721074552797,0.0623777849753818,0.0867100510978514,4.68431781707697e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0465668135371607,0.00388578212471279,0.0389506805727236,0.0541829465015978,6.35848641246848e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D5,TBC1 domain family member 5,42594,0.0962994174428476,0.00803578551028656,0.080549277842686,0.112049557043009,6.3629725571063e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTF1,Cardiotrophin-1,42357,0.103156991392962,0.00860817474136991,0.086284968899877,0.120029013886047,6.42352016779723e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0759061740057594,0.00634251311140099,0.0634748483074135,0.0883374997041054,8.27028894880863e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0696856472803391,0.00582686558554373,0.0582649907326734,0.0811063038280048,8.5787997009143e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0466893255987988,0.00390576921778704,0.0390340179319362,0.0543446332656614,9.14920872415974e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0762614163387809,0.00638605291579016,0.0637447526238322,0.0887780800537296,1.13521843763404e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.110585292730375,0.00928091734713322,0.0923946947299934,0.128775890730756,1.43790726907595e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,LARP1,La-related protein 1,40451,0.0746360843195927,0.00627048505742351,0.0623459336070427,0.0869262350321428,1.79258626379899e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.0695226286370605,0.00584439129454688,0.0580676216997487,0.0809776355743724,1.82985369852564e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0578426732698565,0.00486197278236258,0.0483132066164259,0.0673721399232872,1.91773040069008e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.120407332245422,0.010145451904642,0.100522246512323,0.14029241797852,2.51648394601157e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.105504532701226,0.00889395070748145,0.0880723893145619,0.122936676087889,2.88481257204964e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0727559759230275,0.00613302209307471,0.0607352526206011,0.0847766992254539,2.88726857246939e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0657814667836122,0.00554915630324631,0.0549051204292494,0.0766578131379749,3.20584078111227e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0835094216726479,0.00705812878737202,0.0696754892493987,0.097343354095897,4.14507892913892e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0810003394359746,0.00685016162685058,0.0675740226473474,0.0944266562246017,4.19340807126841e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.056799540449603,0.00480184061386345,0.0473879328464307,0.0662111480527754,4.28255356604804e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0793634536061376,0.00672223660381963,0.0661878698626511,0.0925390373496241,5.67707697469324e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS9,Galectin-9,42620,0.0390258646422817,0.00330830939607632,0.0325415782259722,0.0455101510585913,5.86362809930662e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0742575793297895,0.00630360400153645,0.061902515486778,0.0866126431728009,7.14810334748258e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11,Coagulation factor XI,40383,0.0363798209653153,0.0030877723409632,0.0303277871770275,0.0424318547536032,7.46236373299007e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMVK,Phosphomevalonate kinase,42303,0.130257435870015,0.0110747065473449,0.108551011037219,0.151963860702811,8.87973578662618e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPB,Natriuretic peptides B,42357,-0.17108679383869,0.0145540903824309,-0.199612810988254,-0.142560776689125,9.56460159604239e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0876326674443811,0.007452274068986,0.0730262102691685,0.102239124619594,9.68922549158481e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.0262832444245207,0.00223777405925696,-0.0306692815806644,-0.0218972072683771,1.0648482581254e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX4,Syntaxin-4,42587,0.0714192068498434,0.00608822168970261,0.0594862923380262,0.0833521213616605,1.26655490496506e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0662239822642763,0.00565407806158706,0.0551419892635656,0.0773059752649869,1.67295351951386e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0442880191690194,0.00379433449968555,0.0368511235496357,0.0517249147884031,2.67566942625777e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2,Microtubule-associated protein 2,40483,0.0555838132260796,0.00476220137614806,0.0462498985288294,0.0649177279233298,2.68408654658698e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MENT,Protein MENT,40283,-0.0276434312780635,0.00237482822876691,-0.0322980946064466,-0.0229887679496803,3.90526367597346e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0634848366535885,0.00545708638248126,0.0527889473439252,0.0741807259632518,3.95381872405075e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0289174317075883,0.00248997762461938,0.0240370755633343,0.0337977878518423,4.95070246563445e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGT1,Protein SGT1 homolog,42346,0.0953407704294605,0.00821050607608919,0.0792481785203257,0.111433362338595,5.07113543787579e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0786481064162797,0.00677348931363263,0.0653720673615597,0.0919241454709997,5.11983336654633e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.10615180984856,0.00914320836477277,0.0882311214536058,0.124072498243515,5.4975814340028e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.148743993089499,0.0128215497437842,0.123613755591682,0.173874230587315,5.70166374107358e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0876872097250502,0.00756505767265029,0.0728596966866556,0.102514722763445,6.88400813832516e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSNAX,Translin-associated protein X,40116,0.0469084733190571,0.00404932733955923,0.038971791733521,0.0548451549045932,7.49883186618527e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0624900031346999,0.00539537623939467,0.0519150657054863,0.0730649405639134,7.58251425967071e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.127489449559479,0.0110183130503359,0.10589355598082,0.149085343138137,8.66218797891997e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0851849147171982,0.00737617275507394,0.0707276161172533,0.0996422133171431,1.11298788033751e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACYP1,Acylphosphatase-1,40250,0.0774118333017395,0.00670319724149982,0.0642735667083999,0.0905500998950792,1.12632101032505e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0307042673255489,0.00266030822319832,0.0254900632080802,0.0359184714430176,1.13502342323819e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.110396548886252,0.009570735234265,0.0916379078270923,0.129155189945411,1.23202457284751e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM3,Junctional adhesion molecule C,40283,0.0597727732373911,0.00519211823670221,0.0495962214934548,0.0699493249813275,1.70607730432407e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.0887619914740414,0.0077143477405,0.0736418699026614,0.103882113045421,1.70817370958095e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.10125537362691,0.0088059019975273,0.0839958057117561,0.118514941542063,1.99441632170147e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB1,Heat shock protein beta-1,42448,0.0796364454238338,0.0069337019147334,0.0660463896709564,0.0932265011767113,2.17464093316609e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7,Interleukin-7,42594,0.0747366535984053,0.00651047368993494,0.0619761251661328,0.0874971820306778,2.32012580964612e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP2,Neuropilin-2,42611,-0.0338801138330764,0.00295296963019336,-0.0396679343082553,-0.0280922933578974,2.49020956156723e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PENK,Proenkephalin-A,40283,0.0384777078427768,0.00335854208782111,0.0318949653506474,0.0450604503349062,3.21972116631594e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0395448959345123,0.00345512028609337,0.0327728601737693,0.0463169316952553,3.42911851274063e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.069100048828801,0.00603774001015627,-0.0809340192487073,-0.0572660784088947,3.44490038167156e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK10,Kallikrein-10,42636,0.0477476142194375,0.0041724015648083,0.0395697071524132,0.0559255212864617,3.48928378007876e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0428523838891235,0.00374657904253702,0.0355090889657509,0.0501956788124961,3.99525566069748e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRD2,Protein ZNRD2,40449,0.0816378531528849,0.00714373096707925,0.0676361404574096,0.0956395658483602,4.4433500127976e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.106532777967275,0.00932157455397159,0.088262491841491,0.12480306409306,4.4450007780761e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,MET,Hepatocyte growth factor receptor,42654,-0.0232833291290046,0.00203981036177944,-0.0272813574380923,-0.0192853008199169,4.86710030128047e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0931088024303677,0.00817123257405693,0.0770931865852161,0.109124418275519,6.53520229766987e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0704962373961054,0.00619295129253204,0.0583580528627426,0.0826344219294682,6.98821955558939e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0962795915524652,0.00845550347769378,0.0797068047361854,0.112852378368745,7.10270779652091e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0758400535945815,0.00666732419624643,0.0627720981699385,0.0889080090192245,7.63620720783631e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG2,Secretogranin-2,42636,0.039961198758759,0.00351602647483436,0.0330697868680837,0.0468526106494343,8.49992758007111e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0735089578252303,0.00647387614512562,0.0608201605807841,0.0861977550696765,9.60033664688196e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0653888095841911,0.00575946938517144,0.0541002495892551,0.0766773695791272,9.76730399910084e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRGN,Neurogranin,40532,0.10540276958926,0.00929196192750798,0.0871905242113445,0.123615014967176,1.15500633442072e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.121376090061033,0.0107077036302051,0.100388990945831,0.142363189176235,1.2681898477536e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0521734918177939,0.00460577190612832,-0.0612008047538054,-0.0431461788817823,1.30057466753358e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0595773484314696,0.00526163508181857,0.0492645436711052,0.069890153191834,1.36997295043451e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN1,Ficolin-1,40515,0.0646260580590082,0.00571232814420328,0.0534298948963698,0.0758222212216466,1.62136959726482e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0552028168739593,0.00488356995339101,0.0456310197653129,0.0647746139826056,1.71305751082732e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL7,C-C motif chemokine 7,42594,0.0686468449113103,0.00607337795380802,0.0567430241218466,0.080550665700774,1.72609141528244e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB6,Serpin B6,42679,0.0670186161932291,0.0059312606174318,0.0553933453830628,0.0786438870033955,1.79601136100761e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.0996200544754562,0.00881837582155202,0.0823360378652142,0.116904071085698,1.95605035005989e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CERT,Ceramide transfer protein,42311,0.0707996933109827,0.00627103594310889,0.0585084628624893,0.0830909237594761,2.0108115682635e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPBP,Platelet basic protein,40471,0.0972734572253322,0.00861329381758793,0.0803914013428598,0.114155513107805,2.03446947379456e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0566914748918415,0.00502429354210652,0.0468438595493127,0.0665390902343703,2.29356409525052e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0885519863343047,0.00786052609234402,0.0731453551933104,0.103958617475299,2.78915571579311e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0411019991932032,0.00365153912362765,0.0339449825108931,0.0482590158755134,2.94062698921459e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.114277166957173,0.010149903460723,0.0943833561741554,0.13417097774019,2.99568430684196e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL2,C-C motif chemokine 2,42475,0.0614816756078484,0.00546783264615062,0.0507647236213932,0.0721986275943036,3.34917759198788e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLG,Plasminogen,40285,0.0247188672749347,0.0021975272669735,0.0204117138316667,0.0290260207182028,3.38956655437649e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP3,Stromelysin-1,42611,-0.058350214699096,0.00519177435716301,-0.0685260924391355,-0.0481743369590565,3.54263923599567e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMFG,Glia maturation factor gamma,40511,0.08224350750121,0.0073147481628552,0.0679066011020138,0.0965804139004062,3.55811189320703e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.079583790395118,0.00708142858622802,0.0657041903661111,0.0934633904241249,3.81730789408507e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0732941261648116,0.00653879364883008,0.0604780906131046,0.0861101617165185,4.98368870723028e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.034755114933614,0.00309971013644415,0.0286796830661835,0.0408305468010446,5.05587306203718e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOC1,Apolipoprotein C-I,40516,0.0424159510800308,0.00378434258749236,0.0349986396085458,0.0498332625515158,5.27733590925805e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP3,Caspase-3,42794,0.0995535678452276,0.00888817223401481,0.0821327502665586,0.116974385423897,5.41894443468834e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0323972298916618,0.00289361963545912,0.0267257354061619,0.0380687243771617,5.7091201435646e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDT,D-dopachrome decarboxylase,40527,0.0477392187228796,0.00426259095419905,0.0393845404526494,0.0560938969931097,5.81366284545954e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0394696283823982,0.00352509136325034,0.0325604493104275,0.0463788074543689,6.01299907054732e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTF2,Transcription termination factor 2,40182,0.0562559364926777,0.00502434359070467,0.0464082230548966,0.0661036499304589,6.07098634539216e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA4,Carbonic anhydrase 4,42794,-0.0277428555061104,0.00247921782730779,-0.0326021224476337,-0.0228835885645871,6.09494916545377e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRB1,Chymotrypsinogen B,42611,0.0667061999271095,0.00596128496041239,0.0550220814047012,0.0783903184495178,6.13695964391353e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTD,Deoxycytidylate deaminase,40283,0.107603474650949,0.00961456760906411,0.088758922137183,0.126448027164714,6.39561747828979e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0695017966881339,0.00622008158019282,-0.0816931565853118,-0.057310436790956,7.8258412850097e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.106494222601162,0.00953792310397753,0.0877998933173658,0.125188551884958,8.07631471713638e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.0877635357994969,0.00786680311869476,0.0723446016868552,0.103182469912139,9.44106923953789e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.0981009048084149,0.00879954184505497,0.0808538027921071,0.115348006824723,9.83973895956994e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPSE,Heparanase,40408,0.107130131748933,0.00960969552819937,0.088295128513662,0.125965134984204,1.03493463762419e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.136940641469666,0.0123170420037856,-0.161082043797085,-0.112799239142246,1.37076095135684e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,MESD,LRP chaperone MESD,42611,0.136759850614516,0.0123278207144721,0.112597322014151,0.160922379214881,1.79207835426612e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD22,B-cell receptor CD22,42754,0.0495826505587844,0.00447715868917187,0.0408074195280076,0.0583578815895613,2.20546167628211e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.120669632641119,0.0108931407544325,0.0993190767624315,0.142020188519807,2.29476927008281e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCA,Calcitonin,42476,0.0719397013807778,0.00650258847836469,0.059194627963183,0.0846847747983726,2.5146328031417e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18,Interleukin-18,42566,0.0526895407411288,0.00476611044202335,0.043347964274763,0.0620311172074946,2.74784498444989e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,WDR46,WD repeat-containing protein 46,40451,0.0407440156298186,0.00368656957277696,0.0335183392671758,0.0479696919924615,2.99456677950134e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.123174625412442,0.0111503352213482,0.101319968378599,0.145029282446284,3.00986337694009e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0724186026065942,0.00655456730254816,0.0595716506935998,0.0852655545195886,3.1105214264154e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0599906596027965,0.0054304583185534,-0.0706343579071611,-0.0493469612984318,3.15514335719402e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.125608543949525,0.0113760380775665,0.103311509317495,0.147905578581556,3.18400470892568e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.115074556176502,0.0104323455137691,0.0946271589695147,0.135521953383489,3.81863727882756e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0358079763397242,0.00324838394371258,0.0294411438100475,0.0421748088694008,3.88701430137913e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT1,Angiopoietin-1,42554,0.0946277049707214,0.00859603196030361,0.0777794823285263,0.111475927612916,4.60045985570451e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0844403327157261,0.00767354493568167,0.06940018464179,0.0994804807896621,5.09532797167412e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0778347493371359,0.00707572483786139,0.0639663286549276,0.0917031700193442,5.34414448339003e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0940140236630262,0.00855275900660935,0.0772506160100719,0.110777431315981,5.4743109913454e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST3,Cystatin-C,42659,0.034105087137437,0.00310338544764705,0.0280224516600487,0.0401877226148252,5.63549998299365e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0398411386489045,0.00362951811100682,-0.0469549941464778,-0.0327272831513311,6.87422891351138e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA3,Annexin A3,42681,0.078034611080127,0.00712372934201987,0.0640721015697681,0.091997120590486,8.30961596752678e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.10550804071477,0.00963848925120628,0.0866166017824054,0.124399479647134,9.52579861261253e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0804425685187009,0.00735307605424587,0.066030539452379,0.0948545975850228,9.68368798814062e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0697292563849968,0.00637950938878137,0.0572254179829854,0.0822330947870083,1.13754747108646e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0338598469838028,0.0031004418476832,-0.0399367130052619,-0.0277829809623437,1.19640191270563e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0863058329647804,0.00791061836397309,0.0708010209713932,0.101810644958168,1.42602011793637e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0644764334258327,0.00591615377683649,0.0528807720232332,0.0760720948284322,1.53406972012563e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.044048482958972,0.00404502074320066,0.0361202423022987,0.0519767236156453,1.68254944393822e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0535590606156773,0.00491898716040945,0.0439178457812748,0.0632002754500799,1.79608854801789e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMTN,Smoothelin,40460,0.102978860884172,0.00945791331236314,0.0844413507919399,0.121516370976403,1.7993916830479e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0355353105888442,0.0032677674128487,-0.0419401347180276,-0.0291304864596607,2.0578099948365e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.062166733876832,0.00572042646558799,0.0509546980042795,0.0733787697493844,2.2657240134203e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC4,Syndecan-4,42636,0.0525535377666073,0.00484005524531689,0.0430670294857862,0.0620400460474284,2.3716362895548e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFASC,Neurofascin,42754,0.0323362467772621,0.0029821577455129,0.0264912175960568,0.0381812759584674,2.77855214577752e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLB,Beta-klotho,42311,-0.0832433394951958,0.00767716199377787,-0.0982905770030004,-0.0681961019873912,2.81044816571816e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.03684426527516,0.00340418436841913,0.0301720639130585,0.0435164666372614,3.46141608825499e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0584437114806017,0.00539899537773235,0.0478616805402462,0.0690257424209571,3.56928595001314e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,DXO,Decapping and exoribonuclease protein,40483,0.050675845623587,0.00468326241118057,0.041496651297673,0.0598550399495009,3.7353040948209e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0763371750206031,0.00705919687299836,0.0625011491495264,0.0901732008916799,4.05203178717881e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0743951734919803,0.00689045536646507,0.0608898809737087,0.0879004660102518,4.87716977110641e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0381388471591671,0.00353298052525533,0.0312142053296667,0.0450634889886676,4.95847130659257e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPA,Apolipoprotein(a),40324,-0.200968376086851,0.0186686628410817,-0.237558955255371,-0.164377796918331,6.82945469290779e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL4,C-C motif chemokine 4,42642,0.0755600506245518,0.00702348947919824,0.0617940112453233,0.0893260900037804,6.97545334202556e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM106A,Transmembrane protein 106A,40451,0.077233905812319,0.00718202589587573,0.0631571350564026,0.0913106765682354,7.67903935690898e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0670011259675124,0.00623339495684158,0.0547836718521029,0.0792185800829219,8.09304670205265e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.0929349589782027,0.0086518151911991,0.0759774012034524,0.109892516752953,8.33946898821226e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.138320684120676,0.0128800090072309,0.113075866466503,0.163565501774848,8.97389186405014e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0489791281836026,0.00456416111799319,-0.0579248839748692,-0.040033372392336,9.30975308976252e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0528879637485786,0.00492943265127016,0.0432262757520891,0.0625496517450681,9.59308186693351e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.067461522694086,0.0062923818832934,0.055128454202831,0.0797945911853411,1.03933350700195e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0624679695338285,0.00583006775772601,0.0510410367286855,0.0738949023389714,1.16610602169871e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0870073018063353,0.00813364992948442,-0.102949255668125,-0.0710653479445458,1.34203978700251e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.0336346591972916,0.00314311221629202,0.0274741592533593,0.039795159141224,1.34733596936435e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0729573616205593,0.00682608320914046,0.059578238530644,0.0863364847104746,1.48839001254141e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0298696299118133,0.00279700447577911,-0.0353517586843403,-0.0243875011392862,1.6284302273518e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD2,Polycystin-2,40116,0.063851734854244,0.00598270199810233,0.0521256389379635,0.0755778307705246,1.84357826593983e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0751085301559203,0.00703863534014895,0.0613128048892284,0.0889042554226123,1.87990065716584e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0477500876189223,0.0044774294395539,0.0389743259173966,0.0565258493204479,2.00398044874831e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCA,Tubulin-specific chaperone A,40283,0.0923980785181036,0.00867023963029098,0.0754044088427333,0.109391748193474,2.17162480963154e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,XCL1,Lymphotactin,42721,0.0613133037121749,0.00577004828164139,0.0500040090801578,0.072622598344192,2.85922337889013e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,POMC,Pro-opiomelanocortin,40223,0.0763045246103987,0.00718376777569136,0.0622243397700436,0.0903847094507537,3.15881746682078e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX8,Syntaxin-8,42594,0.052106991547159,0.00490919006182722,0.0424849790259776,0.0617290040683403,3.25391988019797e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0325785833743219,0.00307263895720312,0.0265562110182038,0.03860095573044,3.85713601912267e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.0940603809578636,0.00888107858990659,0.0766534669216466,0.11146729499408,4.15018871990379e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP2,Retinol-binding protein 2,42587,-0.084081367690569,0.00794206207794006,-0.0996478093633315,-0.0685149260178064,4.34833175486771e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0278988870411151,0.00263706510874981,0.0227302394279654,0.0330675346542647,4.94169224561565e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBN,Nibrin,42370,0.0581428217359984,0.00550387682310173,0.047355223162719,0.0689304203092778,5.55992733086105e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0928359218197561,0.00878629852316484,0.075614776714353,0.110057066925159,5.66366727887522e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0587658448086326,0.00556178302128469,0.0478647500869146,0.0696669395303506,5.70309999901261e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0358280300689743,0.00339312891944387,0.0291774973868644,0.0424785627510843,5.82856752529705e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0480025836657275,0.00455111519046401,0.039082397892418,0.056922769439037,6.92078989506849e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBI,Acyl-CoA-binding protein,42562,0.0825222613421972,0.00783240188120897,0.0671707536550276,0.0978737690293668,7.44363605895309e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0934463072156002,0.00887041742579621,0.0760602890610396,0.110832325370161,7.94024601187158e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.097255169121397,0.00924199357068489,0.0791408617228546,0.115369476519939,8.88464850068777e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBN1,Drebrin,40199,0.0538378184454638,0.00512507168392581,0.0437926779449692,0.0638829589459584,1.08606476468592e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLO1,Lactoylglutathione lyase,42357,0.062456852209262,0.00595373616702656,0.05078752932189,0.0741261750966341,1.20745590662497e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0643857851351575,0.0061366257390431,0.052357998686633,0.0764135715836819,1.23144786864526e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0342067910897519,0.00327163861234511,0.0277943794095555,0.0406192027699483,1.73069590538048e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.043013054319682,0.00412061761749328,0.0349366437893951,0.0510894648499688,2.15680239449495e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSTN,Growth/differentiation factor 8,42357,0.0571808717239826,0.00548251657852558,0.0464351392300724,0.0679266042178927,2.27896093998405e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0652546455007411,0.00625495721986391,0.0529949293498078,0.0775143616516743,2.3149138917996e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.0996545811551664,0.00955925963354621,0.0809184322734158,0.118390730036917,2.38276334388489e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0606136340273124,0.00582084021420271,0.0492047872074751,0.0720224808471497,2.70873013852998e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0620431524018841,0.00596488621361348,0.0503519754232017,0.0737343293805666,3.06081301227359e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0312467597764805,0.00300577489302868,0.0253554409861442,0.0371380785668167,3.22813288125329e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.103446093976497,0.00996236059650426,0.0839198672073487,0.122972320745645,3.81485945135147e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0566856165915388,0.00545917974373962,0.0459856242938091,0.0673856088892685,3.84895796342326e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,C3,Complement C3,39989,0.0500568896242532,0.00482616965027175,0.0405975971097206,0.0595161821387858,4.36203814815841e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.11639333635029,0.0112333300683942,0.0943760094162369,0.138410663284342,4.63584093720572e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF23,Fibroblast growth factor 23,42711,0.0578812333603761,0.0055977563658157,0.0469096308833774,0.0688528358373749,5.75059861104675e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN6,Dynactin subunit 6,42311,0.0760465052159711,0.00737343183120597,0.0615945788268074,0.0904984316051348,7.61173072616642e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0429840704654006,0.00417000321639306,0.0348108641612702,0.051157276769531,8.06564082027466e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0742140281407322,0.00720162495967245,0.0600988432197742,0.0883292130616902,8.67057428312367e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0541881592225463,0.00526309983503683,0.0438724835458741,0.0645038348992185,9.08778785226356e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0780556138388962,0.00758790681216438,0.063183316487054,0.0929279111907383,1.00227695140783e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0619188738100886,0.00603193230186491,0.0500962864984334,0.0737414611217438,1.24955231436932e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0374516331874743,0.00365274915899881,0.0302922448358366,0.044611021539112,1.41140463646267e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.124849504786258,0.0121803951225964,0.100975930345969,0.148723079226547,1.45602734784028e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0543527170197804,0.00530387176819284,0.0439571283541224,0.0647483056854384,1.49817612649173e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.0359655060642623,0.00350923571460446,0.0290874040636376,0.0428436080648871,1.53290829118447e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.039440360746216,0.00385076427895783,0.0318928627594587,0.0469878587329734,1.57838112224373e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.123702541054595,0.0120886801567425,0.10000872794738,0.14739635416181,1.73511202054652e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2R,Proteinase-activated receptor 1,42654,0.0586522562227686,0.00574182652895737,0.0473982762260122,0.069906236219525,2.08724997827287e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL8,C-C motif chemokine 8,42706,0.0633941793824298,0.00621067100776808,0.0512212642072043,0.0755670945576552,2.25450644033393e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0449981842503471,0.00441365325593752,0.0363474238687096,0.0536489446319847,2.671383277153e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0349445376003319,0.00343116562669926,0.0282194529720013,0.0416696222286624,2.84481620502422e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA1,Apolipoprotein A-I,40539,-0.0288238451459929,0.0028362476521063,-0.0343828905441213,-0.0232647997478646,3.69249109572609e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12A_IL12B,Interleukin-12,42587,0.0854717729992659,0.00842222483037173,0.0689642123317373,0.101979333666794,4.11911942089087e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0730456217025626,0.00719857290408467,0.0589364188105566,0.0871548245945685,4.32175966409137e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB1,Beta-crystallin B1,40511,0.066034192868753,0.00654069456912207,0.0532144315132738,0.0788539542242323,7.26848146210931e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0539881066055621,0.00535226372891866,0.0434976696968815,0.0644785435142427,7.70269369530962e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0783871073945129,0.00778194721292434,0.0631344908571812,0.0936397239318446,9.17484333000341e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB10,Ras-related protein Rab-10,40511,0.0552088242593938,0.00548363078987647,0.0444609079112359,0.0659567406075516,9.6378012964748e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOL1,Apolipoprotein L1,40532,0.0599645721755043,0.00597335208153446,0.0482568020956968,0.0716723422553119,1.29303885486518e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.039498596375832,0.00393474578356203,0.0317864946400504,0.0472106981116136,1.29780993222559e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,APP,Amyloid-beta precursor protein,42592,0.0684141696286266,0.00682292324862252,0.0550412400613264,0.0817870991959267,1.40305584168657e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0412679505838848,0.00411862024959635,0.0331954548946759,0.0493404462730936,1.50574205531805e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.0997302692956879,0.00996905404512503,0.0801909233672428,0.119269615224133,1.83426101154694e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0247074375050062,0.00247082631036236,-0.0295502570733164,-0.019864617936696,1.84563820373651e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0371299209035823,0.00371324359152913,0.0298519634641852,0.0444078783429794,1.93506414988724e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0812956674934519,0.00814017417152826,0.0653409261172565,0.0972504088696473,2.17468711053324e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.058653634865517,0.00588791529475882,0.0471133208877897,0.0701939488432443,2.71248971121584e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.068358250370833,0.00686600539848363,0.0549008797898051,0.0818156209518609,2.95922460410101e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1R,Complement C1r subcomponent,40539,0.0198631084823825,0.00199654892637669,0.0159498725866842,0.0237763443780808,3.17970119262028e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0481084660270954,0.00483924126551937,0.0386235531466775,0.0575933789075134,3.30338799525652e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLNK,B-cell linker protein,40199,0.0416427295912882,0.00419081516495027,0.0334287318679857,0.0498567273145907,3.60919801356671e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0829153944149698,0.00836023314153171,0.0665293374575676,0.0993014513723719,4.1827927259574e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD276,CD276 antigen,42618,-0.0374758122716678,0.00377905564981961,-0.0448827613453142,-0.0300688631980213,4.22822499768612e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0470308914748447,0.00474510235194236,0.0377304908650377,0.0563312920846517,4.45064640448976e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0306731747902825,0.00309548046306046,0.024606033082684,0.036740316497881,4.56070670556164e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0485805041417895,0.0049111843568623,0.0389545828023393,0.0582064254812396,5.60568055195738e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0530137968726731,0.00536407748939969,0.0425002049934497,0.0635273887518965,5.92686446151152e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0293577794582401,0.00297244339945176,-0.0351837685211656,-0.0235317903953147,6.29308854128681e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.100556854284007,0.010180482848832,0.0806031079002964,0.120510600667718,6.46006693369553e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL2,Chordin-like protein 2,42636,0.0479015480710536,0.00485765557936673,0.0383805431354948,0.0574225530066124,7.34166670768447e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.030751509511526,0.00311942437644681,-0.0368655812893618,-0.0246374377336903,7.55306383596033e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.0496216942227333,0.00503636948083346,-0.0594929784051669,-0.0397504100402997,7.9794291268741e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0472740909433106,0.0047995010791633,0.0378670688281505,0.0566811130584706,8.23714400826522e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,RP2,Protein XRP2,42587,0.042426514286284,0.00430963030704569,0.0339796388844745,0.0508733896880936,8.64382196494565e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0288209282772535,0.0029267876442042,0.0230844244946132,0.0345574320598937,8.76011121369914e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7,Complement component C7,40251,-0.0333095071819263,0.00338867156424713,-0.0399513034478507,-0.026667710916002,1.03936967795454e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0385731201969309,0.00393033370236939,0.0308696661402869,0.0462765742535749,1.20927451224551e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN2,Dynactin subunit 2,42587,0.0942451477095769,0.00961784289343281,0.0753941756384486,0.113096119780705,1.3544293902887e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.043035835396037,0.00439498765965127,0.0344216595831205,0.0516500112089535,1.44844143818236e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.12014581860545,0.0122761499831257,0.0960845646385239,0.144207072572377,1.52463415031437e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0602974232228853,0.00617992527201616,0.0481847696897336,0.072410076756037,2.11014487361667e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLF4,Krueppel-like factor 4,40136,0.0401410264314926,0.00412039298540242,0.0320650561801039,0.0482169966828814,2.45865828848743e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0471897389809307,0.00484893346465886,0.0376858293901993,0.0566936485716621,2.69480216639809e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2,Complement C2,42663,0.0228812342154915,0.0023561753453769,0.0182631305385528,0.0274993378924303,3.19561122999878e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPLAH,5-oxoprolinase,40223,0.0673193503138268,0.00694307175297155,0.0537109296780026,0.080927770949651,3.84651861182004e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA12,Serpin A12,42249,0.103113105043623,0.0106394046044283,0.0822598720189437,0.123966338068303,3.88593981710053e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0338691315438747,0.00349633889823307,0.0270163073033378,0.0407219557844115,4.04602523025894e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,ING1,Inhibitor of growth protein 1,42292,0.0468921655279657,0.00484821689932319,0.0373896604052922,0.0563946706506391,4.69732742962236e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1B,Meprin A subunit beta,42636,0.11736710558167,0.0121474693993629,0.0935580655589187,0.141176145604421,5.16287227003076e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0722264761436004,0.00749017995211189,0.0575457234374611,0.0869072288497397,6.22036569659263e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.081134615479615,0.00843881758375472,0.0645945330154557,0.0976746979437742,8.42056351090446e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSPN,Persephin,42594,0.0920956226351006,0.00958654245504439,0.0733059994232136,0.110885245846988,8.79975618748684e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS1,Galectin-1,42636,0.0345519435671114,0.00360534559156482,0.0274854662076444,0.0416184209265785,1.1000593482546e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.10375228801884,0.0108243905834798,0.0825364824752201,0.124968093562461,1.11747972363808e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0360020658297237,0.0037592233149728,0.028633988132377,0.0433701435270704,1.17339059624121e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX16,Syntaxin-16,42346,0.0569876273743789,0.00595068771023631,0.0453242794623157,0.068650975286442,1.17948365381369e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX,Glutaredoxin-1,42546,0.0551749042503784,0.00576161253169653,0.0438821436882532,0.0664676648125036,1.18059388547678e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0400207183263242,0.00417946580968578,0.0318289653393401,0.0482124713133084,1.19000357794549e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0824355505749633,0.00861105963413365,0.0655578736920613,0.0993132274578652,1.25099578622432e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP6,Platelet glycoprotein VI,42590,0.0854757943811741,0.00893354191061274,0.0679660522363731,0.102985536525975,1.27834076730348e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0511724396183027,0.00536854813136178,0.0406500852808336,0.0616947939557718,1.8116513446239e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0240548948600674,0.00252383949198993,0.0191081694557671,0.0290016202643676,1.82094680793975e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SWAP70,Switch-associated protein 70,40449,0.0348616414048513,0.0036646882275905,0.0276788524787739,0.0420444303309287,2.23182370288246e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0423648215430549,0.00446246746543429,0.0336183853108037,0.0511112577753061,2.68154414952051e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0673241429100927,0.00709963859706393,0.0534088512598474,0.081239434560338,2.97373143832778e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0596604217537718,0.00630133580216734,0.0473098035815238,0.0720110399260198,3.32110613846037e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0699213113496173,0.00738726799946777,0.0554422660706605,0.0844003566285742,3.41908682891074e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP5,Platelet glycoprotein V,40283,0.0350092536721345,0.0037084970482844,0.0277405994574971,0.042277907886772,4.46031591538125e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMB1,Laminin subunit beta-1,40223,0.0294602114227511,0.00312519845079874,0.0233348224591856,0.0355856003863167,5.07834081197009e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN9,Septin-9,42587,0.0275154375634306,0.00292594419656371,0.0217805869381657,0.0332502881886955,6.09717645315611e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0191611939267096,0.00203754947117458,0.0151675969632074,0.0231547908902118,6.25889272065642e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD93,Complement component C1q receptor,42141,-0.0312022179354105,0.00331961834210196,-0.0377086698859303,-0.0246957659848906,6.40111074136152e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0273750717713939,0.00291977107380854,0.0216523204667292,0.0330978230760587,8.17053602180527e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0831600827704112,0.00887557799094031,0.0657639499081682,0.100556215632654,8.67358408618311e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0267944488333298,0.00286086185028587,0.0211871596067695,0.0324017380598901,9.01292271482814e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0649060302289257,0.00695992754854367,0.0512645722337801,0.0785474882240713,1.3077318237369e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0839282424105588,0.00901505872757201,0.0662587273045177,0.1015977575166,1.48127749319764e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX9,Sorting nexin-9,42636,0.0639915337718057,0.00687706005985456,0.0505124960544908,0.0774705714891206,1.54337113937931e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0365911226225789,0.00393451306188736,0.0288794770212797,0.0443027682238781,1.62337880847983e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN4,CCN family member 4,42721,0.0382989301220739,0.00412070783695499,0.0302223427616422,0.0463755174825057,1.7059327911466e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0709602034184351,0.00763749495009802,0.0559907133162429,0.0859296935206272,1.81241648336051e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL1,Growth-regulated alpha protein,42607,0.0911047485552014,0.0098192657212396,0.0718589877415718,0.110350509368831,1.98478428337531e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0504036030033716,0.00543346605781133,0.0397540095300613,0.0610531964766818,2.01602830062109e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,APLP1,Amyloid-like protein 1,42636,-0.0492348425521246,0.00531023543219958,-0.0596429039992358,-0.0388267811050135,2.10763489367847e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.054799809965264,0.00591722610694412,0.0432020467956536,0.0663975731348745,2.32501049472208e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.0567400572828016,0.00613034816924754,0.0447245748710765,0.0687555396945268,2.44937278772581e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0384116010194241,0.00415059343168854,0.0302764378933146,0.0465467641455337,2.47268384329777e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12B,Interleukin-12 subunit beta,42754,0.0539751204513822,0.00583701836965478,0.0425345644468588,0.0654156764559055,2.64787893035232e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0692236289373282,0.0074884343910318,0.0545462975309058,0.0839009603437505,2.73338204499676e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNMT,Histamine N-methyltransferase,42439,0.0455885211799558,0.00494141880450934,0.0359033403231176,0.0552737020367941,3.23547332500798e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0457567092260728,0.00496156414009883,0.0360320435114791,0.0554813749406665,3.42917443499506e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF6,SLAM family member 6,42346,0.0367967949087094,0.00399624781668283,0.028964149188011,0.0446294406294077,3.82484752165831e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.0818471288735652,0.00890296655789979,0.0643973144200816,0.0992969433270488,4.49503912023396e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0497687790553574,0.00541672957463932,0.0391519890890643,0.0603855690216505,4.71885806318513e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABHD14B,Protein ABHD14B,42460,0.0538206614931398,0.00586193412657792,0.0423312706050471,0.0653100523812326,4.87835712457669e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH5,Cadherin-5,42794,-0.0284743599922328,0.00310253273355486,-0.0345553241500003,-0.0223933958344653,5.02652445566981e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0362157319683309,0.00395017258183813,0.0284733937079281,0.0439580702287336,5.51859620313124e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,UMOD,Uromodulin,42764,-0.0520519402746902,0.00568438646057117,-0.0631933377374097,-0.0409105428119708,6.08921269658621e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0330221404692522,0.00360688646080485,0.0259526430060746,0.0400916379324297,6.20165263045768e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMSB10,Thymosin beta-10,42611,0.0696606853816452,0.00760961530057571,0.0547458393925168,0.0845755313707736,6.25207151020086e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD84,SLAM family member 5,42594,0.0295276819482376,0.00322696957030176,0.0232028215904461,0.035852542306029,6.48850963918196e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAP3,Cytosol aminopeptidase,42370,0.0455931940645225,0.00498548304439352,0.0358216472975112,0.0553647408315338,6.81489159537683e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTNB,Dystrobrevin beta,40430,0.0400904355611615,0.00439469109935173,0.0314768410064321,0.0487040301158909,8.59150309949122e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPL14,60S ribosomal protein L14,40223,0.0375593656439635,0.00411805129541533,0.0294879851049494,0.0456307461829775,8.76035027497324e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.031118924907782,0.00341213740279257,-0.0378067142172555,-0.0244311355983086,8.77088393250126e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0812897710063856,0.00891702649595888,0.0638123990743062,0.098767142938465,8.87165708313523e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0618278122962653,0.00678471389986498,0.04852977305253,0.0751258515400007,9.13884083542668e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0427700723179406,0.00469388550851611,0.0335700567212491,0.0519700879146322,9.49487600787845e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,FADD,FAS-associated death domain protein,42636,0.0705971641162287,0.00775246724274115,0.055402328320456,0.0857919999120013,9.7014538706211e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0413403178596637,0.00455285938606462,0.032416713462977,0.0502639222563504,1.26837142021004e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRIB,Protein scribble homolog,40223,0.0845412693649287,0.00933092219305034,0.06625266186655,0.102829876863307,1.51960028440315e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA11,Integrin alpha-11,42594,-0.0316583182465816,0.0034973880962359,-0.0385131989152039,-0.0248034375779592,1.59523209975742e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0484761920505421,0.00535679942838896,0.0379768651708997,0.0589755189301845,1.63044776126919e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSNL1,Visinin-like protein 1,40483,0.0356742038207189,0.00394826959209419,0.0279355954202143,0.0434128122212236,1.89933602927917e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.035366458181769,0.00391428961403853,0.0276944505382535,0.0430384658252846,1.90254804666331e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX2,Heme oxygenase 2,42311,0.042459194897347,0.00470053460964605,0.0332461470624407,0.0516722427322532,1.90382619771378e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0276081521805182,0.00305832927641811,0.0216138267987387,0.0336024775622977,1.99673300580035e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSA,Arylsulfatase A,42611,0.0413374105808965,0.00457953904339079,0.0323615140558505,0.0503133071059424,2.01013545003573e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164,Sialomucin core protein 24,42611,0.0253952476910252,0.00281507824316191,0.0198776943344279,0.0309128010476225,2.11097176137726e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0233358481642779,0.00258747081738076,0.0182644053622116,0.0284072909663442,2.15544941178935e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.110958966794134,0.0123053193991372,0.0868405407718252,0.135077392816443,2.18927515801415e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC79,Protein unc-79 homolog,40080,0.0515396309879158,0.00572168634203661,0.0403251257575241,0.0627541362183076,2.45336018567717e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTC,Probetacellulin,42346,0.0692133571351065,0.00769353023623714,0.0541340378720817,0.0842926763981313,2.65063999463918e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0278179354054766,0.00309232907870904,0.0217569704112069,0.0338789003997464,2.65647353739243e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA2,Integrin alpha-2,40283,0.0322379575642534,0.00358471345166241,0.0252119191989951,0.0392639959295117,2.79161573654502e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.0368178640523982,0.00409819734498378,0.02878539725623,0.0448503308485665,2.96490280780028e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0539672276451788,0.0060059863987089,0.0421954943037094,0.0657389609866482,2.99247978354122e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR3,Toll-like receptor 3,42754,0.0563886118838787,0.0062807067364177,0.0440784266805,0.0686987970872574,3.11399746615411e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,SBSN,Suprabasin,40511,-0.0322228945921403,0.00360440291838449,-0.0392875243121739,-0.0251582648721067,4.49947435832571e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0628419271452162,0.00705047551792464,0.0490229951300839,0.0766608591603485,5.73393043039224e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0345750467811104,0.00388110206300764,0.0269680867376155,0.0421820068246054,5.82440217601909e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0315017273013338,0.00354038195954505,0.0245625786606255,0.0384408759420421,6.57637118421586e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0569244260836978,0.00641168639748049,0.0443575207446361,0.0694913314227596,7.84314400404356e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.0330582082495268,0.00372545570420401,0.0257563150692869,0.0403601014297666,7.98064978036413e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0601261095559997,0.00677731684427064,0.0468425685412293,0.0734096505707702,8.12476939329138e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0297149036103998,0.00335062415475164,0.0231476802670866,0.0362821269537131,8.52865042545222e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC3B,Tetranectin,40269,0.0191483790764156,0.00216131339687762,0.0149122048185355,0.0233845533342957,9.254544892178e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML2,Trem-like transcript 2 protein,42611,0.03170715694624,0.00358104519881132,0.0246883083565698,0.0387260055359102,9.47765180532034e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO1A,Coronin-1A,42353,0.0811667623700805,0.00916864019578009,0.0631962275863515,0.0991372971538095,9.62824028963723e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA13,Carbonic anhydrase 13,42483,0.0932964606701804,0.0105502027629131,0.0726180632548707,0.11397485808549,1.04711085668259e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0319299836651504,0.00361176040414638,0.0248509332730235,0.0390090340572774,1.09744669426214e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0418542599022682,0.00473807708559843,0.0325676288144952,0.0511408909900411,1.16369852384465e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.025390522636918,0.00287996482714118,-0.0310352536981147,-0.0197457915757212,1.32710560279601e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0391092221736819,0.00444491480179537,0.030397189162163,0.0478212551852008,1.58576742457299e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0362477634326147,0.00412151906239467,0.0281695860703211,0.0443259407949082,1.60811009055586e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGF,Hepatoma-derived growth factor,42700,0.083935000950171,0.00956838351678175,0.0651809692572788,0.102689032643063,1.96116883831134e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1F,Protein phosphatase 1F,40511,0.0468712675932398,0.00534470264492292,0.0363956504091909,0.0573468847772887,2.0477371206306e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENR,Density-regulated protein,40199,0.0513304807014021,0.00585676088192723,0.0398512293728247,0.0628097320299795,2.15485024052319e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDA,Cytidine deaminase,40494,0.0422093119859985,0.00482292340171042,0.0327563821186461,0.0516622418533509,2.39719302255178e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0376047458377747,0.00430087816069779,0.0291750246428071,0.0460344670327424,2.52221799240955e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0337534339139719,0.00386730132196429,0.0261735233229219,0.0413333445050219,2.9040028198715e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.0652057257164362,0.0074771134774112,0.0505505833007102,0.0798608681321621,3.08727673323789e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPH,Hephaestin,40511,0.0237629431664106,0.00272448070270917,0.0184229609891006,0.0291029253437205,3.11441106323497e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0467566412423576,0.00536723658429984,0.03623685753713,0.0572764249475853,3.34994831332557e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0870137932773194,0.00999239770148017,0.0674286937824183,0.106598892772221,3.45089433125025e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0306504079450883,0.00352258263540766,0.0237461459796893,0.0375546699104873,3.67073033273659e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF2,Fibroblast growth factor 2,42594,0.0612532654618424,0.00703983177087,0.0474551951909372,0.0750513357327476,3.67121321325356e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM3,Myomesin-3,40283,-0.0828862137387391,0.00952459305555576,-0.101554416127628,-0.0642180113498498,3.7103215841169e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.0255241107536408,0.00293705450862656,0.0197674839167328,0.0312807375905489,4.10873483960389e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.0431958878890833,0.00497352394585591,0.0334477809552057,0.0529439948229609,4.22408542062738e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN4,Cerebellin-4,42721,0.0290970986265711,0.00335102013196461,0.0225290991679204,0.0356650980852217,4.28966843119299e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.051723458446371,0.00596203820815468,0.0400378635583879,0.0634090533343542,4.59756908098299e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0592906089851377,0.00686033375754472,0.0458443548203501,0.0727368631499254,6.13008408281416e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0221535688058759,0.00256811546129205,0.0171200625017435,0.0271870751100083,7.04544929984863e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0508547230764769,0.00589786704885152,0.0392949036607279,0.0624145424922258,7.42014684806129e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.028611710936819,0.00332074344956005,0.0221030537756813,0.0351203680979567,7.85090609907935e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0370798493224021,0.00430510460684279,0.0286418442929902,0.0455178543518139,8.08003149351117e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.0464122620284264,0.00539031117882567,0.0358472521179281,0.0569772719389247,8.27586320754393e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0205252746743911,0.0023840077851869,0.0158526194154247,0.0251979299333574,8.3237644527339e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH7,Protocadherin-7,40449,0.0321299976251975,0.00373381849365089,0.0248117133776418,0.0394482818727532,8.63380517278428e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0463191135421593,0.00538548114514278,0.0357635704976794,0.0568746565866391,8.79090921961524e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0524192020259811,0.00609972620097586,0.0404637386720684,0.0643746653798938,9.52854504369494e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPPK1,Epiplakin,40223,0.0641218545207977,0.0074626054441595,0.0494951478502451,0.0787485611913503,9.66210963965128e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0533387508116368,0.00621979692549797,0.0411479488376607,0.0655295527856128,1.11413193824562e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0615755299596219,0.00718354894291496,0.0474957740315086,0.0756552858877352,1.15415720036472e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA2,Carboxypeptidase A2,42670,0.0582227993578559,0.00679816104990367,0.0448984037000447,0.0715471950156671,1.2022763477306e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0635666678089696,0.00744084741741377,0.0489826068708386,0.0781507287471006,1.44693092796788e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.041622196719591,0.00487205086661265,0.0320729770210302,0.0511714164181518,1.44841648973256e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0728774943304227,0.00853383459928356,0.0561511785158269,0.0896038101450185,1.48807642918051e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0306869534650621,0.00359436779288572,0.0236419925910061,0.0377319143391181,1.52050003026244e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSTB,Cystatin-B,42437,0.0374091485943947,0.00438298796898296,0.0288184921751881,0.0459998050136013,1.55183659862332e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSE,Cathepsin E,40283,0.0449088179680457,0.00526662233136351,0.0345862381985732,0.0552313977375182,1.69574741415749e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA2,Annexin A2,40054,0.0635585828728515,0.00746300589505758,0.0489310913185387,0.0781860744271644,1.8615674122894e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRN1,Secernin-1,42594,0.0483886227142072,0.00568594279224751,0.0372441748414021,0.0595330705870123,1.91897702466288e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0285979218334729,0.00336275124735809,0.0220069293886511,0.0351889142782948,2.05581910275496e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0378814419340174,0.00445854067066557,0.0291427022195129,0.0466201816485219,2.16477799685239e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPQ,Carboxypeptidase Q,40516,0.0312466156700302,0.00367700068715077,0.0240396943232147,0.0384535370168457,2.17276282382386e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARFIP1,Arfaptin-1,40482,0.0596876068536689,0.007024954925797,0.0459186951991068,0.073456518508231,2.1986566596499e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.049454403985638,0.00582502103919141,0.0380373627488228,0.0608714452224532,2.28632555145012e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40LG,CD40 ligand,42754,0.0670849071331964,0.0079686162241844,0.051466419333795,0.0827033949325979,4.18787982120436e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0369153683912192,0.00438982037428563,0.0283113204576194,0.045519416324819,4.63603251112343e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA9,Serpin A9,42538,0.061937373586979,0.00738358379299559,0.0474655493527077,0.0764091978212504,5.41371803997753e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0358059174452468,0.00427013364477187,-0.0441753793889997,-0.0274364555014939,5.56626385828393e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0236631055581752,0.00282142501520281,0.0181331125283777,0.0291930985879727,5.59998754115946e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX1,Heme oxygenase 1,42500,-0.0417442819739894,0.0049796296116157,-0.0515043560127562,-0.0319842079352226,5.67373926846768e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK7,Kallikrein-7,40009,0.0337413549800119,0.00402468805351803,0.0258529663951166,0.0416297435649073,5.77021058311064e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TF,Serotransferrin,40539,0.0183464441956243,0.0021926168283488,0.0140489152120606,0.0226439731791879,6.58088917759274e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMS,Spermine synthase,40136,0.0548615216969191,0.00655920391223961,0.0420054820289294,0.0677175613649087,6.79524735076e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0413373782320489,0.00494394516744275,0.0316472457038611,0.0510275107602367,6.82469858133347e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0356419798120473,0.00426340723726724,0.0272857016270035,0.0439982579970911,7.01188748032869e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0407374004021107,0.00487340897500945,0.0311855188110921,0.0502892819931292,7.08363678591928e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.034537350889367,0.00414401897855252,0.0264150736914041,0.0426596280873299,8.72465511959206e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0497477586401511,0.00597500541149405,0.0380367480336227,0.0614587692466794,9.32711380793126e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0595171317728443,0.00715153215236353,0.0455001287542118,0.0735341347914769,9.45153375473621e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCOF1,Treacle protein,40511,0.0275420885814784,0.00331305527998992,0.0210485002326981,0.0340356769302586,1.03790923484402e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0550537993894774,0.00662457936155802,0.0420696238408237,0.0680379749381311,1.06431919628086e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0681490286691845,0.008212686383633,0.0520521633572639,0.0842458939811052,1.15821682603698e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL18,C-C motif chemokine 18,42477,0.0594643056124797,0.00716979743598471,0.0454115026379497,0.0735171085870097,1.20252971916482e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID1,Nidogen-1,42652,0.0326534413677451,0.0039464789413295,0.0249183426427393,0.0403885400927509,1.41554016723955e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0167419330271438,0.0020264232377623,-0.0207137225731579,-0.0127701434811297,1.56860473053749e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA1,BolA-like protein 1,40136,0.0460427066242046,0.00557188482368549,0.0351218123697811,0.0569636008786282,1.57915620412002e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA4,Ephrin-A4,42475,0.0289285506697361,0.00350320880041533,0.0220622614209221,0.0357948399185502,1.62414896430882e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0465887610527476,0.00564565776647391,0.0355232718304588,0.0576542502750365,1.70028212753455e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,TST,Thiosulfate sulfurtransferase,42277,0.063283841022994,0.00767200062854082,0.048246719791054,0.078320962254934,1.75372052907479e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFB,Complement factor B,40344,0.0274555737527707,0.00332915649329561,0.0209304270259113,0.0339807204796301,1.80630834329201e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRG,Histidine-rich glycoprotein,40479,0.0262062306482765,0.00317774917425193,0.0199778422667427,0.0324346190298103,1.80726270345736e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,OCLN,Occludin,40482,0.0381773821146813,0.00463160509279413,0.0290994361328048,0.0472553280965578,1.86820242000242e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP7,Matrilysin,42333,0.0428244696411067,0.00519654263844514,0.0326392460697542,0.0530096932124592,1.86934985437586e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0371203430531237,0.00450522412073877,0.0282901037764757,0.0459505823297717,1.92684996397538e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA2,Carbonic anhydrase 2,42573,0.058898956672369,0.00715355196645162,0.0448779948181238,0.0729199185266142,1.98522412196088e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0209189632229026,0.00254151869499003,-0.0259003398650831,-0.0159375865807222,2.02866255644589e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNC,Tenascin,42689,-0.0409499227270293,0.00497907471940033,-0.0507089091770539,-0.0311909362770046,2.13985669030975e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0434889863873598,0.00529119265853805,0.0331182487766252,0.0538597239980943,2.28160453788606e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0805984418374545,0.00982072978577848,0.0613498114573287,0.0998470722175804,2.47609967725011e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0375009348642724,0.00457553201338412,0.0285328921180395,0.0464689776105053,2.761263425539e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.081505941349207,0.00996477134955876,0.0619749895040718,0.101036893194342,3.16518746423347e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLMH,Bleomycin hydrolase,42794,0.0263093630531979,0.00322061530444154,0.0199969570564925,0.0326217690499033,3.38077768160032e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0252947186548469,0.00310231344705293,-0.0313752530110706,-0.0192141842986232,3.84594453002871e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADM,Pro-adrenomedullin,42721,0.0224808457643153,0.00276386555084248,0.017063669284664,0.0278980222439665,4.51911644019841e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0376458873079084,0.00463114004896495,0.0285688528119371,0.0467229218038797,4.79770818622657e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0461303105601744,0.00567740650259593,0.0350025938150863,0.0572580273052624,4.93086920591059e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100P,Protein S100-P,42357,0.0455682770308609,0.00561116184556134,0.0345703998135607,0.0565661542481612,5.03260802037449e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0526153349609714,0.00648239440159533,0.0399098419338446,0.0653208279880983,5.20636457869678e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL24,C-C motif chemokine 24,42654,0.069161678106721,0.00852140018752925,0.0524597337391637,0.0858636224742783,5.22362394024822e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.045538414984861,0.0056165466844528,0.0345299834833335,0.0565468464863885,5.5948660675449e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD248,Endosialin,40527,-0.0340535505199736,0.0042005580744573,-0.0422866443459099,-0.0258204566940372,5.72568438206489e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.0943871764901263,0.0116420143723005,-0.117205524659835,-0.0715688283204173,5.73604542179667e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0346456662435749,0.00428590846077328,0.0262452856604593,0.0430460468266905,6.9437208612392e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHPS,Deoxyhypusine synthase,40451,0.0335963996777897,0.00416163544162476,0.0254395942122052,0.0417532051433742,7.56374730708826e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0313029854028146,0.00387908447872968,0.0236999798245044,0.0389059909811248,7.77480463389206e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIT2,Slit homolog 2 protein,42311,0.0436919339323706,0.00541767711481282,0.0330732867873375,0.0543105810774037,7.97553974273368e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGLAP,Osteocalcin,40527,0.0751423322180179,0.00931775971217182,0.0568795231821611,0.0934051412538746,8.09811258302389e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0188835509107286,0.00234336855477118,0.0142905485433771,0.0234765532780801,8.51516153153276e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0335632083186908,0.00416532453938707,0.0253991722214921,0.0417272444158894,8.57925985639267e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0610501407550407,0.00758550890865439,0.0461825432940781,0.0759177382160033,9.23649480479635e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA,Lymphotoxin-alpha,42594,0.0338513484220772,0.00420779488227308,0.025604070452822,0.0420986263913325,9.35212504562078e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0420657932463074,0.00523002290273866,0.0318149483569396,0.0523166381356752,9.50178140973174e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAT,Catalase,40361,0.0448046701374575,0.00557799280687766,0.0338718042359773,0.0557375360389377,1.05183073144433e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA6,Integrin alpha-6,42594,0.0420178581571504,0.00523723439679697,0.0317528787394284,0.0522828375748725,1.1180657622453e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSS,Cathepsin S,39872,0.0201888877265413,0.00251731082102134,0.0152549585173395,0.0251228169357431,1.16782230029534e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0538177457087976,0.00671299894432226,0.0406602677779259,0.0669752236396692,1.19038026019617e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.024634166553966,0.0030741377162887,0.0186088566300402,0.0306594764778919,1.20897440017752e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAL,Integrin alpha-L,40199,0.0366702248613381,0.00459026465157189,0.0276733061442572,0.045667143578419,1.49971198044189e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO2,Gamma-enolase,42711,0.0529201502174699,0.00662814253635305,0.0399289908462179,0.0659113095887219,1.52846570050557e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGRN,Neugrin,40483,0.0190377238084575,0.00238577764543218,0.0143615996234104,0.0237138479935046,1.60900698778863e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0719090405175271,0.00902191763647305,0.05422608195004,0.0895919990850143,1.73304701411031e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0230667349872178,0.00289537741249308,-0.0287416747157042,-0.0173917952587314,1.7590831159046e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR2,Folate receptor beta,42711,-0.0243020026095119,0.00305179222860499,-0.0302835153775777,-0.0183204898414461,1.80981862627813e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC3,Membrane primary amine oxidase,42689,-0.024790938523248,0.00311566668023004,-0.0308976452164988,-0.0186842318299971,1.90453010761122e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVR,Poliovirus receptor,42711,0.0300426528100487,0.00378401944651654,0.0226259746948763,0.0374593309252212,2.19198194763494e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA14,Carbonic anhydrase 14,42721,-0.0293741950010287,0.00370870578003413,-0.0366432583298956,-0.0221051316721618,2.55268160814189e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.059256901693438,0.00749153634085573,0.0445734904653608,0.0739403129215153,2.7825964447956e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX7,Syntaxin-7,40199,0.0406682427639111,0.00514418056437801,0.0305856488577302,0.050750836670092,2.91925468336999e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0618987581680394,0.00783979772721639,0.0465327546226953,0.0772647617133835,3.16475034555646e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0492427531582982,0.00624896313054364,-0.0614907208941637,-0.0369947854224326,3.51870478940714e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0366591853021837,0.00465291339754767,0.0275394750429903,0.0457788955613771,3.56525466388605e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0245818365737921,0.00312196158946793,0.018462791858435,0.0307008812891493,3.75286983960024e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.027832235720505,0.00353756059940159,0.0208986169456779,0.0347658544953321,3.89007662855612e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.0282350464149618,0.00359156066231788,0.0211955875168187,0.0352745053131048,4.14649461130237e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0450764632157205,0.00574565130380605,0.0338149866602606,0.0563379397711804,4.71336191232057e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0287007130641599,0.00365997676487463,-0.0358742675233142,-0.0215271586050057,4.84308184293956e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPR,Nucleoprotein TPR,40116,0.0391723873528501,0.00499786583944085,0.029376570307546,0.0489682043981542,5.0101669736926e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0265904138640709,0.00339940033547829,0.0199275892065334,0.0332532385216083,5.59017670222538e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0486869866325731,0.00622726310014045,0.0364815509562978,0.0608924223088484,5.7527801155805e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0412429482611528,0.00529431394598127,0.0308660929270295,0.0516198035952761,7.28255079462632e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXN,Thioredoxin,40384,0.035659820487856,0.00457939055735865,0.026684214995433,0.0446354259802789,7.46581642057867e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0532062831385483,0.00684136531086279,0.0397972071292572,0.0666153591478394,7.97099914125298e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0280603954190665,0.00361411487780868,0.0209767302585614,0.0351440605795715,8.83012903783386e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOE,Apolipoprotein E,40539,0.058083884817643,0.0074826223930509,0.0434179449272632,0.0727498247080227,9.04169276335299e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.018972211713713,0.00244714929928286,0.0141757990871186,0.0237686243403074,9.78083722669765e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0535987777620297,0.00694120075707914,0.0399940242781546,0.0672035312459048,1.24383040581035e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0451881756803741,0.00586314973352079,0.0336964022026734,0.0566799491580749,1.39590967965736e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS27,Serine protease 27,42603,0.031975980277712,0.00415320691727309,0.0238356947198568,0.0401162658355673,1.4659062827698e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX6,Syntaxin-6,42346,0.0523487794272152,0.00681262559361798,0.038996033263724,0.0657015255907065,1.64988706094293e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.0286526673974601,0.00372846797380992,0.0213448701687926,0.0359604646261275,1.65879019025663e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB8,Serpin B8,42754,0.045609330241548,0.00593978870867284,0.0339673443725492,0.0572513161105468,1.71804917588664e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0216045889300411,0.00281635937627422,0.0160845245525436,0.0271246533075385,1.84502390673971e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.0922917463535793,0.0120331873494628,0.0687066991486321,0.115876793558526,1.86507594224496e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NADK,NAD kinase,42636,0.0431304705702365,0.00563034791376832,0.0320949886592506,0.0541659524812224,1.9807230281007e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3B,Protein FAM3B,42587,0.0278148526299396,0.00363412359288221,0.0206919703878904,0.0349377348719887,2.0844733492283e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0497883210779515,0.00650537484012225,0.0370377863913119,0.0625388557645911,2.11587441211477e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP1,Interstitial collagenase,42136,0.0718910535528608,0.00940153774357558,0.0534640395754527,0.090318067530269,2.20673247163018e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRBP,Acrosin-binding protein,40451,0.0306888245780934,0.00403232952341295,0.022785458712204,0.0385921904439828,2.94392286036906e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.0241914129043412,0.00317944341744391,0.0179597038061511,0.0304231220025313,2.95158112981312e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.038143917123862,0.00501588554410881,0.0283127814574087,0.0479750527903152,3.08471917553433e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0472537512573092,0.00621904638383118,0.0350644203450001,0.0594430821696183,3.24767858476938e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0668956257134585,0.00880719100717129,0.0496335313394027,0.0841577200875142,3.26648556788184e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0236312072815614,0.00311153474853118,-0.0297298153886825,-0.0175325991744403,3.28567311146298e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0289238989881455,0.00381160392630868,-0.0363946426837105,-0.0214531552925805,3.49340482853626e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0632666322055622,0.00834250357112388,0.0469153252061594,0.079617939204965,3.58015248003833e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0548974674553769,0.00724628266580255,0.0406947534304039,0.0691001814803499,3.84883677341961e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM1,Dynamin-1,40449,0.0887413869202103,0.0117174380093316,0.0657752084219203,0.1117075654185,3.91895268366728e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.018534048752963,0.00244779686543217,-0.0233317306092101,-0.013736366896716,3.92362114032917e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0213001670950475,0.0028147750438353,0.0157832080091303,0.0268171261809647,4.05602233927153e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFP,Alpha-fetoprotein,42459,0.0522812844855664,0.00690881236637292,0.0387400122474755,0.0658225567236573,4.0604644310818e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0196211672880152,0.00259649063029317,0.0145320456526406,0.0247102889233898,4.39688979980105e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.0350543615287652,0.00464052902803204,0.0259589246338224,0.044149798423708,4.49643659235145e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH1,Acid ceramidase,40418,0.0354948744702963,0.00470296866909988,0.0262770558788605,0.0447126930617321,4.78639080619494e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0381625718482447,0.00506246894108981,0.0282401327237087,0.0480850109727807,5.12575642849651e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMD,Osteomodulin,42676,-0.032747587448783,0.0043540379078296,-0.0412815017481291,-0.024213673149437,5.77043066365526e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOM,Apolipoprotein M,42663,0.0218100805467029,0.00290667986391125,0.0161129880134369,0.027507173079969,6.60605113152787e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP9,Caspase-9,40199,0.0482848401684595,0.00643600514299913,0.0356702700881812,0.0608994102487378,6.75411686759655e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0235815426389425,0.00314418116664982,-0.0297441377255762,-0.0174189475523089,6.7775383289425e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0204899929931606,0.00273926081077623,-0.025858944182282,-0.0151210418040392,7.88750057976015e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0698744965337565,0.0093546795804378,0.0515393245560984,0.0882096685114146,8.65566137548715e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0510629963482068,0.00683788642866554,0.0376607389480223,0.0644652537483912,8.67638530372988e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.0224666831070105,0.00301729972120852,0.0165527756534418,0.0283805905605791,1.02160144966916e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMM2,Phosphomannomutase 2,40116,0.0460197018016442,0.00618511007872929,0.0338968860473348,0.0581425175559536,1.07919124203612e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0331011236498442,0.00445576778990411,0.0243678187816321,0.0418344285180562,1.16205124216551e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0271680996943358,0.00366542709460795,-0.0343523367997673,-0.0199838625889042,1.32012462087516e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.0886917647010878,0.0120062231529103,0.0651595673213837,0.112223962080792,1.60952615777994e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMD,Dystrophin,40223,0.03905181281032,0.00530536594114131,0.0286532955656831,0.049450330054957,1.95802290704372e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0266410172092587,0.00361970192879712,0.0195464014288163,0.033735632989701,1.97019324594932e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CX3CL1,Fractalkine,42495,-0.0260905755843334,0.00355403903154563,-0.0330564920861628,-0.0191246590825039,2.24138154602198e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0355200950761766,0.00483914242325962,0.0260353759265877,0.0450048142257654,2.27989429053045e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPP1,Osteopontin,42771,-0.0357340194816839,0.0048747315611822,-0.045288493341601,-0.0261795456217668,2.42331604138684e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0663261756184045,0.00905800217073701,0.04857249136376,0.0840798598730491,2.60482395668835e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX5,Sorting nexin-5,40223,0.0219039389381697,0.00299301899135954,0.016037621715105,0.0277702561612344,2.68506105796288e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3C,Protein FAM3C,42613,0.0234452924337141,0.003205578658252,0.0171623582635402,0.029728226603888,2.74202822897662e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0288121780303042,0.00394749600589647,0.0210750858587471,0.0365492702018613,3.06581078598356e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRSF1,G-rich sequence factor 1,40014,0.0606476993182929,0.00831332147057197,0.0443535892359718,0.0769418094006139,3.18990851143761e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB2,Calretinin,42311,0.024095279256138,0.00330611785068626,0.0176152882687929,0.0305752702434831,3.32368979929328e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF22,Kinesin-like protein KIF22,40116,0.0937545744053276,0.0128645372343354,0.0685400814260301,0.118969067384625,3.36733103171854e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0688235662431595,0.00944438549117311,0.0503125706804602,0.0873345618058588,3.3746066479074e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0233317673937379,0.00320364300161219,-0.0296109076768978,-0.017052627110578,3.45325327410802e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.035617074212504,0.00489674777101446,-0.0452146998436923,-0.0260194485813156,3.6938821311643e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNF,Tumor necrosis factor,42339,0.0288266328952246,0.0039638986430987,0.0210573915547511,0.036595874235698,3.73435152449197e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP8,Caspase-8,42674,0.0457680955066665,0.00630867216506551,0.0334030980631381,0.0581330929501949,4.24253569645377e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL26,C-C motif chemokine 26,42594,0.0697297842958722,0.00961574315934783,0.0508829277035504,0.0885766408881939,4.3438120971622e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0330112439567597,0.00455966662674384,0.0240742973683418,0.0419481905451777,4.7396187549747e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0191606323437348,0.00264647189017237,0.0139735474389969,0.0243477172484726,4.77697992050308e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.018509750481797,0.00255978631444107,-0.0235269316581015,-0.0134925693054925,5.05150208480322e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0392579656269191,0.00542885976613458,0.0286174004852953,0.0498985307685429,5.09672684583741e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0172899387145737,0.0023991043107211,0.0125876942655604,0.0219921831635871,6.09074177821055e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.044107989308842,0.00612670476041656,0.0320996479784256,0.0561163306392585,6.44016133399445e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0214284703928119,0.00298218910692949,-0.0272735610423937,-0.0155833797432301,7.04987653447991e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0417453809304477,0.00581088625555634,0.0303560438695572,0.0531347179913381,7.20673577045198e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0464895865480353,0.00647189066105674,0.0338046808523641,0.0591744922437065,7.24412516292041e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0176601330446539,0.00246006512348449,0.0128384054026243,0.0224818606866835,7.40184084738497e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0251896834323083,0.00351048129174761,0.0183091401004829,0.0320702267641336,7.5798749561136e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0338340117345604,0.00471452493532864,0.0245935428613162,0.0430744806078045,7.61320569984073e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0227957256089361,0.00317935229929251,0.0165641951023228,0.0290272561155494,7.89432695276916e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0499093457632076,0.00696479388523685,0.0362583497481433,0.0635603417782718,8.12996783379728e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0401023898076917,0.00559776958752717,0.0291307614161384,0.0510740181992449,8.34140321599033e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0487402047986634,0.00682926337700246,0.0353548485797386,0.0621255610175882,1.00281859173594e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN2,Alpha-actinin-2,40116,-0.0437708556861635,0.00613899724145593,-0.0558032902794171,-0.0317384210929099,1.06735813824139e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0597464884108532,0.00839435018279563,0.0432935620525738,0.0761994147691326,1.15523931097506e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.0725205968305707,0.0101920889239913,-0.0924970911215935,-0.0525441025395478,1.1726630473623e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0592191855915967,0.00832452025169526,0.042903125898274,0.0755352452849194,1.19866512982254e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA6,Carbonic anhydrase 6,42581,-0.0457928804253374,0.00644689476016823,-0.0584287941552671,-0.0331569666954077,1.28160135375398e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF7,SLAM family member 7,42594,-0.0435546490196369,0.00613923281631188,-0.0555875453396082,-0.0315217526996656,1.363621734096e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0610794051066999,0.00862738785566861,0.0441697249095894,0.0779890853038104,1.53009728149075e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID2,Nidogen-2,42611,0.0538592042441651,0.00761658120734483,0.0389307050777693,0.068787703410561,1.61075987417523e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0154409826974306,0.00218821344870447,0.0111520843379698,0.0197298810568914,1.79231253895283e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0327987317950661,0.00465086565851966,0.0236830351043675,0.0419144284857646,1.86461822484902e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0383597008975599,0.00544328389330295,-0.0490285373284337,-0.0276908644666861,1.91532195365667e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0237296930735947,0.00336883725556341,0.0171267720526904,0.0303326140944989,1.96106924450997e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0330206644602649,0.00469857446330478,0.0238114585121875,0.0422298704083423,2.1995881505757e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIT,Citron Rho-interacting kinase,40182,0.0328625400233184,0.00467695912963058,0.0236957001292425,0.0420293799173944,2.24355133865793e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.0192303843243288,0.00273932921732521,0.0138612990583714,0.0245994695902863,2.32302937536119e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0169795337153467,0.00241895785241633,0.0122383763246107,0.0217206911060827,2.33620049061676e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0390819342104896,0.0055726527158055,0.0281595348875108,0.0500043335334684,2.46652476190743e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPF,Centromere protein F,40302,0.0394143789708754,0.00562044799422836,0.0283983009021878,0.050430457039563,2.47383118579539e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0712013442786709,0.0101591971116157,0.0512893179399041,0.0911133706174378,2.54548774311757e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0815669817593192,0.0116409248543468,0.0587507690447995,0.104383194473839,2.57543793029926e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0392590642289231,0.00560401877099072,0.0282751874377813,0.0502429410200649,2.57908138575175e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD209,CD209 antigen,42668,-0.0280536568372734,0.0040063674107883,-0.0359061369624184,-0.0202011767121283,2.63787007482822e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGN,Biglycan,42328,-0.0867094456866447,0.012392205864894,-0.110998169181837,-0.0624207221914524,2.73996752230391e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFC1,Cryptic protein,42346,0.0341816995247697,0.00488733329509756,0.0246025262663785,0.043760872783161,2.80198749060438e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0154157138100013,0.00220725468145076,-0.0197419329856448,-0.0110894946343578,3.00431328662494e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.070116496697337,0.0100457250937739,0.0504268755135403,0.0898061178811338,3.09560669901169e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0161532093498211,0.00231585287995578,0.0116141377051077,0.0206922809945344,3.2282537234965e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF2,Growth/differentiation factor 2,42636,0.0257604489369173,0.00369456394097424,0.0185191036126077,0.0330017942612268,3.25833855227131e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI2,Serpin I2,40449,0.0402242373672047,0.00577177431749892,0.0289115597049068,0.0515369150295026,3.3673298190691e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0228336934961356,0.00327867361989513,-0.0292598937911301,-0.0164074932011412,3.48696191308048e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLTA,Clathrin light chain A,42357,0.0341711164091505,0.00491016069338325,0.0245472014501194,0.0437950313681817,3.58244077630373e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0191680390370919,0.00275477333903104,0.0137686832925911,0.0245673947815927,3.63890101215003e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0184562203361718,0.00265391131404647,0.0132545541606407,0.0236578865117028,3.70589631022687e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA1,Carbonic anhydrase 1,42362,0.0430831604116207,0.00619909896930656,0.0309329264317799,0.0552333943914616,3.82734273844761e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA4,Annexin A4,42584,0.0509416141699864,0.00734520577824846,0.0365450108446194,0.0653382174953534,4.23795452206853e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK4,Dickkopf-related protein 4,42477,0.0330765103919182,0.00478617832911161,0.0236956008668594,0.0424574199169769,5.03771445582978e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0411566182402292,0.0059587010713827,-0.0528356723401393,-0.0294775641403191,5.17418911677867e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0243270816641219,0.0035249790264237,-0.0312360405559124,-0.0174181227723314,5.38224033188495e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.041841356039222,0.0060684170459008,0.0299472586292565,0.0537354534491876,5.6320766158025e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0486625453748704,0.0070599171147577,0.0348251078299453,0.0624999829197955,5.71564419309078e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,F3,Tissue factor,42636,-0.0194035411857491,0.0028155493670461,-0.0249220179451594,-0.0138850644263387,5.764112026225e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0469281784463304,0.00682070547114014,0.0335595957228957,0.060296761169765,6.29080295300316e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.037314980872397,0.00542881860946503,-0.0479554653469484,-0.0266744963978455,6.54137121320108e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0281117379431762,0.00409214452528096,0.0200911346736255,0.0361323412127268,6.71576022238243e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0177195258959714,0.00258252589148929,0.0126577751486524,0.0227812766432904,7.12278344255313e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0293333967517731,0.00427970176234705,0.0209451812975728,0.0377216122059733,7.48773094315209e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH15,Cadherin-15,42692,0.0440650373351557,0.00643171190408381,0.0314588820031514,0.05667119266716,7.63997227050499e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0324772852603116,0.00475012684502465,0.0231670366440633,0.04178753387656,8.42576999865987e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAM,Integrin alpha-M,42611,-0.0223148363120222,0.00326381400033105,-0.028711911752671,-0.0159177608713733,8.43413418885756e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0470423988287004,0.00690287650543276,0.0335127608780521,0.0605720367793486,9.92995267421728e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0374719295159244,0.00551035704790319,0.0266716297020341,0.0482722293298146,1.08805111260606e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRH,Corticoliberin,42322,0.0601594512821595,0.00886460421251245,0.0427848270256351,0.0775340755386839,1.19836022662505e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0302821965411225,0.0044696808116401,0.0215216221503079,0.0390427709319371,1.29563148255703e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.030261085740782,0.00446650128332471,0.0215067432254655,0.0390154282560984,1.29583490949339e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD302,CD302 antigen,42587,0.0223236460367963,0.00330417849867847,0.0158474561793865,0.0287998358942061,1.47525043194403e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY75,Lymphocyte antigen 75,42594,0.0271456237070024,0.00401812265821708,0.019270103296897,0.0350211441171079,1.47916753170637e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL3,Myosin light chain 3,40223,-0.0511082666174425,0.00756885445064677,-0.0659432213407102,-0.0362733118941749,1.52681770491995e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0296812555797005,0.0043957392630575,-0.0382969045352932,-0.0210656066241078,1.5285551238055e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARCL1,SPARC-like protein 1,42644,-0.0192258094369791,0.00285571898088282,-0.0248230186395094,-0.0136286002344488,1.73671026163515e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0464606306386893,0.00690006179070322,0.032936509528911,0.0599847517484676,1.73829607291646e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.041309670420857,0.00614294641203934,0.0292694954532599,0.0533498453884541,1.83169964063659e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0360588154680779,0.00537421102341674,0.0255253618621811,0.0465922690739747,2.04718106129424e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXN,"Frataxin, mitochondrial",42721,0.0504175670920326,0.00753056832098284,0.0356576531829063,0.065177481001159,2.24095410065493e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0356082918183665,0.00531978451864353,0.0251815141618252,0.0460350694749078,2.28188406065433e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0340696522214848,0.00510019563673387,-0.0440660356694831,-0.0240732687734864,2.50037154801231e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSB,Cathepsin B,42659,-0.0369928775332162,0.00554435617317717,-0.0478598156326435,-0.026125939433789,2.61905124321704e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP1,Guanylate-binding protein 1,40466,0.0450876521553628,0.00675785821272829,0.0318422500584153,0.0583330542523102,2.643695818384e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0379049930714157,0.00568770345060266,0.0267570943082345,0.0490528918345969,2.7851561679364e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0361572535995255,0.00543516326095133,0.0255043336080609,0.0468101735909901,3.02046156687693e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA,Adenosine deaminase,42754,0.0237193013881971,0.00357044178377894,0.0167212354919904,0.0307173672844039,3.18568433936562e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAP,Prosaposin,40440,0.01984244038079,0.00298662192819129,0.0139886614015351,0.0256962193600449,3.1986907024267e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBI3_IL27,Interleukin-27,42689,-0.0211448573735205,0.0031835397293347,-0.0273845952430166,-0.0149051195040245,3.21455398432371e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0265644850986404,0.00400037328790469,0.0187237534543472,0.0344052167429336,3.27345332252099e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0357914115153104,0.005398513230113,0.0252103255842889,0.0463724974463318,3.49111852544579e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.024623175150253,0.00372020802883086,-0.0319147828867615,-0.0173315674137445,3.7585434771311e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0260307444812768,0.00393442191169451,0.0183192775343556,0.0337422114281981,3.85615315315e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,C5,Complement C5,40539,0.0102505705026539,0.00155081404248587,0.00721097497938156,0.0132901660259262,4.02093507238047e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST5,Cystatin-D,42357,0.0389212598975888,0.00589750912112867,0.0273621420201767,0.050480377775001,4.28030227826643e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0373132269170534,0.00565983564934784,0.0262199490443317,0.0484065047897752,4.52019108979211e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.026417210915732,0.00401221821175409,0.018553263220694,0.03428115861077,4.77580634113497e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0247926016269191,0.00376882693723589,0.0174057008299368,0.0321795024239015,4.97335290265222e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0332531061694013,0.00506814874913078,0.0233195346211049,0.0431866777176976,5.58244575386365e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0357994241413033,0.00545793079401483,0.0251018797850342,0.0464969684975723,5.64776485001242e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0237502525000771,0.00363081812683341,0.0166338489714836,0.0308666560286706,6.32087646495196e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB2,Plexin-B2,42743,0.0162088956121196,0.00248844669508739,0.0113315400897483,0.0210862511344908,7.59305448515242e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0296610710602637,0.00455378083135033,0.0207356606308171,0.0385864814897104,7.66123929517976e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0294667520555358,0.0045256023865889,-0.0383369327332501,-0.0205965713778216,7.78648177275119e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0389438558333981,0.00600116279495939,0.0271815767552777,0.0507061349115185,8.92745378577831e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0419316259335989,0.0064791539519768,0.0292324841877244,0.0546307676794735,1.0030257558062e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN4,Contactin-4,42611,-0.0160543761794204,0.00248230334105891,-0.0209196907278958,-0.0111890616309449,1.03069381634403e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0264107644878088,0.0040859575532296,-0.0344192412921389,-0.0184022876834788,1.06305983606939e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0383180373928088,0.00593306904959769,0.0266892220555973,0.0499468527300203,1.09559334856938e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0177429875287461,0.00274745329999234,0.0123579790607611,0.0231279959967311,1.09738899779574e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.034866842902868,0.00541124822352102,0.0242607963847668,0.0454728894209692,1.20774771574106e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0250035814176795,0.00388418978121309,0.0173905694465019,0.0326165933888572,1.26587385080468e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0316686576967943,0.00492419018387341,0.0220172449364024,0.0413200704571862,1.30943427210574e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0247192702006017,0.00385536504629753,0.0171627547098585,0.0322757856913448,1.49709904606988e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0228934735043231,0.0035737777041649,0.0158888692041599,0.0298980778044863,1.54404066493134e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0345626014534588,0.00539649729679628,0.0239854667517381,0.0451397361551795,1.56691424995098e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZU1,Azurocidin,42216,0.0503751076766691,0.00788227520228708,0.0349258482801865,0.0658243670731518,1.70493170623262e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMBS,Porphobilinogen deaminase,42721,0.0284450595505,0.00445304673464618,0.0197170879505935,0.0371730311504065,1.73824919165904e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0312927533241282,0.00490271292504634,0.0216834359910374,0.040902070657219,1.79782889929827e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0179855599242393,0.00281966917089792,0.0124590083492794,0.0235121114991992,1.85714983545713e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0377658228005252,0.00592949164479972,0.0261440191767178,0.0493876264243327,1.96404643873696e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL19,C-C motif chemokine 19,42711,0.0860343154605772,0.0135138331651128,0.0595472024569561,0.112521428464198,1.997845398966e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0236435588186543,0.00371674663773852,0.0163587354086868,0.0309283822286218,2.08002764530673e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN1,Tetraspanin-1,42357,0.0442644783994228,0.00700521953218102,0.030534248116348,0.0579947086824976,2.72122096175446e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0340001517583979,0.00538762683527353,0.0234404031612618,0.044559900355534,2.86533282891267e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A12,Protein S100-A12,42434,0.048886605315083,0.00774931519413293,0.0336979475345824,0.0640752630955835,2.90707900830432e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.00531098521960965,0.000844323277399741,-0.00696585884331315,-0.00365611159590616,3.28893781026871e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCOR1,REST corepressor 1,42357,0.0287318706901277,0.00457015618888094,0.019774364559921,0.0376893768203343,3.34211375785479e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0442692099650041,0.00704920980654267,0.0304527587441804,0.0580856611858277,3.51286568406128e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0472517668906579,0.00754080312283186,0.0324717927699075,0.0620317410114084,3.83800525340574e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.020903572771549,0.00334150662411223,0.014354219788289,0.027452925754809,4.0768558353928e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD83,CD83 antigen,42594,0.0227785720561072,0.00364453499498717,0.0156352834659324,0.0299218606462821,4.22721402947948e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0460774687211535,0.00737584340193875,0.0316208156533536,0.0605341217889535,4.31069488358446e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN2,Matrilin-2,42638,0.0190346379375623,0.00305085818501815,0.0130549558949267,0.0250143199801979,4.53268829173124e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0182764832003413,0.00293383424600087,0.0125261680781796,0.024026798322503,4.81618178459478e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0208367568210074,0.00334640712916452,0.014277798847845,0.0273957147941699,4.90668515660609e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTN,Pleiotrophin,42357,0.0317367627147355,0.00510088958390024,0.0217390191302911,0.04173450629918,5.06348972999284e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0339936124783639,0.00546586135990331,0.0232805242129534,0.0447067007437743,5.14632657189561e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0235246341823638,0.00380214748171901,0.0160724251181945,0.030976843246533,6.30656498410147e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.023327531257744,0.00377090661608331,0.0159365542902207,0.0307185082252673,6.34091361912524e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0436859693599952,0.0070651757400168,0.0298382249095623,0.0575337138104281,6.45930628224031e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM2,Paralemmin-2,40483,0.0239756281707808,0.00389024264180408,0.0163507525928448,0.0316005037487168,7.38065612809962e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0642370110163822,0.0104321187035438,0.0437900583574363,0.0846839636753281,7.59732540695856e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0269619324148924,0.00438656572471699,0.0183642635944471,0.0355596012353377,8.14691580901905e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0235819170055411,0.00383670793675718,0.016061969449497,0.0311018645615852,8.20304175348875e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0430250239648254,0.00700560240955903,0.0292940432420897,0.056756004687561,8.40410554879319e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0385492583415778,0.00629388305870474,0.0262132475465165,0.0508852691366391,9.38579327349074e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0194690093793673,0.00317928907708607,0.0132376027882786,0.025700415970456,9.39798569649871e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0248379856304715,0.00406607703169837,-0.0328074966126003,-0.0168684746483427,1.03299390211629e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD1,Leiomodin-1,40482,-0.0225289393661271,0.00369068884263777,-0.0297626894976972,-0.0152951892345571,1.06667032193715e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP6,Gastrotropin,42334,0.0369487122412955,0.00606118312458632,0.0250687933171064,0.0488286311654847,1.11831117413408e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASS1,Argininosuccinate synthase,40116,0.0488109151685374,0.00801115316312977,0.033109054968803,0.0645127753682717,1.1464230470375e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.021472147490969,0.00352720894333222,0.0145588179620378,0.0283854770199002,1.18396922540291e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0392093431059215,0.00645777085021293,0.0265521122395041,0.0518665739723388,1.30783454851363e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOC,Brother of CDO,42357,-0.0146550854442396,0.00241879020427363,-0.0193959142446159,-0.0099142566438633,1.40840091193677e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL1,Fc receptor-like protein 1,42636,0.029351363576088,0.00484672645354033,0.0198517797271489,0.038850947425027,1.43344799558234e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0179702971661616,0.00297761968760849,0.012134162578449,0.0238064317538743,1.63843457369123e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOB,Elongin-B,40116,0.0249346746223402,0.00413643339151901,0.016827265174963,0.0330420840697175,1.71299411245803e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0226231341595463,0.0037564923011813,0.015260409249231,0.0299858590698617,1.77328944357038e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCT,Secretin,40182,0.0310635345838524,0.00516147889052309,0.0209470359584271,0.0411800332092776,1.81837638238743e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD6,Programmed cell death protein 6,42636,-0.0436986083381354,0.00726790215696019,-0.0579436965657774,-0.0294535201104935,1.8736389474799e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSL,Cathepsin L1,42636,0.0153731035027886,0.00255730625939163,0.010360783234381,0.0203854237711962,1.88640685349713e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.0114445150739481,0.00190378160122167,0.00771310313555362,0.0151759270123426,1.8950899660183e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0222865817295402,0.00371228146624548,0.015010510055699,0.0295626534033813,1.98116619424886e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN3,Calsyntenin-3,40483,0.018974464778993,0.00316489139804259,0.0127712776388296,0.0251776519191565,2.09324673272845e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PER3,Period circadian protein homolog 3,40199,0.0760418986178512,0.0126854171051477,0.0511784810917617,0.100905316143941,2.10598934774968e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0298752848697189,0.00499745268135149,0.02008027761427,0.0396702921251678,2.31623925983055e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0466247327063538,0.00781236953269641,0.0313124884222688,0.0619369769904387,2.47525551677159e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0281073434668098,0.00471378385039087,0.0188683271200437,0.0373463598135759,2.5562798405479e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.026612102832825,0.00447610385829027,0.0178389392705761,0.0353852663950739,2.84015313563342e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0363303777027993,0.00612763036678305,0.0243202221839045,0.0483405332216941,3.12286780604654e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0508771263375524,0.00858277974162099,0.0340548780439752,0.0676993746311295,3.1454354705075e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM2,Myomesin-2,40116,-0.0308425814894357,0.00520589624504153,-0.0410461381297171,-0.0206390248491543,3.22606463566187e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17D,Interleukin-17D,42370,0.0210526483026703,0.00355854942595205,0.0140778914278043,0.0280274051775363,3.37895307057456e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMPD3,AMP deaminase 3,40483,0.043102431266774,0.00730615314800058,0.0287823710966928,0.0574224914368551,3.75135295085526e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0249801899983592,0.00423622800884491,-0.0332831968956953,-0.0166771831010232,3.79549388730657e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.0122971135734366,0.00208547707062457,-0.0163846486318608,-0.00820957851501248,3.80051475169652e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPT,Dermatopontin,42794,0.0153447681550562,0.00260848083953763,0.0102321457095624,0.0204573906005499,4.13250048301952e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0235632909307011,0.00401211949400464,0.015699536722452,0.0314270451389502,4.38036299575536e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CABP2,Calcium-binding protein 2,40182,0.039180322851909,0.00667155712078531,0.0261040708951698,0.0522565748086482,4.41066277065647e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0510616391458726,0.00870764636007505,0.0339946522801255,0.0681286260116197,4.62725776873135e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0241563702982671,0.0041245831374251,0.0160721873489139,0.0322405532476203,4.85717536163698e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAN,Versican core protein,42711,-0.0184716618256651,0.00315519127680904,-0.0246558367282109,-0.0122874869231194,4.89928637543854e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0353107313426476,0.00603197700106827,0.0234880564205538,0.0471334062647414,4.91324855757538e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0239109581765407,0.00409633833958382,0.0158821350309564,0.0319397813221249,5.43498499397849e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0213955634387344,0.00367397711457881,0.0141945682941599,0.0285965585833088,5.8962817986282e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTB,Lymphotoxin-beta,40451,0.0214869611611268,0.00369569022763562,0.014243408314961,0.0287305140072926,6.2632597813907e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDHB,Succinate dehydrogenase,40449,0.0397763283196295,0.00684282145050421,0.0263643982766413,0.0531882583626178,6.30838952229126e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0537490602848124,0.00925793721459481,-0.0718946172254182,-0.0356035033442066,6.55763803030193e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYGD,Gamma-crystallin D,40483,0.058281423261205,0.0100389431082747,0.0386050947689865,0.0779577517534234,6.58895044340178e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0323423555951759,0.00557257942898039,0.0214200999143744,0.0432646112759775,6.63065096879463e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA12,Carbonic anhydrase 12,42587,-0.0198198840319616,0.00341589278408004,-0.0265150338887585,-0.0131247341751648,6.69081784323897e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0109386844281575,0.00188612661246881,0.00724187626771866,0.0146354925885964,6.82718903240315e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0199630417159891,0.00344440029101006,-0.0267140662863688,-0.0132120171456094,6.95260343801445e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0297149083288366,0.00513524023245237,0.01964983747323,0.0397799791844433,7.35192821367476e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0259860696405757,0.00449485436999427,0.017176155075387,0.0347959842057645,7.60987881223641e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0272261459110022,0.00472418978324222,-0.0364855578861569,-0.0179667339358474,8.43601688390182e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSHB,Thyrotropin subunit beta,42636,0.0470996704053405,0.00817898013934258,0.031068869332229,0.0631304714784519,8.66572102111741e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDK2,Protein sidekick-2,40283,0.023972703119007,0.00416593476729731,0.0158074709751043,0.0321379352629097,8.92218548708243e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2,Brorin,42456,0.0244594568445179,0.00425339340417998,0.0161228057723251,0.0327961079167106,9.09017001799193e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,KITLG,Kit ligand,42636,-0.0222035879496296,0.00386950740703292,-0.0297878224674142,-0.0146193534318451,9.78143824755876e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALY,RNA-binding protein Raly,40451,0.0280186470814628,0.00488742916832227,0.0184392859115512,0.0375980082513745,1.01326278037035e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.0147747434105766,0.00258812382111049,-0.0198474660999532,-0.00970202072120008,1.16241226406765e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH3,Cadherin-3,42711,0.0220859686244528,0.00387061657457385,0.014499560138288,0.0296723771106175,1.18047363051354e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDM1,Nuclear protein MDM1,40182,0.018456645471557,0.00323451100937154,0.0121170038931888,0.0247962870499252,1.1854026219941e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0127760264915188,0.0022407340296613,0.00838418779338261,0.0171678651896549,1.21112319519501e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCA2A,Guanylin,42563,-0.0214430282855149,0.00376120841308911,-0.0288149967751696,-0.0140710597958603,1.21552946830564e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0492021479506683,0.008633628724989,0.0322802356496899,0.0661240602516468,1.23708262966548e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.0129385874594962,0.00227297291100749,-0.0173936143650709,-0.00848356055392155,1.27898920153746e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD46,Membrane cofactor protein,42580,0.0169602821914562,0.00298261986223511,0.0111143472614754,0.022806217121437,1.32479980394223e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0590409844848991,0.0103967311861306,0.0386633913600831,0.0794185776097151,1.38459806366986e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MILR1,Allergin-1,42370,-0.0301277236849358,0.00532269243785071,-0.0405602008631232,-0.0196952465067484,1.54313185771265e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR15L,Protein GPR15L,40449,0.0354615174875072,0.00627393744043288,0.0231646001042588,0.0477584348707557,1.62264080687745e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0326523803854387,0.00578366681983474,0.0213163934185626,0.0439883673523148,1.6867586556602e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPB2,Coatomer subunit beta',40116,0.0252071411186747,0.00447272750323691,0.0164405952123304,0.0339736870250191,1.78625178271452e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0530469894107391,0.00942047239225586,0.0345828635219176,0.0715111152995606,1.83514993084011e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,VGF,Neurosecretory protein VGF,40482,0.0182855295335327,0.00325581696768033,0.0119041282768792,0.0246669307901861,1.9974400634316e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR1,Complement receptor type 1,40509,0.0207975274277148,0.00372747445519237,0.0134916774955377,0.0281033773598918,2.46724564064357e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL20,C-C motif chemokine 20,42754,0.0526900092542584,0.0094513000333016,0.0341654611889873,0.0712145573195295,2.52407130252293e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL8,Interleukin-8,42494,0.0400553527386705,0.00718708844756287,0.0259686593814473,0.0541420460958937,2.54910097810969e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN1,Contactin-1,42794,-0.0159709468187369,0.00287285227886529,-0.0216017372853129,-0.010340156352161,2.76013653615805e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0247145200100162,0.00444992209051046,0.0159926727126157,0.0334363673074167,2.84739284452118e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.0326687251204348,0.00588335559959211,-0.0442001020956354,-0.0211373481452343,2.86577789832409e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1A,Protein phosphatase 1A,42346,0.0182490378555203,0.00328756099277211,0.0118054183096869,0.0246926574013536,2.89646318271211e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0318138940720115,0.00575525614578653,0.0205335920262699,0.0430941961177531,3.30338798221068e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0222621356788854,0.00403456943960354,-0.0301698917805084,-0.0143543795772625,3.50750108903079e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0279364706929008,0.00506611093922611,0.0180068932520177,0.037866048133784,3.56467108164388e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0246315257860896,0.00447022648875971,0.0158698818681206,0.0333931697040587,3.66642345365877e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0140205364037963,0.00254769404410207,0.00902705607735626,0.0190140167302364,3.81193380678118e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0332116061109081,0.00603494718732681,0.0213831096237475,0.0450401025980686,3.81283295698618e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0370676458944678,0.0067443774701354,0.0238486660530024,0.0502866257359332,3.97074224520213e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN2,Nectin-2,42613,0.0178509348272843,0.00325226701369646,0.0114764914804392,0.0242253781741294,4.12097323055933e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0256904149519462,0.00468289447838846,0.0165119417743048,0.0348688881295876,4.18730260518048e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0245147999077891,0.00446935322058291,0.0157548675954466,0.0332747322201316,4.20794153488861e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0237139128108774,0.00432732947058742,0.0152323470485261,0.0321954785732288,4.33093603951022e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.064814143359583,0.0118494668147409,0.0415891884026909,0.0880390983164751,4.58732168248311e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0218969483425553,0.00401328954783572,0.0140309008287973,0.0297629958563133,4.95387302289931e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGMN,Legumain,42676,0.0199899422284115,0.0036764659210984,0.0127840690230587,0.0271958154337644,5.50449150383975e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGA,Chromogranin-A,40527,-0.0549065198216501,0.0101059309325576,-0.074714144449463,-0.0350988951938372,5.65292346200536e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0194056277728723,0.00357376581591706,0.0124010467736748,0.0264102087720697,5.73175183108975e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0241061538859864,0.00444356538070671,0.0153967657398013,0.0328155420321716,5.89984090968611e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENSA,Alpha-endosulfine,40451,0.0296857677785879,0.00547782348268963,0.0189492337525162,0.0404223018046596,6.10789257649952e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF16,Fibroblast growth factor 16,40199,0.026462598225429,0.00488672653931161,0.0168846142083783,0.0360405822424798,6.25079951922344e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0265105546699154,0.00490322804494972,0.016900227701814,0.0361208816380169,6.54842622235567e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.022782452283516,0.00421738218868507,0.0145163831936933,0.0310485213733388,6.72303855259797e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL14,C-C motif chemokine 14,42618,0.0224585756848061,0.00415952807411517,0.0143059006595403,0.0306112507100718,6.80366769754348e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL15,C-C motif chemokine 15,42794,0.0248319420690323,0.00461394580491527,0.0157886082913984,0.0338752758466662,7.49128859858977e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0233468202653421,0.00435125931468923,0.0148183520085512,0.031875288522133,8.20781060208679e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0311323398924396,0.00582532620200276,0.0197147005365142,0.042549979248365,9.25589443411916e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.013017709321997,0.00243587669329438,-0.017792027640854,-0.00824339100314002,9.26487394033439e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0242583954856486,0.00454153317472977,0.0153569904631783,0.033159800508119,9.37081900417057e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX2,Sorting nexin-2,40451,0.045118060352117,0.00846568098940201,0.0285253256128891,0.061710795091345,1.00371698100305e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL3,Fc receptor-like protein 3,42370,0.0310835685229989,0.0058336256177046,0.0196496623122978,0.0425174747336999,1.00744010995905e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTPN,Myotrophin,42357,0.0182470624609118,0.00342791610777529,0.0115283468896723,0.0249657780321514,1.03701703507276e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN5,CCN family member 5,42611,0.0212103191764419,0.00398586314354576,0.0133980274150922,0.0290226109377916,1.04635947223702e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0241686348717065,0.00454203032305525,0.0152662554385182,0.0330710143048948,1.05158018736127e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0200180640580767,0.00376367640585128,-0.0273948698135452,-0.0126412583026082,1.06173393677557e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHCY,Adenosylhomocysteinase,42636,0.0367560429831688,0.00691228629702291,0.0232079618410039,0.0503041241253337,1.06890537512206e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0205139983502608,0.00385930899694719,0.0129497527162443,0.0280782439842773,1.08485450167014e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB1A1,Uteroglobin,42646,0.0305405881166478,0.00575272825813411,0.019265240730705,0.0418159355025907,1.12049912674446e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAST,Gastrin,40483,0.0796571737158351,0.0150156633787822,0.0502264734934219,0.109087873938248,1.14842716454976e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0286975136504672,0.00541155986353302,0.0180908563179425,0.0393041709829919,1.16059736796556e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_E,,42594,0.0168484113196419,0.00318169601801519,0.0106122871243321,0.0230845355149517,1.20620923855422e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GC,Vitamin D-binding protein,40539,0.0141173001221769,0.00266753071045701,0.00888893992968118,0.0193456603146727,1.23058005424846e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0173046875134889,0.0032718318325478,-0.0237174779052825,-0.0108918971216952,1.25355905413023e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0298139416327333,0.00563857536823743,0.0187623339109879,0.0408655493544786,1.26381833649585e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0339514694925283,0.006424599093829,0.0213592552686235,0.0465436837164332,1.27951315471755e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.0146456658262827,0.00277712743401355,-0.0200888355969493,-0.00920249605561618,1.35767988927678e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0167586363211678,0.00317960619656284,-0.0229906644664309,-0.0105266081759046,1.38531367076228e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.021088375914568,0.00401720557719598,0.0132146529832638,0.0289620988458721,1.54870838778727e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0178870859442244,0.00341401616647447,0.0111956142579345,0.0245785576305144,1.63607674480908e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A14,Protein S100-A14,40482,0.0296441280447035,0.00566261946896168,0.0185453938855386,0.0407428622038684,1.67897786429359e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COLEC12,Collectin-12,42618,0.0150865631734874,0.00288818536239539,0.00942571986319245,0.0207474064837824,1.78156348950439e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0213275173421678,0.00408407966718566,0.0133227211944839,0.0293323134898517,1.79544183818403e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0204332852950557,0.00391725859931645,0.0127554584403955,0.0281111121497159,1.85291834459809e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99,CD99 antigen,42611,-0.0108671367443532,0.0020865897077899,-0.0149568525716214,-0.00677742091708503,1.9362213498697e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0262317712326177,0.00504275051291366,0.0163479802273069,0.0361155622379284,2.00741753431834e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0198096286611724,0.00381841050224796,0.0123255440767664,0.0272937132455784,2.16432737457426e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSC2,Desmocollin-2,42488,-0.0189633893028554,0.00365838344191672,-0.0261338208490121,-0.0117929577566986,2.20901145884839e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECM1,Extracellular matrix protein 1,40269,0.0199378201842439,0.00385331271878581,0.0123853272554237,0.0274903131130641,2.32890852229403e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0202545445027186,0.00392001261820329,0.0125713197710401,0.0279377692343971,2.414157017029e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD109,CD109 antigen,42611,-0.0179313985929622,0.00347419544298993,-0.0247408216612225,-0.0111219755247019,2.48730920115311e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0431819165354398,0.00837434718401406,0.0267681960547723,0.0595956370161074,2.55261588793861e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN2,Calsyntenin-2,42754,-0.0211059860541917,0.00409324632264323,-0.0291287488465724,-0.013083223261811,2.55430084364292e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNLY,Granulysin,42611,0.0284680203139712,0.00552769094551461,0.0176337460607626,0.0393022945671798,2.64070875008548e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0154770102611992,0.00300805631251512,0.00958121988866959,0.0213728006337289,2.71031203304887e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0414714655857388,0.00807630036770272,0.0256419168650414,0.0573010143064361,2.86993460038616e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.0537248923192081,0.0104688910001215,0.03320586595897,0.0742439186794462,2.91021872765396e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR2,Complement receptor type 2,42689,0.0253750751172143,0.00494774784263987,0.0156774893456402,0.0350726608887884,2.9593132511867e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLC,Galectin-10,42611,-0.0348618711840083,0.00679769380512255,-0.0481853510420485,-0.0215383913259681,2.96152933768754e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0305613285063378,0.00596407182960086,0.0188717477203201,0.0422509092923554,3.03692895679636e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRL,Prolactin,42711,-0.0395141808088251,0.00772777956284177,-0.054660628751995,-0.0243677328656552,3.20967384103213e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0182629334006862,0.00359093295736535,0.0112247048042501,0.0253011619971223,3.72016377539243e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.0171596494640136,0.00339178877164022,-0.0238075554564284,-0.0105117434715988,4.27671641170598e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0283120418920509,0.0056111690839485,0.0173141504875118,0.03930993329659,4.57994009861165e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB44,Ras-related protein Rab-44,40451,0.0218422027203384,0.00432988074207102,0.0133556364658792,0.0303287689747976,4.61732195591032e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOB,Apolipoprotein B-100,40532,0.011594983991139,0.00230134983876509,0.00708433830715945,0.0161056296751186,4.76820282524148e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.0137186926034541,0.00272470473848581,-0.0190591138908863,-0.0083782713160219,4.84145472783275e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0202797817389457,0.0040361925363751,0.0123688443676505,0.0281907191102409,5.12779107904842e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0236810447998893,0.00471725613598193,0.0144352227733647,0.0329268668264139,5.24378443513187e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.033896165906402,0.0067530915454859,-0.0471322253355543,-0.0206601064772496,5.25007232223449e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0143548902714385,0.00286290970865094,0.0087435872424827,0.0199661933003944,5.40979179902484e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK4,Kallikrein-4,42721,-0.0328813086537978,0.00656573333496094,-0.0457501459903212,-0.0200124713172743,5.56865032551458e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB6,Integrin beta-6,42370,0.0161436012114737,0.00322679252247263,0.00981908786742738,0.0224681145555201,5.71762998895802e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL,Podocalyxin,42587,0.0078777078288949,0.00157608445030182,0.00478858230630333,0.0109668333514865,5.85753715533771e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAA4,Serum amyloid A-4 protein,40539,0.0166964452677721,0.00334079843687529,0.0101484803314966,0.0232444102040477,5.88713176289919e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0155075007892087,0.00310918995077251,0.00941348848569454,0.0216015130927228,6.20562931149923e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,WIF1,Wnt inhibitory factor 1,42721,-0.0176710084812539,0.00356034896514536,-0.0246492924529388,-0.010692724509569,7.01561866404919e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFA,Protransforming growth factor alpha,42594,0.0242884765837894,0.00489440234181166,0.0146954479938385,0.0338815051737402,7.04457502318735e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH1,Protocadherin-1,42721,0.011118251198431,0.00224115551428548,0.00672558639043145,0.0155109160064305,7.10029949801887e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0151428885491511,0.00305225094694847,0.00916047669313215,0.0211253004051701,7.10992593574843e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0228965866470034,0.00462091535790908,0.0138395925455016,0.0319535807485052,7.34005370674186e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0228221540162588,0.00460745271124132,0.0137915467022259,0.0318527613302918,7.40206052704249e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICOSLG,ICOS ligand,42587,0.00988232401215043,0.00199755355473944,0.00596711904486113,0.0137975289794397,7.61973111861384e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBD,Thrombomodulin,42636,0.0153680680123085,0.00311564260691156,0.00926140850276189,0.0214747275218552,8.21327981113936e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0218483803148423,0.00443010900849632,0.0131653666581895,0.0305313939714951,8.263879408684e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0165894121308653,0.0033682455195456,0.00998765091255596,0.0231911733491747,8.54797177693935e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0195821842575866,0.00398085284939391,0.0117797126727745,0.0273846558423986,8.7978761925624e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.0381759130755756,0.0077642130265538,0.0229580555435301,0.053393770607621,8.89607711652235e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG3,Desmoglein-3,42651,0.0178477238871689,0.00363065420958801,0.0107316416363764,0.0249638061379614,8.94435727756632e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0386700925799625,0.00786594738439866,0.0232528357065411,0.0540873494533838,8.95435687358195e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDK,Midkine,42638,0.025862402605006,0.00526335815784476,0.0155462206156303,0.0361785845943818,9.04402875135344e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASET2,Ribonuclease T2,42749,0.014023315779826,0.00285471117090103,0.00842808188486002,0.0196185496747921,9.10454443270473e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0176905003836706,0.00360202742476247,0.0106305266311362,0.024750474136205,9.1556150814596e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0363770762047049,0.0074256603138665,0.0218227819895265,0.0509313704198832,9.75592970960715e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.018156604971149,0.0037166804040414,-0.0254412985630701,-0.0108719113792278,1.04526817241247e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0271680833771813,0.00557735526415785,0.0162364670594319,0.0380996996949307,1.1222197075493e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE3,Eosinophil cationic protein,42578,0.0551560028626597,0.0113325405657433,0.0329442233538028,0.0773677823715165,1.14570134141692e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0206503871780031,0.00424568617175708,0.0123288422813593,0.028971932074647,1.16677245326893e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0169551168169643,0.00350007495781912,-0.0238152637342898,-0.0100949698996388,1.28535497854315e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0164995910233687,0.00341693993465741,-0.0231967932952972,-0.00980238875144017,1.38927903213937e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPO,Myeloperoxidase,42611,0.0231408488270077,0.00479823485680967,0.0137363085076607,0.0325453891463546,1.43123004162354e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0241583443018473,0.00501349036422346,0.0143319031879693,0.0339847854157253,1.46445982381821e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG1,Arginase-1,42488,0.0257019527619809,0.00534704914794282,0.0152217364320129,0.0361821690919488,1.55078519932765e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0138707242980124,0.00289107961736346,0.00820420824798,0.0195372403480448,1.62490725803347e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.0135236100657751,0.00281895336619596,-0.0190487586635192,-0.00799846146803105,1.62797118012342e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLVRB,Flavin reductase,42611,0.0325254053235195,0.00678560207059932,0.0192256252651448,0.0458251853818941,1.65821904659891e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN1,Nectin-1,40199,0.0161285002117274,0.00337668206294431,0.00951020336835653,0.0227467970550982,1.80734136745034e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.0135435066566907,0.00283591975339116,-0.0191019093733374,-0.00798510394004404,1.80977479766025e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0167861481855496,0.00351884272792208,0.00988921643882232,0.0236830799322769,1.8584936069916e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNG,Interferon gamma,42370,0.0556774912169093,0.0116734309368476,0.032797566580688,0.0785574158531307,1.86578060222468e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0301815001495815,0.0063525155512645,0.0177305696691031,0.0426324306300599,2.0488102118649e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,REN,Renin,42636,-0.0418949335620026,0.00882923484697895,-0.0592002338620814,-0.0245896332619239,2.10627342377959e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0184693352976742,0.00390054018523347,0.0108242765346166,0.0261143940607318,2.21642568472439e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRN,Progranulin,42552,0.0120002931518294,0.0025347540177187,0.00703217527710078,0.0169684110265581,2.22066419133843e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0275042100460794,0.00581366852938964,0.0161094197284757,0.0388990003636831,2.26275539558477e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.016978798557472,0.00359668613474625,0.00992929373336932,0.0240283033815746,2.37416407620512e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROCR,Endothelial protein C receptor,40116,-0.0170448905882527,0.00361086382391497,-0.0241221836831261,-0.00996759749337938,2.38251908912076e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.0114855213758109,0.00243383009712556,-0.016255828366177,-0.00671521438544479,2.39269727745374e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.033102883144752,0.00701699934718392,0.0193495644242715,0.0468562018652325,2.4167094105207e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNU13,NHP2-like protein 1,40116,0.0308475345173881,0.0065454242915864,0.0180185029058788,0.0436765661288975,2.47305826433134e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.0298273169787476,0.00633674324267432,0.0174073002231059,0.0422473337343893,2.54436962956821e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FST,Follistatin,42654,0.0237022208820133,0.00506778958008849,0.0137693533050399,0.0336350884589867,2.93884917232522e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0230078409564746,0.00494776029724431,0.0133102307738757,0.0327054511390734,3.35453192542704e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP4,Guanylate-binding protein 4,42311,0.0235722622777888,0.00510307683947929,0.0135702316724094,0.0335742928831682,3.88838888868406e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB37,Ras-related protein Rab-37,42370,0.0385191830051042,0.00835425551228491,0.0221448422010258,0.0548935238091827,4.05037885789082e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENAH,Protein enabled homolog,42370,0.022419787459259,0.00487495217995579,0.0128648811865456,0.0319746937319723,4.28525805150291e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOC,Myocilin,42611,-0.0211959430244715,0.00461679511688948,-0.0302448614535749,-0.0121470245953681,4.4502430460711e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFAP1,Actin filament-associated protein 1,40283,0.0393087147804025,0.00856166785480748,0.0225278457849798,0.0560895837758252,4.4545574473038e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPE,Carboxypeptidase E,42588,-0.0182888521046917,0.00398617675321442,-0.026101758540992,-0.0104759456683915,4.51425583681094e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA11,Serpin A11,42794,-0.0193533271199117,0.00422070202065328,-0.0276259030803921,-0.0110807511594313,4.57303463702712e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0133252395600488,0.00290850914259075,0.00762456164057092,0.0190259174795267,4.65863518575247e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0221595799587247,0.00484753489240709,0.0126584115696068,0.0316607483478426,4.8912226442672e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300A,CMRF35-like molecule 8,40283,0.0146743761645776,0.00321266015806034,0.00837756225477936,0.0209711900743759,4.9848989216401e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0157463736438766,0.00345719777673198,0.00897026600148196,0.0225224812862713,5.30206217599579e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0209229909345891,0.0046065322660356,0.0118941876931594,0.0299517941760189,5.63084754100649e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0277127317537019,0.00610839254729188,0.0157402823610098,0.039685181146394,5.7602774546769e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAP,Cartilage-associated protein,40182,0.0224633101933159,0.00495550994066848,0.0127505107096057,0.0321761096770261,5.87672723719965e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM,Paralemmin-1,40384,0.0147084676958064,0.00325448315784822,0.00832968070642386,0.0210872546851889,6.26370268040959e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK14,Kallikrein-14,42721,-0.021977946306217,0.00486995474374893,-0.031523057603965,-0.0124328350084691,6.44659943609991e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLU,Clusterin,40539,0.0146590413282808,0.00325361163903806,0.00828196251576615,0.0210361201407953,6.68890724415512e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0272031028893024,0.00604052585894154,-0.0390425335728278,-0.015363672205777,6.74237982875708e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSH,Pro-cathepsin H,42332,0.0346202697578435,0.00769290139309357,0.0195421830273801,0.0496983564883069,6.84444910969812e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH1,Cadherin-1,42188,0.0184885738966463,0.00411022495701876,0.0104325329808896,0.0265446148124031,6.91285608518626e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4C,Semaphorin-4C,42587,-0.0129096730464371,0.00287167914558024,-0.0185381641717743,-0.00728118192109978,6.99845955794315e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0207988683898146,0.00463210296990623,-0.0298777902108308,-0.0117199465687984,7.17642470683766e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEK,Angiopoietin-1 receptor,42679,0.0101401264091837,0.00226548238560484,0.00569978093339818,0.0145804718849692,7.67051991991058e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA7,Carbonic anhydrase 7,40302,-0.0162742667887706,0.00363947514759865,-0.0234076380780639,-0.0091408954994772,7.84076955977922e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0164570001580566,0.00368484200777676,0.00923470982281417,0.0236792904932991,8.02892542104219e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0146131682769139,0.00327276198222934,-0.0210277817620834,-0.00819855479174439,8.06804618246837e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS1,Nephrin,40199,0.0154595866696924,0.00346942750767005,0.00865950875465909,0.0222596645847257,8.4348606746666e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0386811567545598,0.00868676615670675,0.0216550950874146,0.055707218421705,8.54034392859975e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0169571366552331,0.00382020359893843,0.00946953760131377,0.0244447357091524,9.13385617933595e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA7A,Semaphorin-7A,42760,0.0130359483695901,0.00293761406554578,0.00727822480112035,0.0187936719380598,9.16856496288952e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVALB,Parvalbumin alpha,42654,0.0502230512278252,0.0113327303887526,0.0280108996658701,0.0724352027897803,9.42401327860152e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LUZP2,Leucine zipper protein 2,40451,0.0210296431504046,0.00474607978214222,0.0117273267774058,0.0303319595234033,9.47054078493722e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,C4BPB,C4b-binding protein beta chain,42679,0.0184131073098778,0.00415677398743182,0.0102658302945114,0.0265603843252441,9.51238432055317e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0134855376719349,0.00304527016448606,0.00751680814954222,0.0194542671943276,9.56999759386949e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLASP1,CLIP-associating protein 1,40080,0.0332495399694665,0.00751253803132786,0.0185249654280639,0.0479741145108691,9.6987678836195e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWF,von Willebrand factor,42794,-0.0328171887349118,0.00741867685996116,-0.0473577953804357,-0.0182765820893879,9.78280004476489e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI3,Elafin,42446,0.0259678402410562,0.00587442051792378,0.0144539760259256,0.0374817044561868,9.92585596237451e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0364201776316254,0.00825069472125407,0.0202488159779674,0.0525915392852834,1.0236306370984e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBS,Cystathionine beta-synthase,40223,0.0233112131675721,0.00529826881875841,0.0129266062828057,0.0336958200523386,1.09378467761805e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPO,Erythropoietin,42594,0.0334583891251813,0.00763518024146328,0.0184934358519133,0.0484233423984494,1.18415803963401e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCC,Netrin receptor DCC,40182,0.0104911023656191,0.00239766579017009,0.00579167741688574,0.0151905273143525,1.22245269142471e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0298739915820008,0.0068291822561142,0.016488794360017,0.0432591888039847,1.22828110032724e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.026366250632348,0.00602758805156212,-0.0381803232134097,-0.0145521780512862,1.22932044652374e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO2,Roundabout homolog 2,42711,0.010567583784402,0.00241751049680531,0.0058292632106636,0.0153059043581404,1.24450102274719e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB2A2,Mammaglobin-A,40116,-0.0143621098340246,0.00328614915152516,-0.0208029621710139,-0.00792125749703526,1.25108871851842e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0142862275188072,0.00327122120519753,0.00787463395662006,0.0206978210809944,1.26973771650319e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SATB1,DNA-binding protein SATB1,40482,0.0132002298386607,0.00302640144083511,0.00726848301462388,0.0191319766626975,1.30205758957798e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL2,Fc receptor-like protein 2,42681,0.02366524613533,0.00543720153183955,0.0130083311329244,0.0343221611377355,1.35604477954095e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSN,Gelsolin,40488,-0.0086998601460777,0.00200186807586557,-0.0126235215747742,-0.00477619871738118,1.39937325071832e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH6,Cadherin-6,42636,-0.0173579449174507,0.00399628332071738,-0.0251906602260567,-0.00952522960884459,1.4124396108591e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMB,RGM domain family member B,42711,0.012769610111727,0.00294099675183866,0.00700525647812326,0.0185339637453308,1.42262628179455e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK6,Kallikrein-6,42656,0.0142086478639698,0.003274833260963,0.00778997467248228,0.0206273210554572,1.44346609166614e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0394973657434305,0.00911269240588533,0.0216364886278953,0.0573582428589658,1.47269818803474e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPG,Macrophage-capping protein,42461,0.0261507850359496,0.00603692149405571,0.0143184189076004,0.0379831511642988,1.48976739241163e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0136755840842781,0.0031613660010524,-0.0198718614463408,-0.00747930672221537,1.53274644950357e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0124268712351846,0.00287523885860079,-0.0180623393980421,-0.00679140307232707,1.55920641866901e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX5,Syntaxin-5,40199,0.018317881260659,0.00423840301187242,0.0100106113573891,0.026625151163929,1.5606276618037e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300C,CMRF35-like molecule 6,42711,0.0160314351538757,0.00371072417502153,0.00875841577083352,0.0233044545369179,1.56930994848178e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN2,Transcobalamin-2,42771,-0.0137651888822923,0.00318693962469311,-0.0200115905466908,-0.0075187872178938,1.57672217613239e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00935639477784484,0.00216918044575888,-0.0136079884515322,-0.00510480110415743,1.62211955456921e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX2,Peroxiredoxin-2,40333,0.0277945823510868,0.00645345875078088,0.0151458031995563,0.0404433615026173,1.66955593015418e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.018255006769199,0.00424283852829218,-0.0265709702846516,-0.00993904325374631,1.70316410209953e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0249245516857912,0.00580639953804675,0.0135440085912195,0.0363050947803628,1.78104780162298e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0186060424428144,0.00433570751848072,0.0101080557065922,0.0271040291790367,1.7883669177866e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0214638333339678,0.00500217461358665,0.0116595710913379,0.0312680955765976,1.79473697795922e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0118200918735552,0.00275644282216131,-0.0172227198049913,-0.006417463942119,1.81676906444158e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0444769187996851,0.0103771077632499,0.0241377875837152,0.064816050015655,1.83428788275123e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0147169786000914,0.00343520958011247,0.00798396782307092,0.0214499893771118,1.84948638995633e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0191076148433243,0.0044615632255713,0.0103629509212046,0.0278522787654441,1.85932524777155e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0377888137736698,0.00884493147643013,0.0204527480798667,0.0551248794674728,1.94770646118903e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX3,Syntaxin-3,40483,0.0171285602157849,0.00401027597928162,0.00926841929639296,0.0249887011351769,1.96044418051842e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0254411041362962,0.00595996295855622,0.013759576737526,0.0371226315350664,1.98021838763716e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0176444209897618,0.00414658155292137,0.00951712114603587,0.0257717208334876,2.10578380112411e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.00941748745642495,0.00221405102134136,0.00507794745459588,0.013757027458254,2.11868109760719e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBLN2,Fibulin-2,40527,-0.0143252651117504,0.00337350827181877,-0.0209373413245152,-0.0077131888989856,2.18965533553273e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0111984381744989,0.0026383847826227,0.00602720400055837,0.0163696723484393,2.20893356954329e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.011768035909217,0.00277864649808186,0.0063218887729765,0.0172141830454574,2.30183003556209e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0069674665375856,0.00164686719781527,0.00373960682986767,0.0101953262453035,2.34449808057184e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC1,Glypican-1,42721,0.0130179153173282,0.00308713436295937,0.0069671319659278,0.0190686986687285,2.49373950924169e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL1,Follistatin-related protein 1,40223,-0.00983832387896777,0.00233902440870443,-0.0144228117200285,-0.00525383603790709,2.61793091529148e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0171786249871329,0.00408813872296103,0.00916587309012927,0.0251913768841365,2.66236907299796e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0283561790452,0.00675568365103238,0.0151150390891765,0.0415973190012234,2.72108762862189e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.0131031989896068,0.00312251974586755,-0.0192233376915072,-0.00698306028770639,2.72981678811546e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0181090962030342,0.00432134801756152,0.00963925408861362,0.0265789383174548,2.80320183624878e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0140021298311992,0.00334602066669712,0.00744392932447281,0.0205603303379255,2.8774233062836e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAX,Apoptosis regulator BAX,42292,0.038326139906501,0.00916783292251046,0.0203571873783805,0.0562950924346215,2.92757241389608e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.0110081975682871,0.0026368825445507,-0.0161764873556065,-0.00583990778096774,3.00240136293286e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR3,Small proline-rich protein 3,40483,0.0301918830687631,0.00723946189696832,0.0160025377507052,0.044381228386821,3.06258236675645e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0253166655089942,0.00607567705785258,0.0134083384756031,0.0372249925423852,3.11093331364795e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.016643867915248,0.00399958490372849,0.00880468150394014,0.0244830543265558,3.18648922518068e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0188918799587327,0.0045490681234963,0.00997570643667991,0.0278080534807854,3.30724985724344e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPS10,40S ribosomal protein S10,40116,-0.017448763859038,0.00420923951516241,-0.0256988733087563,-0.0091986544093197,3.41859562035414e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH1,Neurexophilin-1,42311,0.0166084329712945,0.00402261094418242,0.00872411552069692,0.024492750421892,3.66967235483541e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0300083707483994,0.00730677648711356,-0.044329652663142,-0.0156870888336568,4.03791162186986e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.016430390090103,0.00400148748108263,0.00858747462718104,0.0242733055530249,4.05359500801783e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP1,Dipeptidase 1,42476,-0.021202973907372,0.00516451543058914,-0.0313254241513268,-0.0110805236634173,4.05835784201488e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0122845885513875,0.00299253290073664,0.00641922406594366,0.0181499530368313,4.0712430431682e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRUNE2,Protein prune homolog 2,40302,0.0127377309167432,0.00310679902074829,0.00664840483607658,0.0188270569974099,4.1617541904408e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPOCK1,Testican-1,42495,0.010910599550099,0.00266196320547123,0.0056931516673754,0.0161280474328226,4.17936004301047e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTP1,Glutathione S-transferase P,42237,-0.029705577322505,0.00725304916377591,-0.0439215536835058,-0.0154896009615042,4.23620900800757e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP13,Collagenase 3,42311,-0.0141232842232925,0.00344893314954422,-0.0208831931963992,-0.00736337525018583,4.2475241987256e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL4,Delta-like protein 4,40223,0.0361974664750995,0.00885766409199391,0.0188364448547914,0.0535584880954076,4.40897346997084e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3,Galectin-3,42669,0.0126056173644399,0.00308674935160036,0.00655558863530323,0.0186556460935767,4.45642723690909e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO4,Roundabout homolog 4,40223,-0.0076759599796518,0.00188045884430369,-0.011361659314487,-0.00399026064481657,4.4972155793195e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0347345950068253,0.00851594069032749,0.0180433512537834,0.0514258387598672,4.5539271082716e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.0101547068884722,0.00249496763553365,-0.0150448434541182,-0.00526457032282626,4.72675199709623e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KEL,Kell blood group glycoprotein,42311,0.0152481281141796,0.00374877506186993,0.00790052899291458,0.0225957272354447,4.77988550073912e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0296032880064344,0.00728129812190772,-0.0438746323253735,-0.0153319436874953,4.82225080710009e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRELP,Prolargin,42618,0.0101983581327362,0.00251471025280046,0.00526952603724733,0.0151271902282251,5.03140087740453e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0232595322285626,0.00575189616268863,0.0119858157496929,0.0345332487074323,5.29418514979639e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSF,Cathepsin F,42679,0.0165198042217506,0.00408729821117089,0.00850869972785567,0.0245309087156456,5.33501686792852e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A11,Protein S100-A11,42531,0.0189642553851727,0.00469815709259278,0.00975586748369085,0.0281726432866546,5.45504499010187e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA1,Annexin A1,40235,0.0172711278137563,0.00428749491953999,0.00886763777145796,0.0256746178560547,5.65684706776314e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOSB,Protein fosB,42311,0.0159618974725763,0.0039650167742779,0.00819046459499159,0.023733330350161,5.71297626463331e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0117364432182794,0.00291868654871019,0.00601581758280744,0.0174570688537514,5.83032571744722e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG3,Secretogranin-3,42638,-0.0141911469121981,0.00352950527118309,-0.021108977243717,-0.00727331658067927,5.83376816941896e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0147091765524312,0.00366257645126806,0.00753052670794582,0.0218878263969166,5.95045919706051e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LF,CMRF35-like molecule 1,42721,0.025171316916435,0.00629166810030257,0.0128396474398419,0.037502986393028,6.3481389699106e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC16,Mucin-16,42587,0.079254087984014,0.0198192574638164,0.0404083433549338,0.118099832613094,6.39947216688345e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0111835818126806,0.00280416708648491,-0.016679749302191,-0.00568741432317021,6.69944987908458e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0161665053102694,0.00405402350014853,0.00822061924997831,0.0241123913705605,6.71302735333133e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0171548670585255,0.00430748973310031,-0.0255975469354021,-0.00871218718164886,6.85370985500744e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERC2,ERC protein 2,40182,0.0312000322759827,0.00785144237233655,0.015811205226203,0.0465888593257623,7.11881843996077e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0417401018587361,0.0105082586439604,0.0211439149165737,0.0623362888008985,7.16785073320072e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0114937008046933,0.00289410397755072,0.00582125700869385,0.0171661446006927,7.18168306095612e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0154068009688252,0.0038811421444009,0.00779976236579938,0.0230138395718509,7.23507439387617e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.0080984629525352,0.00204050654616506,-0.0120978557830187,-0.00409907012205169,7.26654685039659e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0231289824021192,0.00583846096608126,0.0116855989085999,0.0345723658956385,7.48769168384059e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0212068893825936,0.00535514462858758,0.010710805910562,0.0317029728546253,7.53068781889235e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMH,Granzyme H,42357,0.031703570184136,0.00801625409834338,0.015991712151383,0.047415428216889,7.6964233903292e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK8,Kallikrein-8,42154,0.0152912680865759,0.00386657747470392,0.00771277623615624,0.0228697599369956,7.70288492379041e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0331322358101394,0.00839306138220472,0.0166818355010181,0.0495826361192606,7.94273062601856e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIM,Vimentin,42357,0.0472208142997725,0.0119713706495412,0.0237569278266717,0.0706847007728733,8.03885508218601e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.0184959279242094,0.00469104657322627,0.00930147664068586,0.0276903792077328,8.10250885411041e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIF,Leukemia inhibitory factor,42311,0.0209504454889084,0.00531700972130298,0.0105291064351545,0.0313717845426622,8.18123353253201e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0175948538645453,0.00446567711201911,-0.0263475810041028,-0.00884212672498787,8.19746258488078e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.0145709038382105,0.00370455888459745,0.00730996842439947,0.0218318392520215,8.42295920068838e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMB,Granzyme B,42594,0.0269180076853555,0.00685779956215559,0.0134767205435306,0.0403592948271805,8.71029920580057e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PZP,Pregnancy zone protein,40539,0.0205504257297386,0.00525790199434333,0.0102449378208257,0.0308559136386515,9.34170158151987e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0210586793398513,0.00539358353397249,-0.0316301030664374,-0.0104872556132652,9.4925069143613e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROK1,Prokineticin-1,42594,0.0222926453267385,0.00571028472798938,0.0111004872598794,0.0334848033935977,9.51003471312162e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0147863780053498,0.00379314219737507,0.00735181929849462,0.0222209367122049,9.7494962105056e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN2,Prefoldin subunit 2,42311,0.0223108903660958,0.00572405566024732,0.011091741272011,0.0335300394601805,9.75768897470843e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0288454561665276,0.00740206262241939,-0.0433534989064697,-0.0143374134265856,9.79737254538629e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD9,COMM domain-containing protein 9,40451,0.0159813799963212,0.00410115166104729,0.00794312274066849,0.0240196372519739,9.80354734199402e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.011501962976733,0.00295409818913017,0.00571193052603788,0.0172919954274282,9.92556909154079e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0130701567679534,0.00335770354171814,-0.019651255709721,-0.00648905782618588,9.97702396186122e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A13,Protein S100-A13,40199,0.0142764542324398,0.00367342636849747,0.00707653855018473,0.0214763699146948,0.000102332903490473
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLFM4,Olfactomedin-4,39870,0.0494688353552504,0.012745977332969,0.0244867197826312,0.0744509509278696,0.000104596401780093
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0430268777138745,0.011117588102097,0.0212364050337645,0.0648173503939846,0.000109391580956243
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.0240263377325913,0.00621194880687535,0.0118509180711156,0.036201757394067,0.000110360034461915
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLGN,Calmegin,40182,0.0185303197189668,0.00480491998768794,0.00911267654309845,0.0279479628948352,0.000115664086259892
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPTC,Opticin,42587,-0.0184474661874191,0.00478416129986481,-0.0278244223351542,-0.00907051003968411,0.00011582227966484
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.0123008249154289,0.00319790677835786,0.00603292762984751,0.0185687222010103,0.000120479872803005
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0154666947062075,0.00403323367289544,-0.0233718327050825,-0.0075615567073324,0.000126366294886334
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANPEP,Aminopeptidase N,42666,-0.010983277777131,0.00286636231941774,-0.0166013479231897,-0.00536520763107219,0.000127795691342073
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2,Ataxin-2,40136,0.0436794697750359,0.0114033787085547,0.0213288475062687,0.066030092043803,0.000128651092954838
NMR metabolomics,X23501.Triglycerides in Large VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0246540611884238,0.00647871075187424,-0.0373523342620973,-0.0119557881147503,0.00014221778507083
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0106076209006635,0.00279347289846313,-0.0160828277816512,-0.00513241401967577,0.000146931232387473
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0113551736587953,0.00299036761707425,-0.0172162941882608,-0.00549405312932979,0.000146946149326328
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0119222297363789,0.0031398562235554,0.0057681115382103,0.0180763479345474,0.000147071662352678
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0137690068492397,0.00362778506444957,-0.0208794655755609,-0.00665854812291859,0.000148048124540563
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP12,Macrophage metalloelastase,42592,0.0219268800967524,0.00579029346089798,0.0105779049133923,0.0332758552801124,0.000153245271123882
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.0936863588713221,0.0247725422047166,0.0451321761500777,0.142240541592567,0.000156462061512359
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.014788013265945,0.00392235881859423,-0.0224758365503897,-0.00710018998150031,0.000163982015036977
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEG1,Protein LEG1 homolog,39926,-0.0272128412594687,0.00722557674873111,-0.0413749716869817,-0.0130507108319557,0.000166648182279389
NMR metabolomics,X23501.Triglycerides in Large VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0214498946535213,0.00569937838650861,0.0102791130159644,0.0326206762910781,0.000168363511847087
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.017188173774603,0.00458628691402829,0.00819905142310757,0.0261772961260985,0.000179332956756824
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0415214909837682,0.0110871375480751,0.019790701389541,0.0632522805779955,0.000181144318827289
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN10,Ataxin-10,42311,0.0279281154622417,0.00746378548449795,0.0132990959126257,0.0425571350118577,0.000183473958321492
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0158613377881046,0.004247715694548,-0.0241868605494187,-0.00753581502679052,0.000189170679334055
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSG,Basigin,42746,0.00832778886180102,0.00224346509452787,0.00393059727652639,0.0127249804470757,0.000206434595702981
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.015726363668094,0.00425171861297652,0.00739299518666004,0.024059732149528,0.000217481719324689
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAU,Urokinase-type plasminogen activator,42611,-0.0112360600831012,0.00304501106028326,-0.0172042817612564,-0.00526783840494601,0.00022515004122446
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG4,Regenerating islet-derived protein 4,42638,0.0200331795088558,0.00543615651297193,0.00937831274343083,0.0306880462742808,0.000229444768343405
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0136422289548968,0.00371258743254393,0.00636555758711071,0.0209189003226829,0.000239373504047223
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIT,Vitrin,40511,0.0145816692554366,0.00397776060844133,0.00678525846289155,0.0223780800479816,0.000247696273826804
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARCO,Macrophage receptor MARCO,42636,0.00991003861236658,0.00270639221691033,0.00460550986722233,0.0152145673575108,0.000251492872257518
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.0118525037440418,0.00324756902625486,-0.0182177390355014,-0.0054872684525823,0.000263811003221616
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.0209275899829607,0.00573521607381558,0.00968656647828212,0.0321686134876392,0.00026452103148693
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC2,Stanniocalcin-2,42591,0.00936126630767352,0.00256958115282869,0.0043248872481293,0.0143976453672177,0.000270380910507318
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMS1,PMS1 protein homolog 1,40182,0.0195931712501062,0.00537958963975511,0.0090491755561862,0.0301371669440262,0.000271634044575225
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGA4,Pepsin A-4,40532,0.0303151128267726,0.00832790919264213,0.013992410809194,0.0466378148443512,0.000273656533681657
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNXB,Tenascin-X,42611,-0.00970117190911032,0.00266725158134818,-0.0149289850085527,-0.00447335880966789,0.000276713282656575
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0127549585788271,0.0035079072011104,0.00587946046465074,0.0196304566930035,0.000277868367561399
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0128882107732484,0.0035453307335606,0.00593936253546964,0.0198370590110272,0.000278934927007853
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL1,Delta-like protein 1,42679,-0.0118127692163027,0.00325066507227021,-0.0181840727579523,-0.00544146567465311,0.000280147154322833
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0212922175631816,0.00588025191664544,0.00976692380655654,0.0328175113198067,0.000294819117155241
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSR,Insulin receptor,40199,0.00647394307225513,0.00179328833054139,0.002959097944394,0.00998878820011626,0.000307443700862877
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00885166814626942,0.00245246985962161,0.00404482722141107,0.0136585090711278,0.000308157280197103
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0104547286117872,0.00290193743196107,0.0047669312451435,0.0161425259784309,0.000316127759673182
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO1,Roundabout homolog 1,42638,0.00911893884922971,0.00253155926727116,0.00415708268537824,0.0140807950130812,0.000316790765182849
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL6,Fc receptor-like protein 6,42594,0.0260310060984406,0.00724216604323917,0.0118363606536918,0.0402256515431894,0.000326347682385756
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR4,Proline-rich protein 4,40198,-0.0257296550411744,0.00718277289349783,-0.0398078899124301,-0.0116514201699186,0.00034226980980922
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.00969041717098274,0.00270554327135664,-0.0149932819828417,-0.00438755235912373,0.000342867509776189
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0195091686049064,0.00545971504096962,-0.0302102100852069,-0.00880812712460594,0.000353749752717332
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB6,Heat shock protein beta-6,42721,0.0145511228839476,0.00407264723668674,0.00656873430004155,0.0225335114678536,0.000354289710849425
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.011984639849594,0.00335518916630454,-0.0185608106155509,-0.00540846908363706,0.000355825680821342
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.0340613926062745,0.00954471346507967,0.0153537542147183,0.0527690309978306,0.000360414127516945
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0136461127360182,0.00383547516773641,0.0061285814072548,0.0211636440647815,0.000375191229717635
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.01764051639443,0.00497430653268159,0.00789087559037404,0.0273901571984859,0.000391974040302487
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0125132593685171,0.00353514340079263,0.00558437830296352,0.0194421404340706,0.000401964656322453
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G1B,Phospholipase A2,42782,-0.016659096962931,0.00471079127222866,-0.0258922478564992,-0.00742594606936281,0.000407018367520211
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL25,C-C motif chemokine 25,42754,0.0174771002838152,0.00494513557779469,0.00778463455133761,0.0271695660162928,0.000410372588828456
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0105942889798217,0.00300052522271397,-0.0164753184163411,-0.00471325954330233,0.000415688085748779
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0139407636577015,0.00395801736106931,0.00618304963000565,0.0216984776853973,0.000429791267308658
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.0214257919418559,0.00609235300301711,-0.0333668038277695,-0.0094847800559424,0.000438170207075386
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0178251933130569,0.00507569684191653,0.00787682750290046,0.0277735591232133,0.000446760397359977
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0136857457475223,0.0038976246654658,-0.0213250900918353,-0.00604640140320937,0.000447378362433387
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.0143250322908304,0.00409043554881108,0.0063077786151607,0.0223422859665001,0.000463467891256602
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0134747531408767,0.00384920912673345,-0.0210192030292742,-0.00593030325247913,0.00046595693350743
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL21,C-C motif chemokine 21,42676,0.0152104828934243,0.00435732219970041,0.00667013138201146,0.0237508344048371,0.000483140370664033
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.015864151892058,0.00455442132563279,0.00693748609381776,0.0247908176902983,0.000497320329229912
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0102065581351839,0.00293208829996859,0.00445966506724547,0.0159534512031223,0.000501455290446317
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG3,Proteoglycan 3,40527,-0.017903187687094,0.00514715313185647,-0.0279916078255326,-0.00781476754865526,0.000506556094354056
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.0116781372863774,0.00336171970882571,0.00508916665707904,0.0182671079156758,0.000514956763801649
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0156874144268055,0.00451860849694277,0.00683094177279764,0.0245438870808133,0.000518765975557807
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0176740562487408,0.00509610178049723,-0.0276624157385153,-0.00768569675896618,0.000525689983965696
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGT,Angiotensinogen,40532,0.00854696063519694,0.00246507316120565,0.00371541723923386,0.01337850403116,0.00052781360926819
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL34,Interleukin-34,42292,0.0131017964710721,0.00378168139011748,0.0056897009464418,0.0205138919957023,0.000532833611258891
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB1,Calbindin,42587,0.0163191509248165,0.00471043745002445,0.0070866935227686,0.0255516083268644,0.000532947635258365
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0183644641834196,0.00530204609600924,0.00797245383524148,0.0287564745315977,0.000534918586800849
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00975390584362657,0.00281816493765649,-0.0152775091214333,-0.00423030256581984,0.000540002995033246
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCP1,Plastin-2,40527,0.0170761960379208,0.0049538889588869,0.00736657367850251,0.0267858183973392,0.000568846321953869
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0274645027100106,0.00798672995564832,0.0118105119969399,0.0431184934230813,0.000586181408654959
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAFB2,Scaffold attachment factor B2,40482,0.0097445214081947,0.00283936985702019,0.00417935648843512,0.0153096863279543,0.000601448665145652
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00752540459244443,0.0021934292115174,-0.0118245258470185,-0.00322628333787033,0.000603760280583107
NMR metabolomics,X23501.Triglycerides in Large VLDL,TG,Thyroglobulin,40451,-0.0407767251975304,0.0119029446854336,-0.0641064967809802,-0.0174469536140806,0.000615253466121422
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0222967279296278,0.00651090224508448,-0.0350580963299934,-0.00953535952926221,0.000617724482811205
NMR metabolomics,X23501.Triglycerides in Large VLDL,ULBP2,UL16-binding protein 2,42495,0.0141478710992269,0.00413268914267873,0.00604780037957657,0.0222479418188772,0.000620281260767035
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPS,Colipase,42590,0.0255645112991083,0.00752977886140951,0.0108061447307456,0.0403228778674709,0.000687972966015737
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP10,Bone morphogenetic protein 10,40283,-0.0100333745979198,0.00296689421580781,-0.0158484872609031,-0.0042182619349365,0.000722674143790856
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0221412552110181,0.00655230340482357,0.00929874053756389,0.0349837698844723,0.000729538363741352
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0122960322582337,0.003639802120085,0.00516202010286709,0.0194300444136003,0.000731660076244598
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0162372941058497,0.0048088686337174,-0.0256626766279358,-0.00681191158376357,0.000736129246228657
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0177696299488532,0.0052747743201998,0.00743107228126159,0.0281081876164448,0.000757510862139665
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSV,Cathepsin L2,42677,0.0145661101519495,0.00432623967195402,0.0060866803949196,0.0230455399089794,0.000762247245062337
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL3,Insulin-like 3,40483,0.0271713268851414,0.00808339807360966,0.0113278666608664,0.0430147871094163,0.000778129920463079
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA9,Carbonic anhydrase 9,42721,-0.0168295633179918,0.00500786297195146,-0.0266449747430167,-0.00701415189296695,0.000779807001822877
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE,Angiotensin-converting enzyme,40532,-0.00930156746375329,0.00277088130822266,-0.0147324948278697,-0.00387064009963688,0.000790811674951249
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0131320239015881,0.00392001085439909,-0.0208152451762103,-0.00544880262696586,0.000810355433510713
NMR metabolomics,X23501.Triglycerides in Large VLDL,LXN,Latexin,42461,-0.0234477365703869,0.00700620353491799,-0.0371798954988262,-0.00971557764194767,0.000820036482487165
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0152402806860965,0.00459015776862935,0.00624357145958298,0.02423698991261,0.000902444458558951
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGCR6,Protein DGCR6,40136,0.0151673681220455,0.00457776850526097,0.00619494185173404,0.024139794392357,0.000925122530521436
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN2,Neuroligin-2,40136,-0.0163715454948896,0.00496779956602653,-0.0261084326443016,-0.00663465834547765,0.000985478289772771
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH12,Protocadherin-12,40482,0.00878175164003126,0.00266659373979793,0.00355522791002732,0.0140082753700352,0.000993420848091881
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.0213935366560505,0.0065001380480647,-0.0341338072302573,-0.00865326608184366,0.00100062146378911
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.0118271458748007,0.00359894166649709,0.00477322020846636,0.018881071541135,0.00101827482690329
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.0125272066779596,0.00381368540165169,0.00505238329072232,0.020002030065197,0.00102375995007975
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK2,Protein AHNAK2,40223,0.0102175473115378,0.0031224265095517,0.00409759135281642,0.0163375032702591,0.00107000556201395
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0163176165444523,0.00499150904748065,-0.0261009742775143,-0.0065342588113902,0.00108229360406179
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTN,Titin,40116,-0.0221627450302415,0.00678719566102752,-0.0354656485258554,-0.00885984153462754,0.00109655672576849
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0195438159917789,0.00600073849456143,0.00778236854243849,0.0313052634411193,0.00112920226322491
NMR metabolomics,X23501.Triglycerides in Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0613541098670697,0.0189142058037518,0.0242822664917162,0.0984259532424232,0.00118231403024273
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,0.0419690402930585,0.0129517472083909,0.0165836157646124,0.0673544648215046,0.00119710415800751
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0111430486724508,0.00343880577008722,0.00440298936307989,0.0178831079818218,0.00119723869251829
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0100552175413292,0.00310377248883837,0.00397182346320597,0.0161386116194524,0.00119955439336735
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDRG1,Protein NDRG1,42311,0.0218150072597888,0.00673529069057081,0.00861383750626999,0.0350161770133076,0.00120285611750393
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPJ,Centromere protein J,40302,0.0236788532927298,0.00732503671974105,0.00932178132203735,0.0380359252634223,0.00123030702948357
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.010007362055967,0.00309595684541122,0.00393928663896099,0.016075437472973,0.0012305875454042
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0230760322845041,0.00714273800940833,0.00907626578606379,0.0370757987829444,0.00123850313260051
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00852143848264865,0.00264166444489327,0.00334377617065784,0.0136991007946395,0.00125928743451333
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.049575338080756,0.0154391400028694,0.0193146236751319,0.0798360524863801,0.00132585023478987
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.00916019559091908,0.00285485397807876,0.00356468179388472,0.0147557093879534,0.00133676774277829
NMR metabolomics,X23501.Triglycerides in Large VLDL,YY1,Transcriptional repressor protein YY1,40199,0.00932639785816004,0.00291263349767239,0.00361763620272217,0.0150351595135979,0.00136841419612685
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.00995964746422284,0.0031114306552422,0.00386124337994813,0.0160580515484975,0.00137284304766175
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLNS1A,Methylosome subunit pICln,40182,0.0110454336360073,0.00345259403986167,0.00427834931787839,0.0178125179541361,0.0013821537378562
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00945411603948525,0.0029792612522042,0.00361476398516502,0.0152934680938055,0.00151117437378423
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG4,Desmoglein-4,42543,0.016383024153224,0.00517054500130742,0.00624875595066143,0.0265172923557865,0.00153557726371104
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.010819937414133,0.00341555428266135,-0.0175144238081492,-0.00412545102011672,0.0015391843876415
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF15,Growth/differentiation factor 15,42794,-0.0151301302397236,0.00477857096873393,-0.0244961293384421,-0.00576413114100506,0.0015476114127563
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0215522818227916,0.00681167132559931,0.00820140602461691,0.0349031576209662,0.0015601871259918
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0176747388329527,0.00559061360219877,0.00671713617264309,0.0286323414932623,0.00157372655419449
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00945692241593046,0.00299518842116864,-0.015327491721421,-0.00358635311043991,0.00159624329810569
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPL,Periplakin,40199,0.010855808789052,0.00343886554815356,0.00411563231467105,0.017595985263433,0.00159941490372813
NMR metabolomics,X23501.Triglycerides in Large VLDL,XG,Glycoprotein Xg,42734,0.0112257167180166,0.00356152560815414,0.00424512652603454,0.0182063069099988,0.00162543018291882
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0176780285543784,0.00562144209252725,0.00666000205302501,0.0286960550557318,0.00166660152527534
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1,Programmed cell death protein 1,42689,0.0146288561284109,0.00465359017925564,0.00550781937706983,0.0237498928797519,0.00167265835039258
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0132251396815381,0.00421856891521668,-0.0214935347553628,-0.00495674460771341,0.00172319925950251
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0209113210410011,0.00668912142022635,0.00780064305735744,0.0340219990246447,0.00177560102671489
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.0251988921824412,0.00808745195147625,0.00934748635754772,0.0410502980073346,0.00183920461186774
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD5,Sushi domain-containing protein 5,40235,-0.0111817141038909,0.0035917996158135,-0.0182216413508854,-0.00414178685689646,0.00185591903179619
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFR,Epidermal growth factor receptor,42794,0.00523420841425271,0.00168281044895053,0.00193589993430966,0.00853251689419575,0.00187222427240828
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY2,Protein canopy homolog 2,42357,0.0197973802369027,0.00637578696930284,0.00730083777706914,0.0322939226967363,0.00190626208587385
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0216526643545951,0.0069790238542966,0.0079737776001738,0.0353315511090165,0.00192352297940604
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0107408245747704,0.00347422208386363,0.00393134929039768,0.0175502998591431,0.00199508687042283
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.00701853277813725,0.00227478680556284,-0.0114771149170404,-0.00255995063923408,0.00203807511083986
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0300958582208115,0.00976149856926658,0.010963321025049,0.049228395416574,0.00205349215828671
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.0134205814657865,0.00435605508129952,-0.0219584494251336,-0.00488271350643946,0.00206870609914677
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.00829812382631296,0.00270033874647676,0.00300545988321851,0.0135907877694074,0.00212348649389083
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRP15,RRP15-like protein,40136,-0.0291423999335634,0.0094930462400858,-0.0477487705641316,-0.0105360293029953,0.0021467790433103
NMR metabolomics,X23501.Triglycerides in Large VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.0137367860160815,0.0044762734132787,0.00496329012605521,0.0225102819061077,0.00215436788046268
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCC1,Regulator of chromosome condensation,40451,0.016556853736883,0.00542364720783451,0.00592650520952735,0.0271872022642386,0.00227309567346261
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0270356661411927,0.00888301569922375,-0.0444463769116712,-0.00962495537071412,0.00234293081701907
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0111459312106989,0.00366208281893201,0.00396824888559219,0.0183236135358057,0.00234314051591214
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1B,Interleukin-1 beta,42293,0.0178768545113249,0.00587737378978703,0.00635720188334228,0.0293965071393074,0.00235758603481592
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.0076445438149604,0.00251365246521009,0.00271778498314862,0.0125713026467722,0.00236184307753189
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM25,Transmembrane protein 25,40482,-0.0143328869871503,0.00471578584610291,-0.023575827245512,-0.00508994672878859,0.00237638102724362
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSM,Oncostatin-M,42534,0.0219314158867835,0.00722656061071666,0.00776735708977882,0.0360954746837881,0.00241131267252546
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0101924818447406,0.00335852677580971,-0.0167751943253276,-0.00360976936415353,0.00241247155023985
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0222028382980083,0.00731969084455966,0.00785624424267133,0.0365494323533452,0.00242451414504436
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL3,Follistatin-related protein 3,42574,0.0105456762329203,0.00349623973349278,0.00369304635527447,0.0173983061105661,0.00256368159901706
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA4,Apolipoprotein A-IV,40539,0.0112338243033484,0.00372432285206473,0.00393415151330154,0.0185334970933953,0.00256412879080705
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTG,Protogenin,42721,0.0077461854946132,0.00257129071879208,0.00270645568578073,0.0127859153034457,0.0025952730340367
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST1,Cystatin-SN,39042,0.0341675867934037,0.0113694047978951,0.0118835533895294,0.0564516201972781,0.00266055195279653
NMR metabolomics,X23501.Triglycerides in Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0271623853411064,0.00907443401151202,0.00937649467854286,0.04494827600367,0.00276610491157848
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.00981496899091808,0.00328095666135324,0.00338429393466572,0.0162456440471704,0.00278212245697741
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSAP,Gamma-secretase-activating protein,42346,0.0264795821163037,0.00885200394229993,0.00912965438939587,0.0438295098432116,0.00278247340071569
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE1,Ribonuclease pancreatic,40532,0.00813260310298041,0.00272788606089283,0.00278594642363046,0.0134792597823304,0.00287652102262965
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0103046921063199,0.00345722958635355,0.00352852211706696,0.0170808620955729,0.00288293260429047
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS5,Transmembrane protease serine 5,42438,-0.0117343260800114,0.00393870746782264,-0.0194541927169438,-0.00401445944307902,0.00289495297636072
NMR metabolomics,X23501.Triglycerides in Large VLDL,MB,Myoglobin,42794,-0.0163237719619386,0.00548375431967938,-0.0270719304285102,-0.00557561349536703,0.00291833295084901
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.0150371873311601,0.00505232048969703,0.0051346391713539,0.0249397354909662,0.00292285673535783
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXDNL,Peroxidasin-like protein,40451,-0.0171128997921421,0.00576145838832366,-0.0284053582332565,-0.00582044135102777,0.00298197594089387
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0228625079292871,0.00770780544979826,0.0077552092476825,0.0379698066108917,0.00302084230480564
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0137151598567227,0.00462421518188465,0.00465169810022875,0.0227786216132166,0.00302409083950639
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRTN,Neurturin,42370,0.0150759451718844,0.00509080823826468,0.00509796102488565,0.0250539293188832,0.00306785076804767
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0125298412929409,0.00423598837646612,0.00422730407506734,0.0208323785108145,0.00310336263650068
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXTL1,Exostosin-like 1,40116,0.0144664728402657,0.00489506429667198,0.00487214681878859,0.0240607988617427,0.0031301373558757
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR5,Proline-rich protein 5,40199,0.0145760865715172,0.00493855992072362,0.00489650912689895,0.0242556640161355,0.0031691683014365
NMR metabolomics,X23501.Triglycerides in Large VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0118073187163008,0.00400066338289698,0.00396601848582271,0.0196486189467789,0.00317065539658326
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.0127661610237809,0.00432583921871261,-0.0212448058924576,-0.00428751615510418,0.00317150685399892
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0152414749213807,0.00516543760818698,-0.0253657326334272,-0.00511721720933425,0.00317760107291016
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.0193394156762027,0.00659454973348284,0.00641409819857633,0.0322647331538291,0.00336790064203197
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0172369387235438,0.00587942664587627,0.00571326249762631,0.0287606149494613,0.00337650454666569
NMR metabolomics,X23501.Triglycerides in Large VLDL,MBL2,Mannose-binding protein C,40379,-0.0329212974135947,0.0112389208365918,-0.0549495822533147,-0.0108930125738746,0.00340497441003434
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0193991147474409,0.00665473444131157,0.00635583524247017,0.0324423942524115,0.00356310112147232
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0184987896537479,0.00643198109517168,0.00589210670721142,0.0311054726002844,0.00403314341283077
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0222384878886775,0.00774593219378184,-0.0374205149884899,-0.00705646078886511,0.00409950558073885
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0112401959509722,0.00391716084401563,0.0035625606967016,0.0189178312052429,0.00411918531972326
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0182608755526281,0.00636901559604384,-0.030744146120874,-0.00577760498438214,0.00414987336681763
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_DRA,,42549,-0.01093233476212,0.00381801464924904,-0.0184156434746481,-0.00344902604959191,0.00419832059574757
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.00806376099899367,0.0028171150380868,-0.0135853064736438,-0.00254221552434353,0.0042122142329377
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0254719604451403,0.00892836348245309,0.00797236801953228,0.0429715528707484,0.00433987330075577
NMR metabolomics,X23501.Triglycerides in Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.00804245129757469,0.00282000615387056,0.0025152392359884,0.013569663359161,0.00435211274065297
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP1,Caspase-1,42311,0.0203738965057862,0.00714687204283317,0.00636602730183322,0.0343817657097392,0.00436852312000029
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.00985338127168074,0.00346215695281909,0.00306755364415532,0.0166392088992062,0.00443505280709587
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.00996619629884103,0.00350202076184118,0.00310223560563232,0.0168301569920497,0.00443740202327474
NMR metabolomics,X23501.Triglycerides in Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0140569923006732,0.00495672190331343,-0.0237721672311676,-0.00434181737017892,0.00457742787592294
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0149526802777283,0.00527818979838168,-0.0252979322825564,-0.00460742827290019,0.00462071618262707
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE6,Ribonuclease K6,40468,0.00995183691898964,0.00351397364419418,0.00306444857636906,0.0168392252616102,0.00463289722468486
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFLAM,Pikachurin,40449,0.00906239244819544,0.0032013652801823,0.00278771649903814,0.0153370683973527,0.00465155200627326
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.00822527926027138,0.00291327686168183,0.00251525661137499,0.0139353019091678,0.00475915247996307
NMR metabolomics,X23501.Triglycerides in Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0243994435420501,0.00870182653614037,0.00734386353121495,0.0414550235528852,0.00505700615599746
NMR metabolomics,X23501.Triglycerides in Large VLDL,EP300,Histone acetyltransferase p300,40199,0.00893535142671652,0.00319866655839205,0.00266596497226809,0.0152047378811649,0.00522373685353306
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0163334319101989,0.00585577081749816,0.00485612110790249,0.0278107427124953,0.00529000120562076
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00922645133178544,0.00331006402205278,-0.0157141768150089,-0.002738725848562,0.0053208058407743
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0198541970133212,0.00713077004680507,0.00587788772158322,0.0338305063050591,0.00537193176261825
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00788793831950649,0.0028437279302686,-0.0134616450628329,-0.00231423157618004,0.0055480900010071
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0154890326825057,0.00558429076486728,-0.0264342425816456,-0.0045438227833658,0.00555201475608888
NMR metabolomics,X23501.Triglycerides in Large VLDL,OBP2B,Odorant-binding protein 2b,42462,-0.0175912688255781,0.0063504271425808,-0.0300381060250364,-0.00514443162611969,0.0056118341626684
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK1,Kallikrein-1,42505,-0.0370830675501304,0.0134011374342494,-0.0633492969212592,-0.0108168381790016,0.00566253750934839
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNW1,Interferon omega-1,40116,-0.0105296046569817,0.00381254864250077,-0.0180021999962832,-0.00305700931768019,0.00575747525633415
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0285415195516728,0.0103371574506889,-0.0488023481550231,-0.00828069094832254,0.00577101426765228
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGF,Beta-nerve growth factor,42495,0.00342462416420586,0.00124152592105347,0.000991233358941062,0.00585801496947065,0.00581645511159782
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA6C,Semaphorin-6C,40199,0.00745113455333348,0.0027119420996842,0.00213572803795245,0.0127665410687145,0.00601442790826237
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAYN,Layilin,42476,-0.0107242589727303,0.00391489108907268,-0.0183974455073127,-0.00305107243814783,0.00616428374435468
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.00668060507260211,0.00243958665517277,0.00189901522846349,0.0114621949167407,0.00618179323148313
NMR metabolomics,X23501.Triglycerides in Large VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.00828060383653574,0.0030490024657809,0.00230455900360518,0.0142566486694663,0.00661939968565259
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0111123209289585,0.00409428904682672,-0.0191371274607389,-0.00308751439717815,0.00665588560410752
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.0117123284269552,0.0043253771657177,0.00323458918214854,0.0201900676717619,0.00678331924033635
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00960827409536257,0.0035493600963014,-0.0165650198841133,-0.00265152830661182,0.00679720554427835
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0153418795568004,0.00568464484234741,0.00419997566579951,0.0264837834478013,0.00696729385421635
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0223374753833309,0.00828300764634708,0.00610278039649064,0.0385721703701712,0.00701194329792208
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0197022900643196,0.00730889294763771,0.00537685988694967,0.0340277202416895,0.00703534371249282
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.0122189915054782,0.00454400412954501,-0.0211252395993864,-0.00331274341156998,0.00717489169777862
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP2,Dipeptidase 2,42587,-0.00817737724626535,0.00304853050327862,-0.0141524970326915,-0.00220225745983925,0.00731857678647366
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUK1,Guanylate kinase,40116,-0.0106315539785457,0.00397382918813178,-0.018420259187284,-0.00284284876980743,0.0074753015764799
NMR metabolomics,X23501.Triglycerides in Large VLDL,WNT9A,Protein Wnt-9a,42370,-0.00818534652645812,0.00307155037013516,-0.014205585251923,-0.00216510780099321,0.00771071454085144
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0162595868727786,0.00611437311222376,0.00427541557282003,0.0282437581727372,0.00784317311006797
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0119819684957891,0.00452402063726033,-0.0208490489448194,-0.00311488804675887,0.00809393374506936
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX18,Sorting nexin-18,40449,0.0119521775663645,0.00452811156802949,0.00307707889302668,0.0208272762397023,0.00831305820035441
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0122164663180774,0.00464007220709447,0.00312192479217219,0.0213110078439825,0.00847988772614205
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF4,Neurotrophin-4,42346,0.0106164966845023,0.00403621730156987,0.00270551077342534,0.0185274825955792,0.0085406797797312
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0197829567544773,0.00753973016639842,0.00500508562833641,0.0345608278806182,0.00870458649958925
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100G,Protein S100-G,40482,-0.0130580389848508,0.00498847443681455,-0.0228354488810073,-0.00328062908869429,0.00886578383661542
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0143057379005313,0.00547417177811974,0.00357636121541659,0.025035114585646,0.00897708347036596
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.00757548996496466,0.0029033192001193,-0.0132659955971985,-0.00188498433273084,0.00908417046198081
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0113500781612906,0.00436439642617339,0.00279586116599075,0.0199042951565904,0.0093181494839581
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0153610236667535,0.00592521088184544,0.00374761033833648,0.0269744369951706,0.00954100074613906
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM2,Junctional adhesion molecule B,42711,0.00760046519521199,0.00293756232076021,0.00184284304652198,0.013358087343902,0.00968241874898744
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0189961712961865,0.00737235996000637,0.00454634577457405,0.033445996817799,0.00998609407990502
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD59,CD59 glycoprotein,42130,0.00664440104952632,0.00258554823641913,0.00157672650614483,0.0117120755929078,0.01018614577806
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD7,T-cell antigen CD7,40166,0.0118449411424933,0.00461576093270297,0.00279804971439548,0.0208918325705911,0.0102952618336742
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEO1,Neogenin,40482,0.00587748479402432,0.00229765909227587,0.00137407297316361,0.010380896614885,0.0105395898151858
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.0129987282825524,0.00508335927130925,-0.0229621124543186,-0.00303534411078632,0.0105653347530803
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST7,Cystatin-F,42642,0.0247107934535152,0.00967783147722767,0.00574224375814894,0.0436793431488814,0.0106804684484959
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0135283269162276,0.00531025924362886,-0.0239364350337401,-0.00312021879871501,0.0108607580015983
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST6,Cystatin-M,42332,0.0133112160910947,0.00524323408682959,0.00303447728090872,0.0235879549012807,0.0111366369823846
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0129325344562925,0.0050956677604838,-0.0229200432668408,-0.00294502564574426,0.011161659810357
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASN,Vasorin,42449,-0.00719439041306194,0.00284481344133262,-0.0127702247580739,-0.00161855606805001,0.0114519390099647
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0216869833373265,0.00860295403032645,0.00482519343788667,0.0385487732367664,0.0117203127459998
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171B,Protein FAM171B,40451,0.00688301363786857,0.00273054176346294,0.0015311517814812,0.0122348754942559,0.0117241993248039
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD27,CD27 antigen,42679,-0.0115286277624238,0.00457511342065013,-0.0204958500668981,-0.00256140545794959,0.0117517333309745
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00783483550880003,0.00311433469023305,0.00173073951594326,0.0139389315016568,0.0118926432370084
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00665932263395853,0.00264973131986022,-0.0118527960208846,-0.00146584924703249,0.0119780585099048
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0284355377440217,0.011319840643462,0.00624865008283613,0.0506224254052072,0.0120184117532272
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN4,Nectin-4,42679,-0.00890826006399986,0.00356790858550865,-0.0159013608915968,-0.0019151592364029,0.0125447290012323
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0174639541197722,0.00699599156010622,0.00375181066196398,0.0311760975775804,0.0125621940241276
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.00728430605021001,0.00291879038888933,0.00156347688798693,0.0130051352124331,0.0125841897170433
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0149933439018182,0.00600962406142062,0.00321448074143374,0.0267722070622026,0.012614360743327
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0226112558185833,0.0090820437199738,-0.0404120615097319,-0.00481045012743461,0.0127983539046673
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITM2A,Integral membrane protein 2A,42594,-0.0158759128130888,0.00638146498116039,-0.0283835841761631,-0.00336824145001443,0.0128650700141809
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTO1,Protein LTO1 homolog,42370,0.0108056391622991,0.00435640554500853,0.00226708429408236,0.0193441940305158,0.0131358081119902
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0190668107519657,0.00768871062416293,-0.0341366835753251,-0.00399693792860639,0.0131588849647478
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0185530194195186,0.00749112774363751,0.00387040904198909,0.0332356297970481,0.0132761445832381
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL25,Interleukin-25,40036,0.00896255992645811,0.00361930162777292,0.00186872873602319,0.016056391116893,0.0132894883074608
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0134161853742311,0.0054214886246334,0.00279006766994965,0.0240423030785126,0.013352449433805
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDHB15,Protocadherin beta-15,40451,-0.0103014707814202,0.00416460841761494,-0.0184641032799455,-0.00213883828289492,0.0133915197732599
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD58,Lymphocyte function-associated antigen 3,42600,-0.00452578933572784,0.00183319486356503,-0.00811885126831531,-0.000932727403140383,0.0135691168102945
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRXN3,Neurexin-3,40182,0.00908423549228634,0.00368086816885232,0.00186973388133579,0.0162987371032369,0.0136036669099407
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0119137693884696,0.00482791218126405,0.00245106151319205,0.0213764772637471,0.0136137317815858
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.00990845946408337,0.00401913317378331,-0.0177859604846987,-0.00203095844346808,0.0137042615247041
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN3,Matrilin-3,42475,-0.00834669531016496,0.00338709728730126,-0.0149854059932754,-0.0017079846270545,0.0137421393128893
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN5,Contactin-5,42640,-0.00968839895984874,0.00393680289088053,-0.0174045326259746,-0.00197226529372289,0.0138682236565672
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00663365740397353,0.00270225256510952,-0.0119300724315882,-0.00133724237635886,0.0141088424922908
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR4,Complement factor H-related protein 4,40509,0.0188719570598193,0.00769892250047364,0.00378206895889099,0.0339618451607476,0.014251257937348
NMR metabolomics,X23501.Triglycerides in Large VLDL,B2M,Beta-2-microglobulin,40539,0.00790370641250281,0.0032402694402398,0.00155277830963279,0.0142546345153728,0.0147345207202198
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0248106085881095,0.010194066193106,0.00483023884962174,0.0447909783265972,0.0149559833566972
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0131424722306308,0.00541284178233038,0.00253330233726324,0.0237516421239983,0.0151974044277737
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0124564904506787,0.00514378912986658,0.00237466375614022,0.0225383171452172,0.0154661245488352
NMR metabolomics,X23501.Triglycerides in Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00725012652579811,0.00300599071073249,0.00135838473276244,0.0131418683188338,0.0158862195187552
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0129865045123325,0.00538880017388342,0.00242445617152096,0.023548552853144,0.0159725469978924
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.016430831352701,0.00682989700290151,0.00304423322701403,0.0298174294783879,0.0161542448308484
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.00701359307292136,0.00292338632255585,-0.0127434302651308,-0.0012837558807119,0.016447425465147
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.00661887056420664,0.00275962746077801,0.00121000074108174,0.0120277403873315,0.016477645855761
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00543449980917879,0.00227462292659031,-0.00989276074529579,-0.000976238873061788,0.0169024372211635
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR1,Cadherin-related family member 1,42311,0.0105581455667556,0.00442733884476748,0.00188056143101137,0.0192357297024999,0.0171043350007828
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMOD4,Tropomodulin-4,40080,-0.0101805490219907,0.00427048289231861,-0.0185506954909352,-0.00181040255304619,0.0171457103449814
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00512082816198568,0.00214899588281994,-0.00933286009231277,-0.000908796231658592,0.0171941649136183
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAVL4,ELAV-like protein 4,40136,0.0209136477971897,0.008780539652962,0.00370379007738422,0.0381235055169953,0.0172443975180161
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00962676547300729,0.00405107829429615,-0.0175668789298277,-0.00168665201618684,0.0175021753198079
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.0112420123476251,0.00474245967902847,0.00194679137672934,0.0205372333185209,0.0177779948885765
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC1,Hamartin,40199,0.0179452127922344,0.00758484927427008,0.00307890821466507,0.0328115173698038,0.0180021345488407
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL28,C-C motif chemokine 28,42538,0.0143586295366216,0.00606960735738278,0.00246219911615139,0.0262550599570919,0.0180121595891786
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0103717803357575,0.00439478053371683,-0.0189855501818425,-0.00175801048967254,0.0182913761606232
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18BP,Interleukin-18-binding protein,42689,0.00787115142790726,0.00333957367862018,0.00132558701781171,0.0144167158380028,0.0184407748069869
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.00987223856880737,0.0041951844086339,0.00164967712788492,0.0180948000097298,0.0186280440533431
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.012680987128896,0.00541361113991429,0.00207030929466401,0.023291664963128,0.0191731968562351
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN3,CCN family member 3,42779,0.00858270377386562,0.00366628675813817,0.00139678172791481,0.0157686258198164,0.0192475832351147
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00956528293144758,0.00409303799625272,0.00154292845879225,0.0175876374041029,0.0194560173996386
NMR metabolomics,X23501.Triglycerides in Large VLDL,C8B,Complement component C8 beta chain,40539,0.00732334178154882,0.003135210097201,0.00117832999103486,0.0134683535720628,0.0195170333613779
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B4,Protein ATP1B4,40080,-0.0102065849969543,0.00437662797754074,-0.0187847758329341,-0.0016283941609744,0.0197153631484842
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.0087636519333653,0.0037643502375014,-0.016141778398868,-0.00138552546786255,0.0199234410395405
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0103795449560934,0.00446768464955774,0.00162288304296019,0.0191362068692265,0.0201805517902271
NMR metabolomics,X23501.Triglycerides in Large VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00707820846457202,0.00305583296582099,-0.0130676410775812,-0.00108877585156289,0.0205604830405002
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGB,Secretogranin-1,42664,-0.0102851776539115,0.00444241862049083,-0.0189923181500735,-0.00157803715774945,0.0206158311204919
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLON5,IgLON family member 5,40080,-0.0226894233890965,0.00981021515236336,-0.0419174450877287,-0.0034614016904643,0.0207501828804194
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0099667028263889,0.00431412775827772,0.00151101242016458,0.0184223932326132,0.0208930626066722
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00827363422982413,0.0035858130177311,-0.0153018277445771,-0.00124544071507118,0.0210517424576262
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00695593919170239,0.00301680535104065,-0.0128688776797421,-0.00104300070366273,0.0211442420210414
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB2,Lamin-B2,40483,0.00682576786261136,0.00296298706910097,0.00101831320717347,0.0126332225180493,0.0212588080488025
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00838857781036445,0.00364712882959573,0.00124020530435681,0.0155369503163721,0.021464021309228
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKCQ,Protein kinase C theta type,42370,0.0104195717397133,0.00453328310846317,0.0015343368471255,0.0193048066323011,0.0215511789564626
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00816647653194191,0.00357121376296941,-0.015166055507362,-0.00116689755652187,0.0222262202650229
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD70,CD70 antigen,42594,-0.0102327840944287,0.00447608031601871,-0.0190059015138254,-0.00145966667503205,0.0222637220465341
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.00968254173567764,0.00423631721661583,0.00137935999111062,0.0179857234802447,0.022295931697591
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00873469005165801,0.00383191899010206,0.00122412883105796,0.0162452512722581,0.0226589964423048
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.00843010023431212,0.0036987909071711,0.00118047005625676,0.0156797304123675,0.0226739423775209
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKLR,Pyruvate kinase PKLR,42636,0.0153518877930283,0.00673590276120024,0.00214951838107581,0.0285542572049807,0.0226759171469427
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.00859360196207337,0.00377195472722361,-0.0159866332274317,-0.00120057069671509,0.0227279335847819
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0144711179315388,0.00635672299282091,-0.0269302949974678,-0.00201194086560979,0.0228348595976999
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA2,Adenosine deaminase 2,42572,-0.0104096436889559,0.00458611505573734,-0.0193984291982011,-0.00142085817971074,0.0232345063608967
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0133098292705332,0.00587029956685245,0.0018040421195024,0.024815616421564,0.0233867335739017
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTTG1,Securin,40302,0.00960217620030048,0.00423647704300859,0.00129868119600365,0.0179056712045973,0.023437032748759
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.0068805078602906,0.00303853644808252,-0.0128360392985323,-0.000924976422048854,0.0235674052865274
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.00942762959998248,0.00417046815374506,0.00125351201864216,0.0176017471813228,0.0238017757195848
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0106892444935432,0.00473727890019933,0.00140417784915253,0.0199743111379339,0.0240609485854079
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0188826922556221,0.00837846694557906,0.00246089704228712,0.035304487468957,0.0242336935618312
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00756094518319324,0.00335743236481078,-0.0141415126182224,-0.000980377748164116,0.0243382299749624
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS4,Thrombospondin-4,42652,0.0106018887316883,0.00472695652789211,0.00133705393701978,0.0198667235263568,0.0249222297918977
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0200882405956711,0.00896141859509523,0.00252386014928442,0.0376526210420577,0.0250049568701407
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0079256573964411,0.00353581532048913,0.000995459368282402,0.0148558554245998,0.0250077034182743
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.00931891736511411,0.00416463563041234,0.00115623152950593,0.0174816032007223,0.0252652173644254
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEF,Thyrotroph embryonic factor,40116,0.00998216200234241,0.00449336292460075,0.00117517067012494,0.0187891533345599,0.0263351813988178
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK11,Kallikrein-11,42543,0.00751077872257293,0.00338438333591921,0.000877387384171271,0.0141441700609746,0.0264867480822447
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00828336743860872,0.00373316625106377,0.000966361586523737,0.0156003732906937,0.0265133601060541
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.032553496771177,0.0146793210883796,-0.0613249661044011,-0.00378202743795286,0.0265989261724283
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00779541552049631,0.0035173914756169,-0.0146895028127054,-0.000901328228287198,0.0266949423939596
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAD,Chondroadherin,40283,0.0118624175822302,0.00536185127885673,0.00135318907567096,0.0223716460887893,0.0269611695979572
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00667700312899067,0.00302092006056619,0.00075599981028094,0.0125980064477004,0.0271046800318011
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00935897499387211,0.00424591107911786,0.0010369892788011,0.0176809607089431,0.0275286232781269
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0122295594523757,0.00555015636643448,0.00135125297416414,0.0231078659305873,0.027582368773281
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1,Integrin beta-1,42638,-0.00486165678413497,0.00220853747861804,-0.00919039024222633,-0.000532923326043599,0.0277316197527773
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1,DNA topoisomerase 1,40449,0.0255247741994866,0.0115983557191383,0.00279199698997554,0.0482575514089977,0.0277758380232494
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN8,Tetraspanin-8,40449,0.0232741368084951,0.0105845226261139,0.00252847246131198,0.0440198011556783,0.0279064479941574
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0113444182637189,0.00516666635863577,0.00121775220079277,0.021471084326645,0.0281341862143354
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0175379824628897,0.00799344236754923,0.00187083542249317,0.0332051295032861,0.0282495602802782
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0341844263363024,0.0155954762556423,0.00361729287524357,0.0647515597973613,0.0284006212043849
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00857851126658917,0.00392223331028414,-0.0162660885547461,-0.000890933978432261,0.0287526937393235
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.00343134590534957,0.001569235247311,-0.00650704699007913,-0.000355644820620005,0.0287895458093389
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM1,Myomesin-1,40136,0.0107883132657677,0.00497618700562349,0.00103498673474562,0.0205416397967897,0.0301810914879978
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17A,Interleukin-17A,42347,-0.00967873839527474,0.00446647191706743,-0.0184330233527269,-0.000924453437822575,0.0302545583090423
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00723575565469672,0.00335205344206612,0.000665730908247132,0.0138057804011463,0.0309025846532891
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD160,CD160 antigen,42754,0.0109200020948878,0.00506666576556355,0.000989337194383197,0.0208506669953923,0.0311587293086554
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.00618695389263526,0.00287454514994522,0.000552845398742631,0.0118210623865279,0.0313895012601546
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF3,Trefoil factor 3,42613,-0.00957377536081058,0.00445179060440039,-0.0182992849454353,-0.00084826577618582,0.0315299486698771
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI16,Peptidase inhibitor 16,40532,-0.00556903696676664,0.00259237924344955,-0.0106501002839278,-0.00048797364960552,0.0317162987742925
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB5,Integrin beta-5,42679,-0.00824697747309849,0.00384305968145963,-0.0157793744487594,-0.000714580497437604,0.0318955190786112
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.0126510824601118,0.0059031749244922,0.00108085960810705,0.0242213053121165,0.0321265399714112
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHISA5,Protein shisa-5,40527,0.00615986170735452,0.00287567651406577,0.000523535739785619,0.0117961876749234,0.0322101803548384
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0155470587745315,0.00726022186739551,0.00131702391443632,0.0297770936346267,0.0322592934996853
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0108975531968143,0.00511193308627923,0.000878164347707043,0.0209169420459216,0.0330458810494785
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00556994000515065,0.00261565664510058,-0.0106966270295478,-0.000443252980753504,0.0332376063168091
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00521307782980154,0.00245491435761628,-0.0100247099707294,-0.000401445688873638,0.0337313743268277
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.00466814879043749,0.00220007633521519,0.000355999173415722,0.00898029840745925,0.0338718206978997
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA4,Carboxypeptidase A4,40060,0.00967140183357822,0.00456301344211491,0.000727895487032988,0.0186149081801235,0.0340690908288596
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.00769974818722171,0.0036472331159368,0.000551171279985587,0.0148483250944578,0.0347804354646627
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX9,Transcription factor SOX-9,40182,0.0060317544151597,0.00286757777019076,0.000411301985585803,0.0116522068447336,0.0354507103638911
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00616084720080605,0.00294223146594387,-0.011927620874056,-0.000394073527556067,0.0362841763652608
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.00709267044190768,0.00339042729611752,-0.013737907942298,-0.000447432941517346,0.036464104222688
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0274828383432892,0.0131672760101677,-0.0532906993232179,-0.00167497736336053,0.0368880585341074
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTOA,Otoancorin,40136,-0.0116786993334644,0.00564963745508101,-0.0227519887454232,-0.000605409921505651,0.0387426283397168
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00677713022761765,0.0032951639927177,-0.0132356516533443,-0.000318608801890964,0.0397357534824588
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCG22,Protein PBMUCL2,40116,-0.0121008783423845,0.00589653645116308,-0.0236580897866642,-0.000543666898104903,0.0401739096497533
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00888953337587064,0.00433953031649135,-0.0173950127961937,-0.0003840539555476,0.0405340488531683
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP73,Tumor protein p73,40182,0.0073240418276413,0.00358015758586755,0.0003069329593409,0.0143411506959417,0.0408065345637671
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.00808764477235904,0.00395911691026088,-0.0158475139164704,-0.000327775628247715,0.041092723355263
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCN,Decorin,42357,-0.00507437052343682,0.00248525011429127,-0.00994546074744771,-0.00020328029942593,0.0411917920856105
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GL3,Endophilin-A3,40250,0.0180019037050607,0.00882798726287934,0.000699048669817223,0.0353047587403042,0.0414552470784153
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.0120505250148104,0.00591069278702508,0.000465567152241235,0.0236354828773795,0.0414966121493649
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0157021027153062,0.00770542703137515,-0.0308047396968015,-0.000599465733810882,0.0415941994169157
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.010184244804932,0.00500675500966691,-0.0199974846238791,-0.000371004985984826,0.0419655385755034
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.00610498509671888,0.00300251894571428,0.000220047963118894,0.0119899222303189,0.0420433531798559
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0258191885190655,0.0126991949930629,0.000928766332662326,0.0507096107054688,0.0420588402741402
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTL1,Cytokine-like protein 1,40527,0.00535847721894911,0.00264266601095699,0.000178851837473413,0.0105381026004248,0.0426164159298171
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.0113760016738889,0.00561261793209686,-0.0223767328207987,-0.00037527052697902,0.0426967209054246
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00663013265783332,0.00328316921801367,-0.0130651443251401,-0.000195120990526538,0.0434667056797962
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR4,Toll-like receptor 4,40199,0.00611462445033867,0.00302835266748954,0.000179053222059177,0.0120501956786182,0.0434983633941354
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDS,Iduronate 2-sulfatase,42754,0.00182076236803395,0.000902333847539399,5.2188026856724e-05,0.00358933670921117,0.0436279268472157
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0065543540255997,0.0032484821571336,-0.0129213790535816,-0.00018732899761784,0.0436455949680433
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0109690030471826,0.00543702366048314,0.000312436672635646,0.0216255694217296,0.0436710493685996
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB118,Beta-defensin 118,40136,0.0118837984060791,0.00589510235782685,0.000329397784738488,0.0234381990274198,0.0438372851215584
NMR metabolomics,X23501.Triglycerides in Large VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00904212395136675,0.0044918817690892,-0.0178462122187816,-0.000238035683951929,0.0441395076082903
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00447746189175849,0.00222450648639557,0.000117429178423169,0.0088374946050938,0.0441606152956392
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.0106812506506294,0.00531552279531809,-0.0210996753294529,-0.00026282597180593,0.0445145162522171
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0101703437863664,0.005062777806889,0.000247299284863927,0.0200933882878688,0.044573790241029
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0112666991612569,0.00564024038959795,0.000211827997644944,0.0223215703248689,0.0457891025737336
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1B,Protein phosphatase 1B,40199,0.012581783717708,0.00630468802822726,0.000224595182382537,0.0249389722530334,0.0459995235459007
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0104479156266781,0.00524000973760824,0.000177496540965941,0.0207183347123902,0.0461865141333605
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.00932385149242173,0.00468627397773692,0.000138754496057363,0.0185089484887861,0.046654499709571
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.00512827794377116,0.00258027418228924,7.09405464842487e-05,0.0101856153410581,0.0468880769725318
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0112809730136562,0.00568482143089562,0.0001387230091008,0.0224232230182116,0.0472352450111529
NMR metabolomics,X23501.Triglycerides in Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0188963400950915,0.00956515245046886,0.000148641292172531,0.0376440388980104,0.0482321302179987
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTNNA1,Catenin alpha-1,40136,-0.00714598578632075,0.00363655950550148,-0.0142736424171036,-1.83291555378509e-05,0.0494348400814256
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00380064690417518,0.00193430552560076,9.40807399768323e-06,0.00759188573435268,0.0494543695201972
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP2,Guanylate-binding protein 2,42370,0.012332505946548,0.00628127438283594,2.1208156189537e-05,0.0246438037369064,0.0496234528275477
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00876758804517168,0.00449720597336096,-0.0175821117529592,4.69356626158126e-05,0.05125354682146
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUOX2,Dual oxidase 2,42357,0.0144059522063143,0.00739383926571158,-8.59727544804002e-05,0.028897877167109,0.0513916438044614
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0131185746813085,0.00673946400744163,-9.07747732770917e-05,0.0263279241358941,0.0516161810156819
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJP3,Tight junction protein ZO-3,40136,-0.00843407317304225,0.00435030363585252,-0.0169606682993132,9.25219532286869e-05,0.0525596525853453
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0109721443425414,0.00565944056003255,-0.000120359155122434,0.0220646478402052,0.0525607731434173
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.0104412124399539,0.00538747113198298,-0.0210006558586406,0.000118230978732699,0.0526424384705916
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHB,Lutropin subunit beta,42346,0.0167410792721729,0.00871277108496438,-0.000335952054357321,0.0338181105987031,0.0546976671048559
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L,Seizure 6-like protein,42679,-0.0055616672224237,0.00290091710349563,-0.0112474647452751,0.000124130300427745,0.0552323657797207
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00345879045036266,0.00180748585243717,-0.00700146272113951,8.38818204141954e-05,0.0556935257845534
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLN,Mesothelin,42553,0.0117768464642955,0.00615707778386414,-0.000291025992078225,0.0238447189206692,0.0558035885206205
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.00408251768998926,0.00213970598414886,-0.000111306038942514,0.00827634141892103,0.0564197100326187
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.00636315372570435,0.00333836541369588,-0.000180042485139586,0.0129063499365483,0.0566626432896837
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBR1,T-box brain protein 1,40182,0.00956783795264856,0.00502470717072046,-0.000280588101963538,0.0194162640072607,0.05691566166764
NMR metabolomics,X23501.Triglycerides in Large VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00553685752886126,0.00290839963626414,-0.011237320815939,0.000163605758216443,0.056969330947085
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.00860356439181651,0.00452574032430043,-0.000266886643812339,0.0174740154274454,0.0573207104295127
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN3,Perilipin-3,42636,0.00823952694281592,0.00434231790150217,-0.000271416144128331,0.0167504700297602,0.0577840326691049
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNG,Uracil-DNA glycosylase,40451,0.00666929980726869,0.0035273901597165,-0.000244384905775653,0.013582984520313,0.0586876652049077
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB1,Lamin-B1,40434,0.0116656413211453,0.00617327208396727,-0.000433971963430528,0.0237652546057212,0.058823607398824
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTR,Methionine synthase,40116,0.0129097558552793,0.00686477190468602,-0.000545197077905272,0.0263647087884639,0.0600555985764774
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO1,Alpha-enolase,42588,0.015267076190864,0.00812130309071316,-0.00065067786693376,0.0311848302486618,0.0601461053516026
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36G,Interleukin-36 gamma,40154,0.0133678155442311,0.00711313141020715,-0.000573922019774938,0.0273095531082371,0.0602279867135238
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH23,Cadherin-23,40483,-0.00507079627297519,0.00270123120731628,-0.0103652094393151,0.000223616893364724,0.0605141688003062
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.0077116848445589,0.00412077758236574,-0.0157884089059957,0.000365039216877947,0.0613142968336854
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.0104332904410904,0.00557758487317591,-0.0213653567925152,0.000498775910334356,0.0614307442385101
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.00931889034544574,0.00499478798636931,-0.0191086747987296,0.000470894107838104,0.062106930761462
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0569485049275278,0.0306478242137895,-0.00312123053149959,0.117018240386555,0.0631684319545232
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN7,Septin-7,40302,0.0104136284051874,0.00562780792841469,-0.000616875134505424,0.0214441319448802,0.0642841788439195
NMR metabolomics,X23501.Triglycerides in Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00519938028958545,0.00281091147623007,-0.000310006203825494,0.0107087667829964,0.0643810057831288
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX101,Testis-expressed protein 101,40182,0.0101344089419453,0.00547981805226275,-0.000606034440489693,0.0208748523243803,0.0644260326084597
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.00914378035457269,0.00494946113085868,-0.0188447241710557,0.000557163461910331,0.0647066886245059
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAL,Galanin peptides,42676,0.0122536116378099,0.00663651236883964,-0.000753952605115786,0.0252611758807356,0.0648570305353283
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0143053600830881,0.00780505046078141,-0.000992538820043487,0.0296032589862196,0.0668536187907384
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.0085871861370315,0.00468756987260533,-0.017774823087338,0.000600450813274943,0.0669918005028822
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.010245294072456,0.00561625471081608,-0.000762565160743477,0.0212531533056556,0.0681454044522733
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP350,Centrosome-associated protein 350,40080,0.00716989277737571,0.00393563394371827,-0.000543949752312103,0.0148837353070635,0.0685145069145504
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0158347979405784,0.0087057474896154,-0.00122846713906784,0.0328980630202245,0.068955405361275
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.00913674900116326,0.00502500570651397,-0.000712262183604121,0.0189857601859306,0.069047262613396
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX2,Transcription factor SOX-2,40461,0.00446169122311683,0.0024754554094102,-0.000390201379327159,0.00931358382556081,0.0715136306634156
NMR metabolomics,X23501.Triglycerides in Large VLDL,JUN,Transcription factor AP-1,42370,0.00892851745133484,0.00495559481193518,-0.000784448380058107,0.0186414832827278,0.0716147604570871
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH17,Protocadherin-17,42636,0.00692355606046554,0.00384722087487097,-0.000616996854281552,0.0144641089752126,0.0719422381542424
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.010416870819017,0.00580308017676363,-0.000957166327439755,0.0217909079654737,0.072671133421144
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRK1,Protein BRICK1,42311,0.0083165601812279,0.00464663546386307,-0.000790845327943717,0.0174239656903995,0.0735087121676996
NMR metabolomics,X23501.Triglycerides in Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00632365726479976,0.00354287842846582,-0.000620384454993252,0.0132676989845928,0.074305594531679
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17C,Interleukin-17C,42370,-0.0137439402880476,0.00772959987837625,-0.0288939560496651,0.00140607547356982,0.0754117895408432
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00733498767854343,0.00412974846069561,-0.000759319304419971,0.0154292946615068,0.075737721030372
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0118000783107449,0.00665549317307673,-0.00124468830848551,0.0248448449299753,0.0762591270827694
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM25,RNA-binding protein 25,40080,-0.00870048765248525,0.00491426190164612,-0.0183324409797116,0.000931465674741143,0.0766790817456743
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00613412992526982,0.00346623384142807,-0.000659688403929195,0.0129279482544688,0.076807941724001
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPN1,Epsin-1,40302,0.00814510521450316,0.00460410537499107,-0.000878941320479337,0.0171691517494857,0.0769052612311463
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300E,CMRF35-like molecule 2,42677,0.00787035655907733,0.00446738747589113,-0.000885722893669279,0.0166264360118239,0.0781366015061776
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.00635840829914445,0.00362114218216705,-0.0134558469761919,0.000739030377902977,0.0791260747246054
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0115172984871723,0.00657246352722925,-0.0243993270005416,0.00136473002619705,0.0797402183376377
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI1,Neuroserpin,40267,0.00545470113299336,0.00311918276634498,-0.000658897089042789,0.0115682993550295,0.0803602727479839
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.00522430214114066,0.00298927919437274,-0.000634685079829906,0.0110832893621112,0.0805422328716301
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.00560296312273042,0.00320929801825769,-0.000687260993054651,0.0118931872385155,0.0808643733275964
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.0100369865443157,0.00575405826537797,-0.00124096765582512,0.0213149407444565,0.0811291145927564
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.00738030199712657,0.00424148914391537,-0.000933016724947553,0.0156936207192007,0.0818816784776051
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.0124804217172774,0.0071727642567079,-0.00157819622587011,0.0265390396604248,0.0818865808603592
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY96,Lymphocyte antigen 96,42495,-0.00638358347039956,0.00369378610788941,-0.0136234042418628,0.000856237301063682,0.0839764404466489
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00791110193089831,0.00460365769015353,-0.00111206714180262,0.0169342710035992,0.0857441866845064
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX1,Neuronal pentraxin-1,42611,-0.00711484247025908,0.00414231639052985,-0.0152337825956976,0.00100409765517943,0.0858926825390686
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5A,Cytochrome b5,40080,0.0129642091004328,0.00756709050204358,-0.00186728828357262,0.0277957064844382,0.0866976708727839
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP1,"Fatty acid-binding protein, liver",42618,-0.0166669433234519,0.00973888721854958,-0.0357551622718091,0.00242127562490527,0.0870339638128507
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0074702304250304,0.00436824486343494,-0.00109152950730209,0.0160319903573629,0.087266375346947
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.00472023960066961,0.00277066717777792,-0.0101507472691143,0.000710268067775108,0.0884745276782959
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00693485381008654,0.00407838312919314,-0.0149284847433051,0.00105877712313202,0.0890845178693547
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.0115286727175347,0.00679211300375967,-0.0017838687698343,0.0248412142049036,0.0896520144203845
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHPK,Sedoheptulokinase,40302,-0.00720134384198672,0.00424838313900608,-0.0155281747944386,0.00112548711046519,0.0900885165432123
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5L,CD5 antigen-like,40479,0.00832372670715976,0.00493002013708043,-0.00133911276151789,0.0179865661758374,0.091366741831558
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRLB,Fc receptor-like B,42346,0.0113337659890185,0.00671896913142229,-0.00183541350856918,0.0245029454866062,0.0916595517819646
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT2,Angiopoietin-2,42721,-0.00658263983830857,0.00390446004558325,-0.0142353815276517,0.0010701018510346,0.0918326652222445
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,-0.00550425928451206,0.00327124773509757,-0.0119159048453033,0.000907386276279182,0.0924723508189002
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.016799891279243,0.00999035110026695,-0.00278119687728023,0.0363809794357662,0.0926718989637633
NMR metabolomics,X23501.Triglycerides in Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00694883787324426,0.00413402412430222,-0.00115384941038809,0.0150515251568766,0.0928126896686409
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00799520794632608,0.00477285438372924,-0.0173500025384354,0.00135958664578323,0.0939348654379637
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00501462691753885,0.00301012713992117,-0.000885222276706635,0.0109144761117843,0.0957578651067192
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00476605848747155,0.00286213184383513,-0.0103758369013884,0.000843719926445306,0.0958935270609519
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF9,Fibroblast growth factor 9,40065,0.00709789619061088,0.00426587130997403,-0.00126321157693822,0.01545900395816,0.0961653173878024
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.0104005507005676,0.00626104724078253,-0.00187110189136612,0.0226722032925014,0.0967115863278479
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00744092986714946,0.00448025359907285,-0.0162222269213322,0.00134036718703333,0.0967767329924252
NMR metabolomics,X23501.Triglycerides in Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.00871456540350536,0.00525542416526039,-0.00158606596040501,0.0190151967674157,0.0973002072848692
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0105982427750538,0.00639236693884771,-0.00193079642508769,0.0231272819751953,0.0973556550128234
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0106803985668365,0.00646930272883084,-0.00199943478167192,0.023360231915345,0.0987797346363915
NMR metabolomics,X23501.Triglycerides in Large VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.00960530471674618,0.00582132170803735,-0.00180448583100702,0.0210150952644994,0.0989625606330327
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO6,Coronin-6,40136,-0.00630879580048496,0.00384744062083932,-0.01384977941733,0.00123218781636012,0.101088334883594
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNR,Tenascin-R,42495,-0.00717455110919721,0.00438455942520093,-0.015768287582591,0.00141918536419661,0.101795870212376
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.00530590343634965,0.00324379584010093,-0.0116637432829475,0.00105193641024816,0.101928551670779
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00690195024050562,0.00422398175977696,-0.0151809544896685,0.00137705400865722,0.102288524746424
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00447265248399746,0.00274165525957917,-0.000900991824777707,0.00984629679277262,0.102841380853225
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.00875214265079041,0.00538071533514372,-0.0192983447076721,0.00179405940609129,0.103850859566707
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN8,Septin-8,40470,0.0054430942936622,0.00335447606583102,-0.0011316787953666,0.012017867382691,0.104695152697169
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_A,,40482,-0.00555475801369936,0.00343140312286186,-0.0122803081345086,0.00117079210710989,0.105518073967656
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0120667907280914,0.00745778830570342,-0.00255047435108731,0.0266840558072701,0.10568795828554
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0118263790560602,0.00731298614931128,-0.00250707379658989,0.0261598319087103,0.105868885972303
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.0083241665689322,0.00516745983052525,-0.0184523878367617,0.00180405469889728,0.107234401892391
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.0101431738974469,0.00634677053233218,-0.0225828441408179,0.00229649634592419,0.110030790083385
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00787448534239298,0.00493513148670634,-0.0175473430563374,0.00179837237155143,0.110607629008692
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0142917882745577,0.0089707350904591,-0.00329085250274209,0.0318744290518576,0.111148589094479
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.00603135933478501,0.00379723316104319,-0.0134739363304297,0.00141121766085965,0.112229349019091
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00796657181829335,0.00503134667202184,-0.0178280112954562,0.00189486765886946,0.113362105819939
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.00964618494199699,0.00612440591310207,-0.00235765064768306,0.021650020531677,0.115276150633976
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,-0.00452346095992967,0.00287978628697365,-0.010167842082398,0.0011209201625387,0.116266303917937
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.00470315354911506,0.00300238272988288,-0.00118151660145539,0.0105878236996855,0.117261302848826
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00503195066499223,0.00322088710964269,-0.00128098806990745,0.0113448893998919,0.11824371426771
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0142038673231659,0.00910208714695945,-0.00363622348487465,0.0320439581312064,0.118669177887634
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0103433916318805,0.00663019276080331,-0.00265178617929398,0.023338569443055,0.118777543619011
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALCAM,CD166 antigen,42794,0.00315548950802257,0.00203044768554847,-0.000824187955652436,0.00713516697169758,0.120187268618985
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPS,Calcyphosin,40483,0.0166241039952172,0.0107090188585347,-0.00436557296751076,0.0376137809579453,0.120607457544606
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00557577158081769,0.00359321896356648,-0.00146693758777262,0.012618480749408,0.120746308142494
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS2,Thrombospondin-2,42611,0.00621223197993187,0.00401217358725128,-0.00165162825108065,0.0140760922109444,0.121562657219584
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0182404866936818,0.0117938643577949,-0.00487548744759619,0.0413564608349597,0.121981780710061
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.00926759889479976,0.00600084632479539,-0.0024940599017992,0.0210292576913987,0.122524743257285
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAV,Integrin alpha-V,42721,-0.00261178422278485,0.00169298554622588,-0.00593003589338757,0.000706467447817871,0.122924762894755
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP6,Guanylate-binding protein 6,40116,-0.00734816732256431,0.00477295037816984,-0.0167031500637772,0.00200681541864857,0.123700503476484
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.00623582957156183,0.00405201818869624,-0.00170612607828281,0.0141777852214065,0.123841562630837
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00486978484790114,0.00316918783740429,-0.00134182331341126,0.0110813930092135,0.124414335652578
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF8,SLAM family member 8,42346,0.00874478471866943,0.00572166332372183,-0.00246967539582536,0.0199592448331642,0.126446215755886
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.00736249760297673,0.00481926630786048,-0.0168082595663833,0.00208326436042982,0.12660547012005
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A3,Protein S100-A3,40451,0.00687090009715647,0.00449967064181825,-0.0019484543608073,0.0156902545551202,0.126794465496075
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMP,Cartilage oligomeric matrix protein,42511,-0.00528454267081178,0.00347761256030446,-0.0121006632890085,0.00153157794738496,0.12863798096022
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QL2,Complement C1q-like protein 2,40199,0.00688737338181036,0.00455464496010596,-0.00203973073999733,0.015814477503618,0.130520679981739
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00899296262314389,0.00595009544765803,-0.0206551497005536,0.00266922445426584,0.130715945248604
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00937218250625292,0.00620335880138983,-0.021530765756977,0.00278640074447115,0.130862262848394
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.00625401809422498,0.00414064865869807,-0.00186165327682324,0.0143696894652732,0.130966012027589
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC2,Mucin-2,40527,0.0145101964037164,0.00960971735249934,-0.00432484960718234,0.0333452424146151,0.131083963756436
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENG,Endoglin,42794,-0.00270986658031966,0.00179678409922687,-0.00623156341480432,0.000811830254164997,0.131532727354044
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0118865506933385,0.0078843700077569,-0.00356681452186499,0.0273399159085421,0.131683156045661
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00543017813649145,0.00360446292626753,-0.0124949254719758,0.0016345691989929,0.131958404005721
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0157246836041111,0.0104999732577349,-0.00485526398104924,0.0363046311892714,0.134267777074755
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYAL1,Hyaluronidase-1,42544,-0.00356170147596558,0.00239704961646143,-0.00825991872422998,0.00113651577229882,0.137337414851523
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.00732332090460357,0.00493483961321234,-0.0169956065464998,0.00234896473729262,0.137836760199578
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.00981689664955274,0.00662722167068332,-0.00317245782498657,0.022806251124092,0.138555865024539
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME3,Nucleoside diphosphate kinase 3,42638,-0.00365850807180377,0.00247572944190767,-0.0085109377779428,0.00119392163433527,0.139498251607312
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM3,Paralemmin-3,40116,0.0109257092389052,0.00740161892225641,-0.00358146384871732,0.0254328823265278,0.139939366491896
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00610415043643634,0.00413602843821531,-0.0142107661753383,0.00200246530246567,0.140013455366077
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA1,Ephrin-A1,42590,0.0046225286125438,0.00313221544348605,-0.00151661365668887,0.0107616708817765,0.140020660446877
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMCH,Pro-MCH,40116,-0.0129256159541103,0.00876658689067999,-0.0301081262598431,0.00425689435162251,0.140397828084242
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRING1,SREBP regulating gene protein,40080,0.00897111799492498,0.00612563966255054,-0.00303513574367407,0.020977371733524,0.143080969098417
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.00839097076274817,0.00573277877972699,-0.00284527564551674,0.0196272171710131,0.143304465156914
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00552145713331967,0.0037747749255154,-0.0129200159873299,0.00187710172069052,0.143571281422967
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAPPA,Pappalysin-1,42370,0.0070602904719521,0.00483580269451445,-0.00241788280929622,0.0165384637532004,0.144312862089801
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLNL,Mesothelin-like protein,40182,-0.00593358056817392,0.00407658749827231,-0.0139236920647877,0.00205653092843981,0.145552166218423
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0075131759702837,0.0051637571389259,-0.00260778802201106,0.0176341399625785,0.145702808492531
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHH,Sonic hedgehog protein,40199,-0.00634769169115393,0.00436613302895822,-0.014905312427912,0.00220992904560419,0.146017100842833
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD1,Polycystin-1,40511,0.00400449228293071,0.00277177411231949,-0.00142818497721548,0.0094371695430769,0.148558681540739
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN7,Tetraspanin-7,40136,-0.0140167726830915,0.00974617165445049,-0.0331192691258145,0.00508572375963142,0.150410902755447
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00721101195786074,0.00503051610545173,-0.0170708235245461,0.00264879960882465,0.151756844305691
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO1,R-spondin-1,42495,0.00502050169421668,0.00350886967127334,-0.00185688286147907,0.0118978862499124,0.152510139248917
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0178507212005275,0.012480337270605,-0.00661073984985834,0.0423121822509133,0.152657309581436
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00987728950168286,0.00691851251901909,-0.00368299503559457,0.0234375740389603,0.153413304429374
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00809343296605792,0.00567587368709332,-0.0192181453927608,0.00303127946064498,0.153915326753607
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL21R,Interleukin-21 receptor,40199,0.00821870862771071,0.00578365529173431,-0.00311725574408853,0.0195546729995099,0.155338334662843
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00522120055015675,0.00367511589158471,-0.00198202659734928,0.0124244276976628,0.155430127144542
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSTN,Osteocrin,40182,-0.00615429276856001,0.00433261776001347,-0.0146462235781864,0.00233763804106639,0.155503351750312
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.010001996926269,0.00704159676480804,-0.0238035265852928,0.00379953273275473,0.155509885836546
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.0049204439857589,0.00346504665965427,-0.00187104746716347,0.0117119354386813,0.155629416092152
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.0047555826824803,0.00335941848277163,-0.00182887754375209,0.0113400429087127,0.156917212957093
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACHE,Acetylcholinesterase,40283,0.00484418492332993,0.00343344782175199,-0.00188537280730398,0.0115737426539638,0.158307876034344
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00420971413217684,0.00300084472434085,-0.0100913697918849,0.00167194152753123,0.160692022554226
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0167157409246337,0.0119215974073487,-0.00665058999376975,0.0400820718430372,0.160901134599189
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.0055239769241196,0.00394339683715074,-0.00220508087669585,0.0132530347249351,0.161296768571692
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00864989971100221,0.00619229079841075,-0.00348699025388287,0.0207867896758873,0.162472599707138
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3D,Protein FAM3D,40449,0.0123486391821557,0.00886283497390826,-0.00502251736670451,0.0297197957310159,0.163554858605761
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCL2,Phosducin-like protein 2,40080,0.00764753367226921,0.00549267307679041,-0.00311810555824,0.0184131729027784,0.163855329808566
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00488177958357359,0.00351120651940398,-0.0117637443616054,0.00200018519445821,0.1644532341805
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,-0.0070338830571404,0.0050713551812638,-0.0169737392124175,0.00290597309813665,0.165470041944607
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00718721817497245,0.00519117482691615,-0.0173619208357281,0.00298748448578319,0.166231096998427
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00538906414420127,0.0038954052983629,-0.00224593024059002,0.0130240585289926,0.16655686560864
NMR metabolomics,X23501.Triglycerides in Large VLDL,AREG,Amphiregulin,42587,0.00607747722630325,0.00439781970108811,-0.00254224938782944,0.014697203840436,0.167016366250484
NMR metabolomics,X23501.Triglycerides in Large VLDL,MN1,Transcriptional activator MN1,40182,-0.00848552773568122,0.00614064621350498,-0.020521194314151,0.00355013884278854,0.167042066189046
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.0067923978168189,0.00491787560446808,-0.00284663836793853,0.0164314340015763,0.167251689203975
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0090520062317043,0.00658861952777505,-0.00386168804273481,0.0219657005061434,0.169504710386628
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00514977443961779,0.00375712358581347,-0.00221418778857662,0.0125137366678122,0.170506026740254
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDSN,Corneodesmosin,42710,-0.00630594989892224,0.00460259683438746,-0.0153270396943217,0.00271513989647718,0.170683057913601
NMR metabolomics,X23501.Triglycerides in Large VLDL,GKN1,Gastrokine-1,42017,0.00397517066473036,0.00290638429243605,-0.0017213425484443,0.00967168387790502,0.171418239719314
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB2,Integrin beta-2,42569,-0.00404439670729533,0.00295948689332195,-0.00984499101820636,0.00175619760361569,0.171777724362682
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRC1,Macrophage mannose receptor 1,40532,-0.00409936310553989,0.00301555881139556,-0.0100098583758752,0.0018111321647954,0.17404559838116
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.00586018856107715,0.00431182846454727,-0.00259099522943549,0.0143113723515898,0.174139370140181
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB5,Serpin B5,42357,0.00681254911065348,0.00503328157667094,-0.00305268277962156,0.0166777810009285,0.175919032798718
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD48,CD48 antigen,42654,0.00432648201264711,0.00320484705433767,-0.00195501821385472,0.0106079822391489,0.17704484021759
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.00727491268800751,0.00541841331489252,-0.00334517740918182,0.0178950027851968,0.179419432815172
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00743898832727766,0.00554128246352481,-0.00342192530123096,0.0182999019557863,0.179472504047838
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO6,Unconventional myosin-VI,40482,0.00504425281697834,0.00375976240781863,-0.00232488150234617,0.0124133871363029,0.179739291805821
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00502875630959758,0.00374934786523193,-0.00231996550625701,0.0123774781254522,0.179871911345291
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2,T-cell surface antigen CD2,40116,0.00534356962570873,0.00398534590114885,-0.00246770834054302,0.0131548475919605,0.180011827000142
NMR metabolomics,X23501.Triglycerides in Large VLDL,RYR1,Ryanodine receptor 1,40116,-0.00476175451862949,0.00356831529270755,-0.0117556524923363,0.00223214345507731,0.182082757479239
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.0037046194081077,0.00278478323980929,-0.00175355574191852,0.00916279455813391,0.183444681695646
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0106955150538888,0.00804591417388166,-0.00507447672691926,0.0264655068346968,0.183773537193502
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0055448199287525,0.00417382125812344,-0.0137255095946744,0.00263586973716943,0.184044258343963
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGN,Mimecan,42611,0.00607148366022983,0.00458135383428792,-0.00290796985497449,0.0150509371754341,0.185107593372729
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00694434194606454,0.00526609574532406,-0.0172658896068997,0.00337720571477061,0.187300792410514
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.00421896652140648,0.00320165151559199,-0.00205627044915382,0.0104942034919668,0.187615112290743
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.0100779833206344,0.00764857255450514,-0.00491321888619567,0.0250691855274645,0.187650723012475
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.00975588988438932,0.0074093471401087,-0.00476643051022374,0.0242782102790024,0.187961474968091
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.00757958238726663,0.00576441937047612,-0.00371867957886656,0.0188778443533998,0.188569466679993
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00441263861294816,0.00336021060019154,-0.00217337416342725,0.0109986513893236,0.189141249394861
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS2,Podocin,40199,-0.0142065462507558,0.0108571427443716,-0.0354865460297241,0.00707345352821255,0.190731882057819
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH7B,Myosin-7B,40080,-0.00607020027730675,0.00464402086669879,-0.0151724811760364,0.00303208062142287,0.1912063157106
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00736271582132293,0.0056352749192977,-0.0184078546631464,0.00368242302050057,0.191395862244066
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM2,Intercellular adhesion molecule 2,42794,-0.00434672298923904,0.00335079068337058,-0.0109142727286454,0.0022208267501673,0.194576448855856
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00573490068154598,0.00443401891715974,-0.00295577639608711,0.0144255777591791,0.195904569366034
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.00397103703636756,0.00307065017786916,-0.00998951138499111,0.00204743731225598,0.195960305150549
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC2,Plexin domain-containing protein 2,40483,-0.00363833049576067,0.00282341148064774,-0.00917221699783024,0.00189555600630889,0.197553432309466
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS4,Galectin-4,42618,0.00752333438376001,0.00583891185312394,-0.00392093284836291,0.0189676016158829,0.197600343919958
NMR metabolomics,X23501.Triglycerides in Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00531018292014605,0.00413568431763591,-0.00279575834242034,0.0134161241827124,0.199172052645833
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00842791893966147,0.00656661044758479,-0.0212984754169277,0.00444263753760471,0.199361385301431
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.00850511145476878,0.00663224983001972,-0.00449409821206988,0.0215043211216074,0.199733907367726
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.00602716778688232,0.00470308406702972,-0.00319087698449593,0.0152452125582606,0.200032493837841
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH4,Myosin-4,40116,-0.00598899279641655,0.00469135797210913,-0.0151840544217504,0.00320606882891735,0.201770251758516
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.00372497454364613,0.00292368941416702,-0.00200545670812124,0.0094554057954135,0.20266205038582
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.0101466479515239,0.00797117950162146,-0.0257701597747019,0.0054768638716542,0.203074676775968
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00636266606672666,0.00500570961229979,-0.0161738569068343,0.00344852477338093,0.203722112020926
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00498275539159511,0.00392135616872338,-0.00270310269910272,0.0126686134822929,0.203867571006534
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0087611764500675,0.00689996714765151,-0.00476275915932947,0.0222851120594645,0.204199397870031
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00658216088272358,0.00519755740977392,-0.0167693734058805,0.00360505164043331,0.205395127472981
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD177,CD177 antigen,42595,-0.0172393275198014,0.0136251728186342,-0.0439446662443245,0.00946601120472158,0.205801681886274
NMR metabolomics,X23501.Triglycerides in Large VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00687866889999852,0.00545319872343584,-0.0175669383979328,0.00380960059793574,0.207191531429961
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.00557929839836761,0.00442465159053017,-0.0142516155158068,0.00309301871907152,0.207350768247339
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00961737646140466,0.00766047317217412,-0.0246319038788659,0.00539715095605661,0.209340179521478
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO3,R-spondin-3,42721,0.00385449414521518,0.00307248105361683,-0.00216756871987381,0.00987655701030416,0.209674120344327
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00280336894864856,0.00223504275578705,-0.00157731485269405,0.00718405274999118,0.2097622644507
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.00531279002616559,0.004241907114443,-0.0030013479181427,0.0136269279704739,0.210430625359644
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00415635132049692,0.00332179117506683,-0.00235435938263407,0.0106670620236279,0.210873525251345
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.00294135799978623,0.00235111505939994,-0.00754954351621012,0.00166682751663766,0.210938453973471
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13,Interleukin-13,42370,-0.00614034024106051,0.00491458192205305,-0.0157729208082845,0.00349224032616347,0.211536421219173
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00624464005200425,0.00502057929689143,-0.00359569536990295,0.0160849754739114,0.213592138910881
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBN,Ameloblastin,42370,-0.00368033048057957,0.00296523313098218,-0.00949218741730465,0.0021315264561455,0.214568529324385
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00520230330039879,0.00419165412502919,-0.00301333878465843,0.013417945385456,0.214591373665767
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00623940948262454,0.00503510126550827,-0.0161082079630208,0.00362938899777167,0.215303747157247
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.00658115045939997,0.00533240065849092,-0.00387035483124223,0.0170326557500422,0.217161906749016
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00682229121404973,0.00554534444574277,-0.0040465838996061,0.0176911663277056,0.218620940841042
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0160377072739968,0.0131242157122559,-0.00968575552202472,0.0417611700700184,0.221731957492336
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00846116776699205,0.00693090065840838,-0.0220457330574725,0.00512339752348838,0.222187837206239
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.00432057401548997,0.00355394803659008,-0.0112863121672065,0.00264516413622659,0.224121228687698
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLI2,Zinc finger protein GLI2,40199,-0.0039984923869003,0.00331717467126638,-0.0105001547425824,0.0025031699687818,0.228078324105696
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.00890297473063104,0.00740677263911353,-0.00561429964203147,0.0234202491032936,0.229387809065539
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00838777148298901,0.00698991932348223,-0.00531247039103616,0.0220880133570142,0.230172529985145
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0112658578035075,0.00939366237703833,-0.00714572045548766,0.0296774360625026,0.230435691011727
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNPO1,Transportin-1,40302,0.00437785422282927,0.00366559519048712,-0.00280671235052549,0.011562420796184,0.23238252478972
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSP90B1,Endoplasmin,42247,-0.00815517403259326,0.00690369842992617,-0.0216864229552486,0.00537607489006203,0.237514576167423
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA3,Carbonic anhydrase 3,42770,0.00726714951739475,0.00615516356983108,-0.00479697107947417,0.0193312701142637,0.237758883510975
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN15,Lipocalin-15,40482,-0.00763451316976244,0.00647489381766412,-0.0203253050523841,0.00505627871285924,0.238385309010431
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0107373274280388,0.00911802302918153,-0.00713399770915702,0.0286086525652346,0.238984324954612
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00547295020798738,0.00465347459738512,-0.00364786000288745,0.0145937604188622,0.239576275406039
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF3,Neurotrophin-3,42594,0.00436154309137459,0.00370989350879609,-0.00290984818586574,0.0116329343686149,0.239754922457619
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00710053912539203,0.00604643121822494,-0.0189515443131129,0.00475046606232884,0.240286206638569
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00417852229415064,0.00356152378713362,-0.0111591089169325,0.00280206432863125,0.240720388913771
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.0106433984914939,0.0090925373784625,-0.0284647717532804,0.00717797477029261,0.241799622363098
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.00609738488766213,0.00522374376682004,-0.00414115289530515,0.0163359226706294,0.243132962855097
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.00962902444098621,0.0082652733961489,-0.00657091141546563,0.0258289602974381,0.244044943962578
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0117200343064663,0.0100818047629619,-0.00804030302893915,0.0314803716418717,0.245060344385887
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00459019421870209,0.0039525606001093,-0.00315682455751214,0.0123372129949163,0.245532248657243
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUCL3,Mucin-like protein 3,40080,-0.00510937874696869,0.00440755061977857,-0.0137481779617347,0.00352942046779732,0.246386592935715
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL3A1,Collagen alpha-1(III) chain,40527,0.00279599679925615,0.00241376468169106,-0.00193498197685833,0.00752697557537063,0.246743534485855
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALB,Ras-related protein Ral-B,40199,0.00357197574160752,0.00309806909240973,-0.00250023967951556,0.00964419116273059,0.248948399972876
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOP56,Nucleolar protein 56,40116,0.0132873507856913,0.0115769352719697,-0.00940344234736935,0.035978143918752,0.251099657399047
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKIV2L,Helicase SKI2W,40116,-0.00472550536586048,0.00411907686677763,-0.0127988960247446,0.00334788529302367,0.251314031370911
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL2,Interferon lambda-2,40136,0.00730907576267945,0.00640170819739305,-0.00523827230421092,0.0198564238295698,0.253587779098695
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAG,Myelin-associated glycoprotein,40182,0.00578065124186239,0.0050810159372759,-0.00417813999519838,0.0157394424789232,0.255272273011558
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00481519275892168,0.00424505405577386,-0.0131354987082384,0.00350511319039508,0.256690714003704
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.0099161399657777,0.00875687982210699,-0.0270796244171074,0.007247344485552,0.257498480263776
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.00449333530261129,0.00400200058803165,-0.00335058584993074,0.0123372564551533,0.261554381755365
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC4A1,Band 3 anion transport protein,40527,0.00543170136727919,0.00484807048142679,-0.00407051677631732,0.0149339195108757,0.262573834329646
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00461926727346994,0.00413522107967376,-0.0127243005896305,0.00348576604269063,0.263995361393429
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRC,Chymotrypsin-C,42626,0.00759917277015135,0.00683988649371362,-0.00580700475752735,0.02100535029783,0.266584531001128
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA2,Protein disulfide-isomerase A2,40080,-0.00482872978853049,0.00436325012478622,-0.0133807000331115,0.00372324045605051,0.268455952715163
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI2B,Protein EVI2B,40080,-0.00468832605735068,0.00423906699519357,-0.0129968973679301,0.00362024525322871,0.268759336757353
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0128085807395979,0.0115822823062406,-0.00989269258063369,0.0355098540598296,0.26880403249274
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00561771255926641,0.00510238151430063,-0.00438295520876282,0.0156183803272956,0.270921584185648
NMR metabolomics,X23501.Triglycerides in Large VLDL,RETN,Resistin,42598,0.0049315538625025,0.00448558395516267,-0.00386019068961633,0.0137232984146213,0.271603378536639
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00640831349941189,0.00583946016479516,-0.00503702842358663,0.0178536554224104,0.27248403890504
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20,Interleukin-20,42370,-0.00557658481607522,0.0050894629842465,-0.0155519322651984,0.00439876263304793,0.273224929729751
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDNRB,Endothelin receptor type B,40199,0.00504090651532266,0.00460841425248643,-0.00399158541955075,0.0140733984501961,0.274045418121627
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.00879234791984805,0.00803945603456022,-0.00696498590788997,0.0245496817475861,0.274128697544953
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.00838561129141881,0.00769602751114529,-0.00669860263042595,0.0234698252132636,0.275911454652276
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL4,Myosin light chain 4,40223,0.00585682913863171,0.005393511749788,-0.00471445389095277,0.0164281121682162,0.277545762055489
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR1,Folate receptor alpha,42600,0.0034023931299154,0.00313693989462686,-0.00274600906355325,0.00955079532338406,0.278108737712156
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.00824721720252766,0.00760881645938798,-0.00666606305787278,0.0231604974629281,0.278431658965466
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTN3,Myeloblastin,42276,-0.00546603751106078,0.00504748065115045,-0.0153590995873157,0.00442702456519411,0.278862154893745
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00381999397002341,0.00353769328676407,-0.00311388487203417,0.010753872812081,0.280256085501681
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00555242480508978,0.00517172609139393,-0.00458415833404233,0.0156890079442219,0.28301984108459
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5,Interleukin-5,42370,0.0153511703591124,0.0144289910055607,-0.0129296520117866,0.0436319927300114,0.287388261940666
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00403008370250578,0.00379058803373214,-0.00339946884360922,0.0114596362486208,0.287719059573623
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00616090655067745,0.00581063238753946,-0.00522793292889989,0.0175497460302548,0.28903991486178
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.00881195877621105,0.00832579203096131,-0.0251305111568952,0.00750659360447312,0.289895814859862
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00696136866488014,0.00658371716065063,-0.0059427169699951,0.0198654542997554,0.29036965610333
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR1,Toll-like receptor 1,40199,0.00292438401225124,0.00276704178421804,-0.00249901788481612,0.0083477859093186,0.290597327090916
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00310384782130882,0.00293905512650955,-0.00265670022664989,0.00886439586926754,0.290959437351197
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELB,Transcription factor RelB,40199,0.00541847020756875,0.00513574468105408,-0.00464758936729724,0.0154845297824347,0.291425371550366
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1B,Lithostathine-1-beta,42794,-0.00637811110083425,0.00605202971046647,-0.0182400893333485,0.00548386713168002,0.291956732297718
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEB,Nebulin,40116,-0.00416734153916948,0.00397279230681849,-0.0119540144605337,0.00361933138219476,0.294214951993322
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00338716552984371,0.00326586967911788,-0.00978827010091476,0.00301393904122734,0.29969344538549
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.0036872013368106,0.00357249503144558,-0.00331488892482274,0.0106892915984439,0.302039796663369
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH22,Cadherin-22,40302,-0.00299526931507772,0.00290727795717836,-0.00869353411114729,0.00270299548099186,0.302907637958645
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.0067258601657893,0.00653699777151713,-0.00608665546638427,0.0195383757979629,0.303553614573869
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00526531130180387,0.00512583897278303,-0.0153119556884586,0.00478133308485087,0.304344499221918
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR2,Toll-like receptor 2,40302,0.00248691391730558,0.00242239123217405,-0.00226097289775555,0.00723480073236671,0.304614275791206
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAG,S-arrestin,40136,-0.00553593799498365,0.00541841124507893,-0.0161560240353383,0.00508414804537106,0.306950110069186
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00753252529554643,0.00738599192951968,-0.022009069477405,0.00694401888631215,0.307827105180307
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RA,Interleukin-17 receptor A,42611,0.00460409158078062,0.00454741988665138,-0.00430885139705609,0.0135170345586173,0.311335280928983
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4,Interleukin-4,42370,0.00979355177711072,0.00969500689084743,-0.00920866172895025,0.0287957652831717,0.312435034691412
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00392694510018182,0.00389242626454087,-0.0115561005786819,0.00370221037831829,0.313056740064291
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00509931686006221,0.00506350930720882,-0.0150237951021915,0.00482516138206708,0.313919185958038
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00457234310385617,0.00454162138080441,-0.00432923480252048,0.0134739210102328,0.31406960937249
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.00876431042053085,0.00872081206015297,-0.00832848121736897,0.0258571020584307,0.314921159893969
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.0072304082969197,0.00719614940735193,-0.0213348611353295,0.00687404454149007,0.315034338895392
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.00283355987762851,0.00283270414529398,-0.00838566000240471,0.0027185402471477,0.317182132957947
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD82,CD82 antigen,40302,-0.00421739694398054,0.00423756112678054,-0.0125230167524704,0.00408822286450931,0.319640472430777
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00483851545091424,0.00487803277200745,-0.00472242878222037,0.0143994596840488,0.321268642769016
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSHB,Follitropin subunit beta,40223,-0.00554262046114154,0.00559732593029635,-0.0165133792845224,0.00542813836223931,0.322085146518658
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD10,Frizzled-10,40182,0.00621868246528225,0.00628458351261595,-0.00609910121944502,0.0185364661500095,0.322433582736356
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00265687852941923,0.00270294315891415,-0.00795464712089097,0.00264089006205251,0.325646090735207
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL33,Interleukin-33,42370,0.00391264037207471,0.00401140444864415,-0.00394971234726782,0.0117749930914172,0.329390115086299
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00854959486876526,0.00876705258804461,-0.0257330179413327,0.00863382820380217,0.329484419901604
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00608417758173508,0.00624092618605879,-0.00614803774294016,0.0183163929064103,0.329639513730656
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00452479902874963,0.00464247500630901,-0.0136240500411153,0.00457445198361603,0.329753695361315
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPN3,Calpain-3,40451,-0.00384755937022524,0.00395334147399094,-0.0115961086592475,0.003900989918797,0.330453776335402
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00369296570749725,0.00381111024463727,-0.0037768103719918,0.0111627417869863,0.332566302508878
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00597820393753206,0.00619748517223403,-0.0181252748751108,0.00616886700004665,0.334757683871905
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.00589966977078714,0.00613807200234598,-0.00613095135381099,0.0179302908953853,0.336488865530611
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAGE2A,G antigen 2A,40080,0.00662589984196716,0.00690210170855861,-0.00690221950680771,0.020154019190742,0.337085125529328
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00598456403513924,0.00624563690906236,-0.0182260123769015,0.00625688430662298,0.337983511967428
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.0055434105073893,0.00579484601094353,-0.0169013086888386,0.00581448767406001,0.338784935801053
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLHL41,Kelch-like protein 41,40482,-0.00473826150576087,0.00495682672443799,-0.0144536418856593,0.00497711887413758,0.339140086235259
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR3,Folate receptor gamma,42629,-0.0182412054493741,0.0191729634093494,-0.055820213731699,0.0193378028329507,0.341417203333068
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00228701277556489,0.00240727959067969,-0.0024312552221673,0.00700528077329707,0.342108729696238
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARTN,Artemin,42370,0.0043826971489135,0.00462744224248252,-0.00468708964635224,0.0134524839441792,0.34360006265282
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00381281223299439,0.00405316959880788,-0.0117570246466578,0.00413140018066906,0.346879980895984
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSND,Barttin,40080,0.00331985705218506,0.00353477051480287,-0.00360829315682857,0.0102480072611987,0.34764882219458
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00524842711937177,0.00559142893914742,-0.00571077360135717,0.0162076278401007,0.347927910584393
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAN,Neurocan core protein,42711,-0.00368183366532173,0.0039269946523291,-0.0113787431838868,0.00401507585324331,0.348482017212955
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00591092378007282,0.00631168827259801,-0.00645998523421928,0.0182818327943649,0.349030734201542
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFAP,Glial fibrillary acidic protein,42326,0.00473183338662637,0.00505943286884838,-0.00518465503631646,0.0146483218095692,0.349676796293014
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTXR,Neuronal pentraxin receptor,42636,-0.00327768427207029,0.0035107267823258,-0.0101587087654289,0.00360334022128828,0.35051678319513
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1A,Interleukin-1 alpha,42370,0.00562652882479078,0.00603424959736509,-0.00620060038604479,0.0174536580356264,0.351130278690111
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSCA,Prostate stem cell antigen,40449,0.0255112343681616,0.0275188453237176,-0.0284257024663249,0.0794481712026481,0.353922550852091
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00750990302239541,0.00811251830602792,-0.0234104389022101,0.0083906328574193,0.354613043721469
NMR metabolomics,X23501.Triglycerides in Large VLDL,STEAP4,Metalloreductase STEAP4,40136,0.00695456262054365,0.0075305093949277,-0.00780523579351464,0.0217143610346019,0.355757574808533
NMR metabolomics,X23501.Triglycerides in Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00560353805563958,0.00607871128272167,-0.00631073605849489,0.0175178121697741,0.356637716820995
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00742467340761482,0.00805766545338507,-0.00836835088101991,0.0232176976962496,0.35683989273649
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL9,Interleukin-9,40302,0.00534640517655011,0.00581865532248872,-0.00605815925552779,0.016750969608628,0.358199944463133
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBN2,Fibrillin-2,40182,0.00579188198469209,0.00630658186184651,-0.00656901846452707,0.0181527824339112,0.358436519956454
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,-0.00413790989693458,0.00451946622653466,-0.0129960637009425,0.00472024390707336,0.359906266168811
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00613679716416504,0.00672138661071565,-0.0193107149211677,0.00703712059283763,0.361245494797473
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGN,Secretagogin,42370,-0.004242135926532,0.00468019765266603,-0.0134153233257574,0.00493105147269342,0.364740208070141
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.00246849655656429,0.00272914781575955,-0.00288063316232443,0.00781762627545301,0.365752978773693
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.00783785153997403,0.00869223511822318,-0.00919892929174341,0.0248746323716915,0.36723224082184
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMI,N-myc-interactor,40421,0.00670042081879549,0.0074345049388662,-0.00787120886138227,0.0212720504989732,0.367469507861962
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.00493892311664729,0.00548471977847513,-0.00581112764916396,0.0156889738824585,0.367880282900734
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00716586051986762,0.00798010572872444,-0.00847514670843229,0.0228068677481675,0.369223558375237
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00279484889993978,0.00312088791125251,-0.0089117892059947,0.00332209140611514,0.370523510351283
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00321612971141111,0.00359152945817042,-0.0102555274494251,0.00382326802660292,0.370552233880991
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL1,Interferon lambda-1,42311,0.00424279767241801,0.00473821063640877,-0.00504409517494318,0.0135296905197792,0.370566740312896
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF7,Fibroblast growth factor 7,40080,-0.0073385312919254,0.00820908431561682,-0.0234283365505344,0.00875127396668356,0.371367079217678
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0108811690817818,0.0122677424228697,-0.0349259442306063,0.0131636060670428,0.37510877447244
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERVV_1,,40116,-0.00399679648611802,0.00451516768828441,-0.0128465251551555,0.00485293218291942,0.376071836561194
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTKN2,Rhotekin-2,40116,-0.0047121857906572,0.00533891254752697,-0.0151764543838101,0.00575208280249566,0.377465619707913
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP8,Neutrophil collagenase,42681,0.0066196945149781,0.00754318067271994,-0.00816493960355299,0.0214043286335092,0.380190915866122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00496446620419584,0.00566645573868767,-0.0160707194520237,0.00614178704363198,0.380986705295863
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.0041298240991102,0.00471913670629912,-0.00511968384523607,0.0133793320434565,0.381523119453746
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL1,Chordin-like protein 1,42654,0.00291519847249282,0.00333960076208637,-0.00363041902119646,0.0094608159661821,0.382723206795828
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA3,GDNF family receptor alpha-3,42474,-0.00259674243192285,0.00297739343394604,-0.00843243356245709,0.00323894869861139,0.383140717160028
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA10,Annexin A10,42311,-0.00778337699110873,0.00892720159092013,-0.0252806921093122,0.00971393812709473,0.383294175186017
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.00608059283596963,0.00697494933420566,-0.0197514935310127,0.00759030785907347,0.383349683960828
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00249785350497651,0.00286629072928212,-0.00312007632441644,0.00811578333436946,0.383519733517015
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00340015091054941,0.00392993810520852,-0.00430252777565929,0.0111028295967581,0.386951814232315
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.00400543985849849,0.00463415644289708,-0.0130883864865768,0.00507750676957979,0.387422077222271
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00331564346194657,0.00383951828981926,-0.0108410993099923,0.00420981238609918,0.387849561344359
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALLD,Palladin,40199,-0.00347169493121553,0.00402853091093691,-0.0113676155166519,0.00442422565422081,0.388829068732441
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3G,Semaphorin-3G,40283,0.0039763277178163,0.00462137290329719,-0.00508156317264619,0.0130342186082788,0.389575446335779
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.0153222000369708,0.017820664578118,-0.0502507026100821,0.0196063025361404,0.389915105272114
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS53,Serine protease 53,40483,0.00331106991870078,0.00385915020035456,-0.00425286447399417,0.0108750043113957,0.390922261553139
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAN,Brevican core protein,42495,-0.00306498542203797,0.00358291771710223,-0.0100875041475584,0.00395753330348241,0.392320809011879
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.00377293676075544,0.00444951419473789,-0.00494811106093082,0.0124939845824417,0.396484548261047
NMR metabolomics,X23501.Triglycerides in Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00301079549113004,0.0035524499682466,-0.00395200644663329,0.00997359742889337,0.396720303855181
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX1B,Syntaxin-1B,40182,0.00355976409810328,0.00420195621903304,-0.00467607009120147,0.011795598287408,0.396919772212935
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAEP,Glycodelin,42495,-0.00789109533069943,0.00932016409075749,-0.0261586169485841,0.0103764262871853,0.397194795917281
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC5D,Netrin receptor UNC5D,40199,-0.00228521981340236,0.00270423241930639,-0.00758551535524288,0.00301507572843817,0.398099599797402
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.00322124596775277,0.00382167161369814,-0.00426923039509558,0.0107117223306011,0.399308167676769
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00284520426237889,0.00338808498772269,-0.00379544231355758,0.00948585083831536,0.40105389613811
NMR metabolomics,X23501.Triglycerides in Large VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.00249531888652453,0.00297362924038939,-0.00333299442463867,0.00832363219768773,0.401403304454774
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00361434081177172,0.00433487632383365,-0.0121106984064857,0.00488201678294223,0.404422176075448
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.00532295697848319,0.00640778546623753,-0.00723630253534238,0.0178822164923088,0.406160438701738
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA5,Annexin A5,42261,-0.00263342797766183,0.00317470910896611,-0.00885585783123541,0.00358900187591175,0.406835483087637
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.00425517599590819,0.00514508200037095,-0.00582918472481888,0.0143395367166353,0.408233943090187
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF2,Trefoil factor 2,42654,0.00497137235263298,0.00601704815032321,-0.0068220420220005,0.0167647867272665,0.408697076145919
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00605646205014183,0.00738205001232367,-0.00841235597401255,0.0205252800742962,0.411988294734352
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00255275579795727,0.00312285729943323,-0.00867355610484641,0.00356804450893187,0.41369024835348
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00355787730121429,0.00435267689404379,-0.00497336941111154,0.0120891240135401,0.41371770256947
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.0031364327151922,0.00384323346779498,-0.0106691703120704,0.00439630488168597,0.414465116458709
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15,Interleukin-15,42594,0.00279875309240627,0.00343092136369369,-0.00392585278043336,0.00952335896524589,0.414661138179812
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0044653016602526,0.00547770118656223,-0.0152015959859146,0.00627099266540938,0.414987658076927
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC1,Sialoadhesin,42676,-0.00361934541476303,0.00446280497172523,-0.0123664431593445,0.00512775232981842,0.417378625259758
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00279252050440132,0.0034568667733899,-0.00398293837144289,0.00956797938024552,0.41921273775499
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN1,Calsyntenin-1,42311,-0.00443885831607498,0.00549946079853191,-0.0152178014811975,0.00634008484904757,0.419597999663252
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH3,Neurexophilin-3,40199,0.00255769118366946,0.00317627215471991,-0.00366780223958157,0.00878318460692049,0.420693183328443
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.00477719586400623,0.00594427174307023,-0.0164279684804239,0.00687357675241143,0.421605349897987
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00394367615190998,0.00496902700172202,-0.00579561677146518,0.0136829690752851,0.427415534899291
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLINT1,Clathrin interactor 1,40080,0.00378408211919461,0.00478273457521011,-0.00559007764821721,0.0131582418866064,0.42884666099415
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.00723963010471583,0.00916030843960632,-0.0107145744369126,0.0251938346463442,0.429354424733381
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00577814462045752,0.00736293598366661,-0.0202094991484441,0.00865320990752903,0.432610730492854
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN1,Neuroligin-1,40182,-0.00566805466373506,0.00723752256471118,-0.019853598890569,0.00851748956309885,0.433556814277798
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00229185864331613,0.00292787840743441,-0.00344678303525532,0.00803050032188758,0.4337752818083
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAX,Integrin alpha-X,40302,0.00440274344684994,0.00563044236967427,-0.00663292359771162,0.0154384104914115,0.434258638808538
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.0042165220641054,0.00539732939058086,-0.00636224354143308,0.0147952876696439,0.434687721332989
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.0029135394778608,0.00373279061587714,-0.00440273012925839,0.01022980908498,0.435097799251356
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00372263427973391,0.0047823393375993,-0.00565075082196072,0.0130960193814285,0.436339683423221
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00330958579472065,0.00425175918364061,-0.00502386220521495,0.0116430337946562,0.436344501345792
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00315469249780299,0.00407856764493265,-0.004839300086265,0.011148685081871,0.439254811184589
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00719937267913435,0.00936754238554787,-0.0255597557548082,0.0111610103965395,0.44217991801579
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00243841466375639,0.00317553215887285,-0.00378562836763439,0.00866245769514718,0.442574681601898
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00320477722068548,0.00418134076548925,-0.00499065067967344,0.0114002051210444,0.443424007705523
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBZ,Hemoglobin subunit zeta,40511,0.00839519001836472,0.0109902131335967,-0.0131456277234849,0.0299360077602143,0.444955440587955
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRAS,GTPase Hras,40286,0.00784839375286132,0.0103108684051673,-0.0123609083212665,0.0280576958269892,0.446567658880595
NMR metabolomics,X23501.Triglycerides in Large VLDL,REST,RE1-silencing transcription factor,40080,-0.00268694722202448,0.00355178289077009,-0.00964844168793385,0.0042745472438849,0.449361883998753
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPGN,Epigen,40451,0.00354250777822537,0.00470566402169214,-0.00568059370429124,0.012765609260742,0.451575133144596
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHIT1,Chitotriosidase-1,42699,-0.0119280909166517,0.0159553288124761,-0.0432005353891048,0.0193443535558014,0.454718750876889
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00236534168839572,0.00317658045661263,-0.00386075600656503,0.00859143938335647,0.456515473291982
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00386453774415975,0.00520149885753978,-0.00633040001661822,0.0140594755049377,0.457518105819549
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABO,Histo-blood group ABO system transferase,40532,-0.0111103285157722,0.0150036861146674,-0.0405175533005204,0.018296896268976,0.459007995233564
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00368101684452723,0.00498902922548809,-0.0134595141264839,0.00609748043742943,0.460638312687961
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31,Interleukin-31,40199,0.0042538301339593,0.00582523405860891,-0.00716362862091417,0.0156712888888328,0.465257863892561
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00467683788165092,0.00641974364659505,-0.00790585966567538,0.0172595354289772,0.466317862232139
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD2,Leiomodin-2,40136,0.00469266384518468,0.0064506122993674,-0.00795053626157543,0.0173358639519448,0.466950146929591
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00531992970736579,0.00733900208817846,-0.00906451438546399,0.0197043738001956,0.468538231361936
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00276541964004522,0.0038178597525687,-0.00471758547498943,0.0102484247550799,0.46887387727035
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCLRE1C,Protein artemis,40080,0.0023381521501628,0.0032356095695645,-0.00400364260618362,0.00867994690650923,0.469922070711638
NMR metabolomics,X23501.Triglycerides in Large VLDL,L1CAM,Neural cell adhesion molecule L1,42679,-0.00218533827583065,0.00302561133180758,-0.00811553648617351,0.00374485993451222,0.470134927696638
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD55,Complement decay-accelerating factor,42201,0.00202865366018023,0.00281884977353978,-0.00349629189595773,0.00755359921631819,0.471738500845998
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNN,Tenascin-N,40527,0.00326452874459298,0.00455547312533889,-0.00566419858107125,0.0121932560702572,0.4736253193732
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00280866543560262,0.00392842196642281,-0.00489104161858609,0.0105083724897913,0.474648820582354
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAGLN3,Transgelin-3,40080,0.00453344458168583,0.00634668982818304,-0.00790606748155293,0.0169729566449246,0.475056614508082
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00215334129976708,0.00303089410637952,-0.00378721114873678,0.00809389374827094,0.477429407684095
NMR metabolomics,X23501.Triglycerides in Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00160958992225195,0.00230073837594236,-0.00289985729459507,0.00611903713909897,0.484191079087526
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC8,Histone deacetylase 8,40199,0.00427346925483373,0.00610947556464755,-0.00770110285187547,0.0162480413615429,0.484265532874454
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK12,Kallikrein-12,42346,0.0100520045357786,0.0144427916078874,-0.0182558670156807,0.0383598760872379,0.486448864786198
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00204647346793689,0.00294409085944219,-0.00781689155244358,0.00372394461656979,0.486999236131312
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRAXIN,Draxin,42495,0.00313524349840689,0.00453625740844547,-0.00575582102214624,0.01202630801896,0.489482070420437
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN1,Prorelaxin H1,40482,0.00344606690042386,0.00500871657648314,-0.0063710175894831,0.0132631513903308,0.491458131152685
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0041335479966412,0.00601614802316141,-0.00765810212875518,0.0159251981220376,0.492046996520414
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00572362249272508,0.00833544959793626,-0.0220611037046802,0.01061385871923,0.492311140594088
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00345785956325474,0.00504762677591791,-0.00643548891754436,0.0133512080440538,0.493328545417431
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRN1,Neuritin,40482,0.00256966305239394,0.00376319201346292,-0.00480619329399339,0.00994551939878128,0.494721121510814
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,-0.00222705268092187,0.00327137658794267,-0.0086389507932895,0.00418484543144577,0.496029466386468
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBX2,Chromobox protein homolog 2,40116,-0.00280713675193417,0.00415286350332197,-0.0109467492184452,0.00533247571457689,0.499085377867368
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00175351981204931,0.00261331835453618,-0.00336858416284161,0.00687562378694023,0.502238300484009
NMR metabolomics,X23501.Triglycerides in Large VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00592584373763382,0.00885172193333504,-0.0114235312517029,0.0232752187269705,0.503218377217948
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESR1,Estrogen receptor,40199,-0.00382645090611317,0.00571708157718648,-0.0150319307973987,0.00737902898517232,0.50331725200557
NMR metabolomics,X23501.Triglycerides in Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00454255932969257,0.00680747950957232,-0.00880010050906919,0.0178852191684543,0.504601118722563
NMR metabolomics,X23501.Triglycerides in Large VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.00557588250847796,0.00835900228778983,-0.021959526992546,0.0108077619755901,0.504753587465903
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17F,Interleukin-17F,42370,0.00521794811748655,0.00782290828343946,-0.0101149521180548,0.0205508483530279,0.50477823746223
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.00398541834767126,0.00597701878921317,-0.0157003751745291,0.00772953847918655,0.504917611998034
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00395634199868413,0.00601748107529858,-0.00783792090890109,0.0157506049062693,0.51088722382183
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.00334476402540446,0.00511383904120541,-0.0133678885461671,0.00667836049535814,0.513085973791268
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00320552152540848,0.00492176634989545,-0.0128521835712036,0.0064411405203866,0.514867185388134
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP1,Retinol-binding protein 1,40182,0.00460159798777212,0.00707803296527423,-0.00927134662416538,0.0184745425997096,0.515625821159143
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00452617911357165,0.0069932757619773,-0.0182329996070472,0.00918064137990387,0.517503987871991
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00356522953873157,0.00553536236128572,-0.0144145397668516,0.00728408068938845,0.519535315171308
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,-0.00188425382685618,0.00293310308612553,-0.00763313587566222,0.00386462822194987,0.52061816964238
NMR metabolomics,X23501.Triglycerides in Large VLDL,GM2A,Ganglioside GM2 activator,40269,0.00266183030979114,0.00422732767043131,-0.00562373192425422,0.0109473925438365,0.528922126652063
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL11,Interleukin-11,42370,0.00406306782382758,0.00648639809971331,-0.00865027245161052,0.0167764080992657,0.531064668849873
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDAN1,Codanin-1,40483,0.00146185060588097,0.0023400391943987,-0.00312462621514048,0.00604832742690243,0.532172709968116
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00216893265408075,0.0034820972412163,-0.0089938432468647,0.00465597793870319,0.533375646098827
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMP,Olfactory marker protein,40136,-0.00321780076493036,0.00520402063830631,-0.0134176812160107,0.00698207968615,0.536370867194322
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3,Interleukin-3,40080,0.00393969592868329,0.00639809456127538,-0.00860056941141644,0.016479961268783,0.538065265708469
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMCN2,Hemicentin-2,40269,-0.00370641991934334,0.00603913035745115,-0.0155431154199476,0.00813027558126091,0.539403690476781
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.0031260053689755,0.0050994662929888,-0.00686894856528254,0.0131209593032335,0.539882749652145
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBB,Inhibin beta B chain,40283,-0.00344522707332619,0.00563139257729235,-0.0144827565248192,0.00759230237816682,0.540689553805371
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.00349136877918061,0.0057710085070566,-0.00781980789465034,0.0148025454530116,0.545202085051978
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.00398568385457827,0.00665493285955145,-0.0170293522592991,0.00905798455014257,0.549247504071058
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF20,Fibroblast growth factor 20,40199,-0.00279080723599618,0.00466483556765513,-0.0119338849486002,0.00635227047660788,0.549675526319332
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.00222235310054185,0.00371570190154755,-0.00950512882757505,0.00506042262649135,0.549784792126078
NMR metabolomics,X23501.Triglycerides in Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.0045286194230737,0.0075846518137419,-0.0193945369780078,0.0103372981318604,0.550468479246004
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN4,Alpha-actinin-4,42370,0.00201614181131038,0.00338884112432164,-0.00462598679236004,0.00865827041498079,0.551896818209847
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPLX2,Complexin-2,40080,-0.00194734263798714,0.00328780151000049,-0.0083914335975881,0.00449674832161382,0.553666537424713
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR1B,Cornifin-B,40302,-0.00504843515530274,0.008592478863347,-0.0218896937274629,0.0117928234168574,0.556852245901886
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEFL,Neurofilament light polypeptide,42262,-0.00280886347333075,0.00478624181288344,-0.0121898974265823,0.00657217047992078,0.557306526345039
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.0042791383236561,0.00729380339178722,-0.0100167163242468,0.018574992971559,0.55742966685216
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.00175364767575677,0.00299266147287712,-0.00411196881108238,0.00761926416259591,0.557896989063462
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00280455910992261,0.00481506329628838,-0.0122420831706478,0.0066329649508026,0.560271713489282
NMR metabolomics,X23501.Triglycerides in Large VLDL,GJA8,Gap junction alpha-8 protein,40080,0.00393249729311905,0.00675657944364185,-0.00931039841641898,0.0171753930026571,0.56056197986583
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB116,Beta-defensin 116,40136,-0.0046114663299444,0.00796289300959792,-0.0202187366287563,0.0109958039688675,0.562520488953668
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00225600342052644,0.00391125937725359,-0.00541006495889059,0.00992207179994348,0.564088354872473
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00246274276082801,0.00428699998449173,-0.0108652627304318,0.00593977720877578,0.56566313493856
NMR metabolomics,X23501.Triglycerides in Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00213746750682175,0.00375106222605674,-0.00948954946989296,0.00521461445624946,0.568804776826543
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.00181025187918495,0.00319518796735984,-0.00807282029521024,0.00445231653684034,0.571027393225786
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00269938234562246,0.00476638491130645,-0.0120414967717831,0.00664273208053818,0.571175945527811
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00190770152923642,0.00336986935227879,-0.00469724240123001,0.00851264545970284,0.571333704597222
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSG1,Tryptase gamma,40199,0.00155405601751655,0.00274829717994879,-0.00383260645518309,0.00694071849021619,0.571771488187756
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36A,Interleukin-36 alpha,40199,-0.00336125926349171,0.00595071233168707,-0.0150246554335984,0.00830213690661495,0.572187376379113
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF3,Fibroblast growth factor 3,40199,0.0016750377947366,0.0030075926095883,-0.00421984372005647,0.00756991930952966,0.577582210777568
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00238760180570932,0.00430987960905359,-0.0108349658394544,0.0060597622280357,0.579601454952396
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.0027110999141218,0.00489779193032487,-0.00688857226931495,0.0123107720975586,0.579908170133504
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00362334545002359,0.00655637208736891,-0.0164738347412666,0.00922714384121947,0.580517725643275
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.0022860399893277,0.00414778066205037,-0.00584361010829102,0.0104156900869464,0.581543581852309
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.00257245073537086,0.00471866715048937,-0.01182103835033,0.0066761368795883,0.585649313013545
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00202890670395343,0.00372550307741124,-0.0052730793277726,0.00933089273567946,0.586039832312377
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPO,Lactoperoxidase,42134,-0.0034238959074901,0.00629966451207808,-0.0157712383511631,0.00892344653618294,0.586791867400609
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00140550669867402,0.0026108967646832,-0.0065228643574531,0.00371185096010506,0.590364838442507
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00166949693040428,0.00310711252546127,-0.00442044361949981,0.00775943748030836,0.59106086988082
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH2,Growth hormone variant,42346,0.00925413809183753,0.0172578497691879,-0.0245712474557707,0.0430795236394457,0.591810220371712
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00386633875793591,0.00725619074173823,-0.010355795095871,0.0180884726117428,0.594159925009722
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.00330042413293928,0.00619790176427335,-0.00884746332503649,0.015448311590915,0.594384044711607
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC1,Plexin domain-containing protein 1,42346,0.00173601357004526,0.00326173933841435,-0.00465699553324686,0.00812902267333738,0.594571867511864
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.00117010327098217,0.00223393196808333,-0.00320840338646115,0.00554860992842549,0.600437633956468
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00405502772319054,0.00774951128977884,-0.0192440698511571,0.011134014404776,0.600802272597007
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSD1,Tryptase delta,40482,-0.00207318482700484,0.00397264163062314,-0.00985956242302619,0.00571319276901652,0.601774182408627
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.00215828321005094,0.00415374503251611,-0.0102996234737825,0.00598305705368064,0.60335304092438
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.00179618586746466,0.00348125220160966,-0.00502706844769026,0.00861944018261959,0.605891372888072
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00307653229864651,0.00597120668852262,-0.00862703281085782,0.0147800974081508,0.606404234917743
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK3,Prostate-specific antigen,40527,0.00521661401684294,0.0101522598839083,-0.0146818153556174,0.0251150433893033,0.607375475255307
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCP11,T-complex protein 11 homolog,40302,0.00312766112703687,0.00612409337796878,-0.00887556189378194,0.0151308841478557,0.609561382242567
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00428118519367384,0.00839252294443293,-0.0207305301647624,0.0121681597774147,0.609978248686887
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22,Interleukin-22,40451,0.00368680873078916,0.00723839050755054,-0.0105004366640099,0.0178740541255882,0.610523239754711
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.00342602252725914,0.0067651253730334,-0.0166856682584046,0.00983362320388632,0.61256743336206
NMR metabolomics,X23501.Triglycerides in Large VLDL,MELTF,Melanotransferrin,40511,0.00156339350951512,0.00311875469142274,-0.00454936568567344,0.00767615270470369,0.61617837850218
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL19,Interleukin-19,42261,0.00369127442632196,0.00747392427610194,-0.0109576171548378,0.0183401660074818,0.621394250928026
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00189596295453361,0.0038451874195128,-0.00564060438771148,0.0094325302967787,0.621969862108498
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00204158505106175,0.00420126954485074,-0.0061929032568457,0.0102760733589692,0.627016040974717
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,0.00517611660723316,0.010655827655594,-0.015709305597731,0.0260615388121973,0.627150898721218
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP7,Retinoid-binding protein 7,40449,0.00299879907812247,0.00620209376568371,-0.00915730470261761,0.0151549028588626,0.628740237751072
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0032610348469706,0.00676725686031459,-0.0165248582931872,0.010002788599246,0.629895947816524
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.0026439543827709,0.0055226804230807,-0.00818049924646727,0.0134684080120091,0.63212979372743
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00284154632445577,0.00594398092263151,-0.0144917489328135,0.00880865628390199,0.632621075065567
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.0023447092901039,0.00492287177559332,-0.00730411939005901,0.0119935379702668,0.633878084083486
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSMB,Beta-microseminoprotein,42559,-0.00351952316067747,0.0074900753177495,-0.0182000707834665,0.0111610244621116,0.638440162574691
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL5A1,Collagen alpha-1(V) chain,40283,-0.00199609416176482,0.00426357083973936,-0.010352693007654,0.00636050468412433,0.639669172866498
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.00356885166022228,0.00766472821830718,-0.0114540156476598,0.0185917189681043,0.641496707104158
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00198511142351732,0.00427213589994357,-0.00638827494037208,0.0103584977874067,0.642178969218099
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRND,Prion-like protein doppel,40483,-0.00250123608900375,0.00541508088084919,-0.0131147946154682,0.00811232243746065,0.644160579928852
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCNA,Proliferating cell nuclear antigen,40080,-0.0029273162905354,0.00647588897003028,-0.0156200586717948,0.00976542609072395,0.651254129866123
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPN,Asporin,40511,0.00130636462293949,0.00290386144970791,-0.004385203818488,0.00699793306436699,0.65281168612475
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC9,Histone deacetylase 9,40136,-0.00304518251513405,0.00678639825411728,-0.0163465230932039,0.0102561580629358,0.653643615788154
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANK2,Ankyrin-2,40116,-0.00338425857918769,0.00761776556479851,-0.0183150790861928,0.0115465619278174,0.656864363472266
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.00165782193679055,0.00374292990354681,-0.00899396454774231,0.0056783206741612,0.657830210271418
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH17,Cadherin-17,42636,-0.003150267726271,0.00718330114306611,-0.0172295379666806,0.0109290025141386,0.6609915525896
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAC1,Cartilage acidic protein 1,42794,-0.00135091702756929,0.00308708476952056,-0.0074016031758296,0.00469976912069102,0.661681169372795
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.00316174982059859,0.007225764405635,-0.0173242480556432,0.011000748414446,0.661709330111222
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.0020046111556901,0.00461361533334465,-0.0110472972090456,0.00703807489766542,0.663934575362835
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00340831746711385,0.00796112447548781,-0.01901212143907,0.0121954865048423,0.668572147671228
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST2,Bone marrow stromal antigen 2,42711,0.0022428792650448,0.00528309839985864,-0.00811199359867813,0.0125977521287677,0.671179808429551
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN2,Contactin-2,42721,-0.00194364753127472,0.00460917740708918,-0.0109776352491695,0.00709034018662006,0.673257449426752
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00379489459847498,0.00905830450356643,-0.0215491714254652,0.0139593822285152,0.675267472436071
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.00275991021676609,0.00659589459125689,-0.0156878636156296,0.0101680431820974,0.675642071749089
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN6,Prefoldin subunit 6,40182,0.00280545154995809,0.00670995257944888,-0.0103460555057617,0.0159569586056779,0.675879955255105
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00143599555125317,0.00343980946263769,-0.00817802209802305,0.0053060309955167,0.676347468384563
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0061634559099738,0.0148374993049842,-0.0229180427277951,0.0352449545477427,0.677859331209183
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00127620907174928,0.00307998810573948,-0.0047605676155001,0.00731298575899865,0.678620742286989
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM2,Isthmin-2,40527,0.00185250237687657,0.00448055030101465,-0.00692937621311215,0.0106343809668653,0.679281688572034
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00181911843693948,0.00447168033995922,-0.0105836119032596,0.0069453750293806,0.684156458019544
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.00177872186079738,0.00441580073229736,-0.0104336912961002,0.00687624757450545,0.687097052267516
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00252266605901201,0.00630812925709823,-0.00984126728490052,0.0148865994029245,0.689232704310144
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.00197541432459064,0.00497911840476601,-0.00778365774875073,0.011734486397932,0.691567101935452
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.0013292564370563,0.0033520334374948,-0.0052407291004335,0.00789924197454611,0.691704113507031
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP9,Matrix metalloproteinase-9,42594,-0.00243884930769816,0.00621000238438569,-0.0146104539810941,0.00973275536569779,0.6945257437489
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.00240467783935378,0.00612339269860804,-0.0144065275286255,0.00959717184991799,0.694546123533121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00119008388345398,0.00304759793326769,-0.00716337583265865,0.00478320806575069,0.696174978515992
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.00181551060357632,0.00468252313628514,-0.00736223474354255,0.0109932559506952,0.698230402098044
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00124404686255648,0.00327317703545315,-0.00765947385204466,0.00517138012693169,0.703898457607728
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00144911813400671,0.00381793055235932,-0.00603402574861755,0.00893226201663097,0.704282344528383
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,-0.00235307679433842,0.0062165882379648,-0.0145375897407494,0.00983143615207259,0.705054585464758
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00258130460050327,0.00683326327909943,-0.0159745006275382,0.0108118914265316,0.705619401853105
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD8,Frizzled-8,40136,-0.00176105626752065,0.00473165876400479,-0.01103510744497,0.00751299490992874,0.709761715359808
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA8,Carbonic anhydrase-related protein,40199,0.00110176859707677,0.00296031329985756,-0.00470044547064404,0.00690398266479758,0.709766205194728
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00235184227066327,0.0063412957924218,-0.01478078202381,0.0100770974824835,0.710736162154124
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGN,Cingulin,40182,0.00157796030741478,0.00426841789642184,-0.00678813876957203,0.00994405938440159,0.711626038163698
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,-0.00105143328404632,0.00284601729876868,-0.00662962718963293,0.0045267606215403,0.711805417582509
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00241562729635973,0.00655695547638228,-0.0104360054373495,0.015267260030069,0.712577056042136
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.00199790571059744,0.00544870061565412,-0.0126773589172795,0.00868154749608464,0.713867881179912
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASQ2,Calsequestrin-2,40116,-0.00184890170457341,0.00508076955118217,-0.0118072100248905,0.00810940661574364,0.715938307972451
NMR metabolomics,X23501.Triglycerides in Large VLDL,NENF,Neudesin,40451,0.00411019596437158,0.0113806713809513,-0.0181959199422929,0.0264163118710361,0.717989727274731
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0101102953220572,0.0280146114950205,-0.044798343208183,0.0650189338522974,0.718185864747939
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.000902387351436141,0.00250802822632257,-0.0040133479721561,0.00581812267502838,0.719002698766552
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.00191875524695067,0.00537728357358493,-0.0124582310511771,0.0086207205572758,0.721228872348726
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.0018804866972655,0.00527630027461309,-0.00846106184097616,0.0122220352355072,0.721545987832326
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH4,Cadherin-4,40136,0.0018260226637824,0.00514425426719078,-0.00825671569991152,0.0119087610274763,0.722623753114389
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00262426282574329,0.00742708513997087,-0.0119328240485996,0.0171813497000862,0.723842705252038
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00132742571667483,0.00378594689773821,-0.00609303020289206,0.00874788163624172,0.725880602289755
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSPN,Claspin,42292,-0.00127162070803426,0.00362873101469059,-0.00838393349682781,0.0058406920807593,0.726020720222224
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2BP,LRP2-binding protein,40182,0.003128795721175,0.00893803414542021,-0.0143897512038486,0.0206473426461986,0.726304787730701
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00271254217591501,0.00781922499648152,-0.0126131388171888,0.0180382231690188,0.72866802319598
NMR metabolomics,X23501.Triglycerides in Large VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.00107746529858752,0.00311335316165876,-0.00502470689826365,0.0071796374954387,0.729288936532502
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00174436863267907,0.00506163595266375,-0.00817643783454188,0.0116651750999,0.7303825460583
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00138170251901405,0.00403920369476283,-0.0065351367227211,0.0092985417607492,0.732302538940866
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPE4,NXPE family member 4,40116,-0.00119168734454671,0.00348783351481087,-0.00802784103357601,0.0056444663444826,0.732605982688379
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK15,Kallikrein-15,40429,0.00187903791845339,0.00551906333643321,-0.0089383262209557,0.0126964020578625,0.73351410316351
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00195683991891079,0.00574932621528278,-0.00931183946304345,0.013225519300865,0.733592103614139
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.00195626699138051,0.00581933172856248,-0.013362157179363,0.00944962319660195,0.736750352222308
NMR metabolomics,X23501.Triglycerides in Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00164335797786358,0.00493856090999276,-0.0113229373614494,0.00803622140572224,0.739321487729695
NMR metabolomics,X23501.Triglycerides in Large VLDL,RUVBL1,RuvB-like 1,42346,0.00363709083874464,0.0109331356451481,-0.0177918550257457,0.025066036703235,0.739391143625976
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D2,DCN1-like protein 2,40080,0.00272738493802144,0.00829783422302255,-0.0135363701391028,0.0189911400151456,0.742399086533026
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD2,Bromodomain-containing protein 2,40136,0.0012070836390601,0.00369804012812229,-0.00604107501205958,0.00845524229017978,0.744119114145469
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAND5,DAN domain family member 5,40199,0.00182002035654435,0.00572955282541305,-0.00940990318126522,0.0130499438943539,0.750752774724701
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF75D,Zinc finger protein 75D,40302,0.00201208441706437,0.0063469869857255,-0.0104280100749576,0.0144521789090864,0.751238855184946
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00164239218437299,0.00523717940260382,-0.0086224794447305,0.0119072638134765,0.753828966865787
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00166595326892693,0.00533446293153604,-0.0121215006147376,0.00878959407688371,0.754818420456783
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00104918369055785,0.00343930035707432,-0.00569184500930781,0.00779021239042351,0.760327332792889
NMR metabolomics,X23501.Triglycerides in Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00153713768058266,0.00506031503707668,-0.00838107979208763,0.0114553551532529,0.761314018633043
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPE,Coatomer subunit epsilon,42311,0.00148850448576244,0.00490956776316509,-0.00813424833004114,0.011111257301566,0.761754124964097
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.00152068731676295,0.00503192558085441,-0.00834188682171169,0.0113832614552376,0.762499389151271
NMR metabolomics,X23501.Triglycerides in Large VLDL,POF1B,Protein POF1B,40199,0.00144753050772777,0.00482137519563247,-0.00800236487571188,0.0108974258911674,0.764005965210371
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.000893305634560963,0.00302970185778767,-0.00504491000670286,0.00683152127582479,0.768114524417504
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG2,"Arginase-2, mitochondrial",40451,0.00129519525603576,0.00441809022662367,-0.00736426158814663,0.00995465210021815,0.76940734959641
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00195327228804944,0.00667428443417335,-0.0111283252029303,0.0150348697790292,0.769789380765736
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKZF2,Zinc finger protein Helios,42346,0.00266313441726,0.0091003562822713,-0.0151735638959917,0.0204998327305117,0.769801435381636
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAN,Aggrecan core protein,42488,-0.000837854358785145,0.00286959020177436,-0.0064622511542629,0.0047865424366926,0.770308760047541
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.0016258887362801,0.00556880265509761,-0.0125407419402714,0.00928896446771121,0.770319843774954
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,0.000843529638502884,0.00292655150755259,-0.00489251131630019,0.00657957059330596,0.773173441306996
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAP1,Antigen peptide transporter 1,40302,-0.00182169655680813,0.00637388323138323,-0.0143145076903193,0.010671114576703,0.7750317430091
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB7,Integrin beta-7,42721,0.00132960308334547,0.00476298174302965,-0.00800584113299266,0.0106650472996836,0.780131285287711
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00139909426121294,0.0050691939586135,-0.0113347144200954,0.00853652589766953,0.78255380099459
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRX,Cone-rod homeobox protein,42357,-0.0030098640284703,0.0109921593585363,-0.0245544963712015,0.0185347683142609,0.784227881959578
NMR metabolomics,X23501.Triglycerides in Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00270632206824585,0.00989632710997531,-0.0166904790673058,0.0221031232037975,0.784499179716653
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN1,Transcobalamin-1,40337,-0.000935840223109137,0.00352995953454583,-0.00785456091081896,0.00598288046460069,0.79092686713911
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.000708071342937391,0.00267613057381941,-0.00595328726762342,0.00453714458174864,0.791332057594092
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF1,Trefoil factor 1,42556,0.00226283341993187,0.0085741985947998,-0.0145425958258757,0.0190682626657395,0.791851841685791
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00155005309522725,0.00588996881508051,-0.0130943919727851,0.00999428578233055,0.79242581592067
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.0016959957730477,0.00647366605379103,-0.0143843812384781,0.0109923896923827,0.793338846611841
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBQLN3,Ubiquilin-3,40116,0.00146805327138468,0.00561289551055012,-0.00953322192929356,0.0124693284720629,0.793673266468528
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELL,L-selectin,40539,0.000643510801026527,0.00246417819022199,-0.00418627845180857,0.00547330005386162,0.793984495613008
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00166678415050664,0.00638936976511034,-0.0108563805891096,0.0141899488901229,0.794198095410635
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFRC,Transferrin receptor protein 1,42673,-0.00100650486517618,0.00391055423847352,-0.00867119117258428,0.00665818144223193,0.796888103224589
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.00113234948921599,0.00440193862785098,-0.00749545022137192,0.00976014919980391,0.796998327620827
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.00120239695829981,0.00470268713179979,-0.00801486982002777,0.0104196637366274,0.79819958160362
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVPL,Envoplakin,40302,-0.000915730611909382,0.00364126560980072,-0.00805261120711879,0.00622114998330003,0.801442338794011
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHDC3L,KH domain-containing protein 3,40080,-0.00179070873205939,0.00714658599253618,-0.0157980172774303,0.0122165998133115,0.802152531920236
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,0.00155965180111904,0.00626929083707789,-0.0107281582395536,0.0138474618417917,0.80353760056784
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3A,Uroplakin-3a,40136,0.00130634305283844,0.00528584819878535,-0.00905391941678085,0.0116666055224577,0.80480473015654
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB2,Beta-crystallin B2,40483,-0.00208192307632782,0.0084475480733828,-0.0186391173001581,0.0144752711475025,0.80533610883026
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD1,Glutamate decarboxylase 1,40080,-0.000665253811570368,0.00270989020922121,-0.00597663862164394,0.00464613099850321,0.806080859665978
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00133675876318629,0.00550913591702912,-0.0121346651605634,0.00946114763419077,0.808284988023367
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6,Interleukin-6,42587,0.00187995288629258,0.00794304172551773,-0.0136884088957222,0.0174483146683073,0.812909279954736
NMR metabolomics,X23501.Triglycerides in Large VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00104894871863692,0.00443632268752813,-0.00764624374891822,0.00974414118619205,0.813091368372032
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,0.00144519804850076,0.00628353706897928,-0.0108705346066986,0.0137609307037001,0.818097153012506
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00120320763615888,0.00523435128021376,-0.0090561208730601,0.0114625361453779,0.818198991870616
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL6B,Myosin light chain 6B,40182,0.00215705436403872,0.00942106956908252,-0.016308241991363,0.0206223507194404,0.81890374907929
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.0040367223832361,0.0181109392708489,-0.0314607185876278,0.0395341633540999,0.823626232986023
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX33,Testis-expressed protein 33,40302,-0.000872547085675744,0.00394695589381914,-0.00860858063756126,0.00686348646620978,0.825043265311232
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,-0.000658414943375363,0.00300858915650929,-0.00655524969013358,0.00523841980338285,0.826774130689345
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHC1,SHC-transforming protein 1,40080,-0.00265810570985292,0.0122320606747776,-0.0266329446324169,0.0213167332127111,0.827973601537811
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELENOP,Selenoprotein P,40539,0.000504736124719138,0.00237712280342202,-0.00415442456998802,0.00516389681942629,0.831852868768346
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.00132387105875461,0.00625529003819144,-0.0135842395336098,0.0109364974161006,0.832390937220461
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.00196213227008056,0.00936208475955556,-0.0203118183988095,0.0163875538586483,0.833997156868815
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPA33,Cell surface A33 antigen,42587,0.0030010567444001,0.0143497058273009,-0.0251243666771096,0.0311264801659098,0.834344346140078
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2,Interleukin-2,42370,-0.000640156347252504,0.00332092133842035,-0.00714916217055638,0.00586884947605137,0.847146234960221
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,-0.000955779253954207,0.00499647754786425,-0.0107488752477681,0.00883731673985973,0.848300867724366
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.0015527072666208,0.00813837556978714,-0.014398508850162,0.0175039233834036,0.848694939235559
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGEA3,Melanoma-associated antigen 3,40302,-0.00169451994193321,0.00898171290282587,-0.0192986772314719,0.0159096373476055,0.850360133697787
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00149442434177026,0.00792369520949417,-0.0140360182688383,0.0170248669523788,0.850408206738636
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY6D,Lymphocyte antigen 6D,42548,0.0007839605944924,0.00421787438108166,-0.00748307319242765,0.00905099438141245,0.852552453941648
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL24,Interleukin-24,42370,0.000966292855298004,0.00523155216417726,-0.00928754938648942,0.0112201350970854,0.853463414942476
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL12,Stromal cell-derived factor 1,42370,-0.000754608705119302,0.00415990262525087,-0.00890801785061101,0.00739880044037241,0.856055962199378
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000967653145702677,0.00536539879555078,-0.0114838347849822,0.00954852849357685,0.856880622618969
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.000528710563518563,0.00305676661258563,-0.00546255199714927,0.0065199731241864,0.862682822433527
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA6,Corticosteroid-binding globulin,40539,-0.000270415141350029,0.00162128441405938,-0.00344813259290641,0.00290730231020636,0.867537719161642
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTN,Neuroplastin,42346,-0.0013447008645696,0.00813631549480935,-0.0172918792343959,0.0146024775052567,0.868732849657922
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYT1,Synaptotagmin-1,40483,-0.000723498049086613,0.00438315929132944,-0.00931449026009232,0.00786749416191909,0.868897238097124
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDN1,Endothelin-1,40223,0.000516679953186637,0.00314481202256204,-0.00564715161103497,0.00668051151740824,0.869501161919989
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGR,Progesterone receptor,40199,0.00165907577264042,0.0101105202138974,-0.0181575438465985,0.0214756953918794,0.869660153243185
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCLN,Nicalin,42370,-0.000864330423396787,0.00536650405254075,-0.0113826783663767,0.00965401751958308,0.872048425570172
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC1,Syndecan-1,42636,0.000672119881074974,0.00420060009152634,-0.00756105629831665,0.00890529606046659,0.872879002737201
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON1,Spondin-1,42638,0.000553025439337745,0.00350329046595801,-0.00631342387393996,0.00741947475261545,0.874570387247885
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,-0.000652074674319316,0.00413116593539743,-0.00874915990769828,0.00744501055905965,0.874583564611399
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.000710575981253033,0.00461227056162848,-0.00975062628204486,0.00832947431953879,0.877563630836781
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.000527950754259663,0.00346359969704906,-0.0062607046519565,0.00731660616047583,0.878851441926282
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00033973256809231,0.0022629984673708,-0.00409574442795445,0.00477520956413907,0.880668268875815
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.000579976073303924,0.0038952504352638,-0.00705471477981312,0.00821466692642097,0.881640660854473
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.000638914272058886,0.00435088325871265,-0.00916664545913568,0.00788881691501791,0.883255458747741
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.00104012420910381,0.00729374713701779,-0.0153358685976587,0.013255620179451,0.886604362709444
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEBP1,Heme-binding protein 1,42357,0.000752957503545194,0.00545392027815735,-0.00993672624164322,0.0114426412487336,0.890196664980804
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.000551745036973089,0.00403643935934717,-0.00846316618129355,0.00735967610734737,0.891277550970717
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.000995164381335134,0.00741516108105991,-0.0135385513375423,0.0155288801002126,0.893241591991933
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP4,Caspase-4,40302,0.00235212626004227,0.0178697512316451,-0.0326725861539822,0.0373768386740667,0.895282397728427
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF174,Zinc finger protein 174,40199,-0.000503092832395319,0.00386981048763062,-0.00808792138815133,0.00708173572336069,0.896565231239337
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,-0.000522688590108161,0.00408012225582053,-0.0085197282115164,0.00747435103130007,0.898067293752072
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000497349407257879,0.00390417348559829,-0.00814952943903053,0.00715483062451477,0.89863473521136
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,-0.000721572564375625,0.00599568771135457,-0.0124731204786306,0.0110299753498793,0.904209235238371
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCIN,Adseverin,40136,0.000904497634895912,0.00754088077878681,-0.0138756286915262,0.0156846239613181,0.90452821628872
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGA,Fibrinogen alpha chain,40284,0.000376625131731305,0.00319593184287796,-0.0058874012803095,0.00664065154377211,0.906192472469617
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNIP4,Kv channel-interacting protein 4,42311,-0.000594713949839704,0.00510426801189238,-0.0105990792531488,0.00940965135346937,0.907247709870829
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.000804033767912824,0.00693465339130742,-0.0143959544148754,0.0127878868790497,0.907698755173254
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.000944177792835954,0.00816371042403024,-0.0169450502239352,0.0150566946382633,0.907927709960149
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOS,Proto-oncogene c-Fos,40065,-0.000423367456376904,0.00369974441523849,-0.00767486651024434,0.00682813159749053,0.908897825039114
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,-0.000441231540740703,0.00388845954047177,-0.00806261224006537,0.00718014915858397,0.909658002191406
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYMP,Thymidine phosphorylase,42563,0.000754161545385021,0.00670437227789605,-0.0123864081192912,0.0138947312100613,0.910438159050042
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000395868530642856,0.00358148566002123,-0.00741558042428446,0.00662384336299875,0.911989564252935
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF12,Fibroblast growth factor 12,40199,-0.000523965816813282,0.00484016542076475,-0.0100106900415122,0.00896275840788563,0.913796422050016
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXOSC10,Exosome component 10,40116,-0.000671736039060116,0.00624895926966189,-0.0129196962075974,0.0115762241294772,0.914397737802821
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRNN,Cornulin,42209,0.00075195114943244,0.0071545879250286,-0.0132710411836236,0.0147749434824885,0.916297639885218
NMR metabolomics,X23501.Triglycerides in Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00118668197806086,0.0114051210492023,-0.0211673552783756,0.0235407192344973,0.917133031999571
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.000309219250796532,0.00303096039187971,-0.0056314631172877,0.00624990161888076,0.918742148085897
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSB,Lupus La protein,42311,0.000607439907424431,0.00602750527247734,-0.0112064704266311,0.01242135024148,0.919728234109746
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBQ1,Hemoglobin subunit theta-1,42721,0.000626372342000387,0.00622850550013949,-0.011581498438273,0.0128342431222738,0.91989692974863
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXK,Tyrosine-protein kinase TXK,40302,0.000779388688781744,0.00776222406308638,-0.0144345704748676,0.0159933478524311,0.920022302949382
NMR metabolomics,X23501.Triglycerides in Large VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00103732890782533,0.0105889183472759,-0.0197169510528355,0.0217916088684861,0.921962941395469
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLMP,CXADR-like membrane protein,42721,-0.000220540251483205,0.00226983478973692,-0.00466941643936757,0.00422833593640116,0.922599686809109
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.000410992122224845,0.00438883695309367,-0.00819112830583875,0.00901311255028844,0.925392959636875
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESPL1,Separin,40080,0.000552491625483529,0.00595587020580352,-0.0111210139778914,0.0122259972288584,0.926092587543239
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.000440638450703418,0.00495945822937833,-0.0092798996788781,0.0101611765802849,0.929203956703375
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.000446599904261398,0.00504375989682739,-0.0103323693020431,0.00943916949352029,0.929444814111819
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD86,T-lymphocyte activation antigen CD86,40449,-0.000272627060629558,0.0031381781315785,-0.00642345619852341,0.0058782020772643,0.930772965172888
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNB2,Ephrin-B2,40182,0.000465828849620836,0.00565124126438575,-0.0106106040285752,0.0115422617278169,0.934306699691078
NMR metabolomics,X23501.Triglycerides in Large VLDL,HK2,Hexokinase-2,42357,0.000225334213015977,0.00285384226726924,-0.00536819663083172,0.00581886505686368,0.937067080902386
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.000218644277073261,0.00281282608400643,-0.00529449484757933,0.00573178340172585,0.938043266553659
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.000456454069880921,0.00592906573153295,-0.0120774229036855,0.0111645147639237,0.938636224533704
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53BP1,TP53-binding protein 1,40199,0.000679543133315813,0.00897311160169448,-0.0169077556060054,0.018266841872637,0.939634451822438
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.000219343239052221,0.00293678610279428,-0.005975444000529,0.00553675752242456,0.940464161779945
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.000378066317114301,0.00531593823574968,-0.0107973052591837,0.0100411726249551,0.943304066648065
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN4,Prefoldin subunit 4,40080,0.000378465408649068,0.00543710114202843,-0.0102782528297267,0.0110351836470248,0.944506995809003
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.000315106644591981,0.00463204777757415,-0.00876370699945336,0.00939392028863732,0.945764945554574
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,0.000258933339713218,0.00392038323889362,-0.00742501780851827,0.0079428844879447,0.94734084613728
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,0.00024367247939405,0.00380594037281987,-0.0072159706513329,0.007703315610121,0.948952092940641
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNLZ,DNL-type zinc finger protein,40136,-0.000599013149436958,0.00941428288302732,-0.0190510076001705,0.0178529813012966,0.949267500435394
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A16,Protein S100-A16,42292,-0.000396078612415333,0.00628472625901747,-0.0127141420800896,0.0119219848552589,0.949749618656404
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM132A,Transmembrane protein 132A,40223,0.000406921321944517,0.00647922685201478,-0.0122923633080045,0.0131062059518935,0.949923723789556
NMR metabolomics,X23501.Triglycerides in Large VLDL,NINJ1,Ninjurin-1,42346,-0.000345127579959248,0.00558284279858825,-0.0112874994651922,0.0105972443052737,0.950707652225363
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN15,Tetraspanin-15,40116,0.000322627353743288,0.00539181833885313,-0.0102453365904089,0.0108905912978954,0.952286976818357
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF830,Zinc finger protein 830,40451,-0.000440817219831401,0.00801838027989695,-0.0161568425684294,0.0152752081287666,0.956158684347458
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD33,Myeloid cell surface antigen CD33,42679,-0.000427156964500028,0.0082846645882224,-0.0166650995574159,0.0158107856284159,0.958880088842258
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN1,Cerebellin-1,40136,0.00046460640740329,0.00981367510204905,-0.0187701967926128,0.0196994096074194,0.9622409174101
NMR metabolomics,X23501.Triglycerides in Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000207203145308026,0.00454069452857902,-0.0091069644213229,0.00869255813070684,0.963604002337263
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,0.000700411021538477,0.0153645457209416,-0.0294140985915071,0.0308149206345841,0.963640889357275
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFD,Complement factor D,40539,9.77865456496235e-05,0.00216538489917556,-0.00414636785673448,0.00434194094803373,0.963981395086205
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.000308676352520165,0.00683799367681702,-0.0130937912540412,0.0137111439590815,0.96399530536246
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171A2,Protein FAM171A2,40482,0.000631992225984245,0.0165441108819269,-0.0317944651025924,0.0330584495545609,0.969528549906218
NMR metabolomics,X23501.Triglycerides in Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.000241991082431223,0.0072329874516458,-0.014418646487657,0.0139346643227945,0.97331109541463
NMR metabolomics,X23501.Triglycerides in Large VLDL,BEX3,Protein BEX3,40080,0.000164507782310149,0.00495012336225677,-0.00953773400771312,0.00986674957233341,0.97348933815205
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.00021403082411077,0.00651029231283155,-0.0129742037572606,0.0125461421090391,0.973774251716805
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.000199898616970634,0.00634700912854289,-0.0122402392749734,0.0126400365089147,0.974875406335808
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.000125515140136687,0.00423445339894128,-0.00817401352178821,0.00842504380206159,0.976353495856231
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,-8.9206801205693e-05,0.00317104798961111,-0.00630446086084346,0.00612604725843207,0.977557669439019
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLGAP5,Disks large-associated protein 5,40482,0.000144705351864287,0.00525619414381929,-0.0101574351700215,0.0104468458737501,0.978037145927185
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.000271519590292954,0.00996858242518684,-0.0198099411436592,0.0192669019630732,0.978270779265386
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10,Interleukin-10,42370,-0.000197616928119577,0.00879155810483785,-0.0174290708136018,0.0170338369573626,0.982066975537597
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,7.71264225001352e-05,0.00360026785770981,-0.0069793985786111,0.00713365142361137,0.982909013141473
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGM2,Phosphoglucomutase-2,40182,-0.000108139780096444,0.00619287746637289,-0.0122461796141873,0.0120299000539944,0.986068396587287
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,5.62979997902944e-05,0.00329241348051367,-0.0063968324220165,0.00650942842159709,0.98635764382773
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTH3,Cytohesin-3,40080,-8.5980303481869e-05,0.0077338384590708,-0.0152443036832606,0.0150723430762969,0.991129971443605
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,5.37060278410554e-05,0.00575248823163306,-0.0112211709061598,0.0113285829618419,0.992551118387811
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLLT1,Protein ENL,40080,4.36354782066851e-05,0.00687365195446541,-0.0134287223525455,0.0135159933089589,0.994935000901837
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,1.33332670591397e-05,0.00406358760017317,-0.00795129842928028,0.00797796496339856,0.997382070220137
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,1.5021404951544e-06,0.00310668700497279,-0.00608760438925151,0.00609060867024182,0.999614215294802
